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Function of a psoriasis predisposition SNP: TNFAIP3 rs610604 SNP regulates IKKα binding 
to chromatin and sensitivity to TNFα
F Moretti,2 F Fausti,2 E Botti,1 A Narcisi,1 G Spallone,2 B Marinari2 and A Costanzo1 1 
University of Rome “La Sapienza”, Rome, Italy and 2 University of Rome “Tor Vergata”, 
Rome, Italy
So far 36 genomic loci for psoriasis predisposition have been identified, most located within or in 
proximity to innate and adaptive response regulating genes. Psoriatic keratinocytes are hypersensi-
tive to inflammatory stimuli. On this scenario, treatment with TNFα enables the activation of IKKα, 
which induces the nuclear translocation of NFkB transcription factors, while its nuclear fraction 
is necessary for definite exit of keratinocytes from the cell cycle and termination of NFkB-depen-
dent transcription of inflammatory genes. We found dowregulation of IKKα in psopriatic plaques, 
correlating with increased NFkB activation. ChIP-seq experiment performed on primary keratino-
cytes identified inflammatory genes involved in psoriasis pathogenesis as directly bound by IKKα. 
Moreover, siRNA mediated IKKα knock-out keratinocytes showed induction in IL6 gene expression, 
upon TNFα stimulation, while treatment of patients with TNFα blocking reagent etanercept induces 
re-expression of IKKα in keratinocyte nuclei, correlating with decreased NFkB activation. Prelimi-
nary results by ChIP-seq analysis of differentiating keratinocytes indicate that IKKα translocates to 
the nucleus to bind chromatin in intron 3 of the TNFAIP3 gene on the exact region where a psoriasis 
predisposition SNP (rs610604) is located. TNFAIP3 is rapidly activated by TNFα and encodes for a 
ubiquitin-editing enzyme that favours inhibition of NFkB activation and TNFα-induced apoptosis. 
We observed that TNFα failed to induce TNFAIP3 gene activation in IKKα-depleted keratinocytes 
and the TNFα stimulation caused preferential binding of IKKα on the G allele of rs610604 that has 
been described to favour a good response to all TNFα blockers and etanercept. These data suggest 
that IKKα molecule contributes to keratinocyte sensitivity to inflammatory stimuli in psoriasis.   
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Epidermal Protease-activated receptor-2 (PAR2) overexpression causes spontaneous atopic 
dermatitis-like skin disease: Neuro-Epidermal Communication
T Buhl,1 A Ikoma,2 F Cevikbas,2 C Kempkes,2 M Sulk,2 T Akiyama,3 E Carstens,3 P Elias,2 
M Steinhoff5 and S Coughlin4 1 Dermatology, UMG, Göttingen, Germany, 2 Dermatology, 
UCSF, San Francisco, CA, 3 Center for Neuroscience, UCD, Davis, CA, 4 Cardiovascular 
Research Institute, UCSF, San Francisco, CA and 5 Charles Institute for Translational 
Dermatology, UCD, Dublin, Ireland
Protease-activated receptor-2 (PAR2) activation has been implicated in the pathophysiology of atopic 
dermatitis, Netherton syndrome, pruritus, as well as impaired skin barrier regulation. With the aim to 
study the effects of epidermal PAR-2 function on skin inflammation and itch, we generated a mouse 
that overexpresses PAR2 in keratinocytes only (KC-PAR2OE). Although KC-PAR2OE newborns dis-
play no overt abnormalities, they spontaneously develop dry skin, severe pruritus, and subsequently 
eczematous skin lesions after several weeks. Analysis of barrier function and immune response in 
lesional KC-PAR2OE mice revealed the hallmarks of atopic dermatitis-like skin lesions including 
parakeratosis, downregulation of filaggrin and other epidermal structure proteins, a mast cell- and 
macrophage-driven inflammatory infiltrate. Of note, and in close correlation to patients with atopic 
dermatitis, repeated topical application of house dust mite allergens onto KC-PAR2OE mice induced 
earlier and more severe lesions and pruritus in these mice (as determined by increased skin lesion 
score, scratching bouts, TEWL, total IgE). Our electrophysiological, morphological and molecular 
studies show that KC-PAR2OE mice have an increased density of nerve fibers, increased NGF and 
endothelin expression levels in the skin, which may explain our findings of higher susceptibility of 
KC-PAR2OE mice to pruritogens and the development of spontaneously increased pruritus. In sum, 
our results suggest that certain proteases and KC-PAR2 are critically involved in the pathophysiology 
of pruritus and atopic dermatitis. KC-derived PAR2 seems to be an important link in neuro-epidermal 
communication with the keratinocyte-protease-PAR2 system as a forefront of sensory signaling and 
neuro-immune communication in inflammatory skin diseases.    
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Genome-wide comparative analysis of atopic dermatitis and psoriasis gives insight into shared 
and opposing genetic risk mechanisms 
H Baurecht,2 M Hotze,2 JT Elder,3 S Weidinger,2 HJ Cordell4 and SJ Brown1 1 Dermatology 
& Genetic Medicine, University of Dundee, Dundee, United Kingdom, 2 Dermatology, 
Allergology and Venerology, University Hospital Schleswig-Holstein, Kiel, Germany, 3 
Dermatology, University of Michigan, Ann Arbor, MI and 4 Institute of Genetic Medicine, 
Newcastle University, Newcastle upon Tyne, United Kingdom
HB & MH, SW, HJC & SJB contributed equally This study used genome-wide analysis data from the 
Wellcome Trust Case-Control Consortium and 17 additional co-authors who will be listed in the 
presentation. Atopic dermatitis (AD) and psoriasis are common chronic inflammatory skin diseases 
with strong heritability. Genome-wide studies have identified shared risk loci at chromosomes 
1q21.3, and 5q31.1 but AD and psoriasis rarely co-occur within the same patient, indicating 
mutually exclusive pathogenic and immunological features. Shared risk loci for AD and psoriasis 
may represent overlapping pathophysiological mechanisms whilst opposing effects may indicate 
determinants of disease-specific susceptibility. We have used GWAS and ImmunoChip data from 
cohorts comprising >19,000 individuals to systematically compare and contrast AD and psoriasis on 
a genome-wide level, using methodologies adapted from meta-analysis. This approach has identified 
risk variants with opposing effects on AD and psoriasis in the epidermal differentiation complex 
on chromosome 1q21.3, the cytokine cluster on 5q31.1, the major histocompatibility complex 
on chromosome 6p21.32 and elsewhere in the genome. Our analyses demonstrate an opposing 
effect locus at RAD50, suggesting that DNA repair may play a role in controlling the differential 
Th2 response in AD and psoriasis. We have identified a previously unreported association within 
PRKRA showing opposing effects in each disease and a new risk variant for AD with an opposing 
effect on psoriasis in ANXA6. In contrast, there were no shared susceptibility loci with genome-
wide significance. This statistical approach has shown strength to provide new insight into genetic 
variation leading to distinct but related complex traits.    
004
Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis 
and eczema
NV Garzorz,1 M Quaranta,2 B Knapp,3 M Mattii,2 C Andres,1 F Theis,3 J Ring,1 C Schmidt-
Weber,2 S Eyerich2 and K Eyerich1 1 Department of Dermatology and Allergy, Technische 
Universität Munich, Munich, Germany, 2 ZAUM – Center of Allergy and Environment, 
Technische Universität and Helmholtz Center Munich, Munich, Germany and 3 Institute of 
Computational Biology, Helmholtz Center Munich, Neuherberg, Germany
Psoriasis and eczema are prevalent inflammatory skin diseases with high individual disease-burden 
and major socio-economic impact. Previous attempts to gain insight into their pathogenesis by 
using transcriptomic approaches were hampered by the high inter-individual variability of those 
complex diseases. In patients affected by both psoriasis and non-atopic or atopic eczema simulta-
neously (n=24), we compared the molecular signature of psoriasis and eczema by performing whole 
genome expression analysis of lesional as compared to autologous non-involved skin. Genes as 
well as signaling pathways regulated in common and exclusive for each disease across all patients 
were identified. Psoriasis-specific genes were crucial regulators of glucose and lipid metabolism, 
epidermal differentiation as well as immune mediators of Th17 responses, IL-10 family cytokines, 
and IL-36. In eczema, genes related to epidermal barrier, reduced innate immunity, increased IL-6 
and a Th2 signature. Deeper analysis within eczema subtypes unrevealed a mutually exclusive 
regulation of epidermal differentiation. Besides, only contact eczema was driven by inflammasome 
activation, apoptosis and cellular adhesion. Based on this comprehensive picture of the pathogenesis 
of psoriasis and eczema, a disease classifier at the level of RT-PCR consisting of NOS2 and CCL27 
was created. In an independent cohort of eczema (n=28) and psoriasis patients (n=25), respectively, 
this classifier diagnosed all patients correctly and also identified initially misdiagnosed or clinically 
undifferentiated patients. Since therapeutic strategies for psoriasis and eczema are distinct and 
sometimes opposing, this diagnostic tool could help to set the correct diagnosis in special cases.   
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A humanized NOG mouse model for atopic dermatitis
BC Poulsen,1 B Dyring-Andersen,2 L Skov,2 B Aasted,1 K Thestrup-Pedersen,2 K Skak3 and 
L Poulsen2 1 Veterinary Disease Biology, Faculty of Health and Medical Sciences, University 
of Copenhagen, Copenhagen, Denmark, 2 Dermato-Allergology, Copenhagen University 
Hospital Gentofte, Copenhagen, Denmark and 3 Skin Research, LEO Pharma, Ballerup, 
Denmark
The aim of this project is to establish a humanized mouse model for atopic dermatitis (AD). Previous 
studies have shown that human AD derived T cells injected s.c. into NOD.Cg-Prkdcscid Il2rgtm1Sug/
JicTac (NOG) mice disappear from the skin within a few days. Concurrent injections of human IL-2 
and IL-4 might prolong residence of the human cells in murine skin and promote development of 
a clinical phenotype. Human skin derived T cells from lesional skin of AD patients were cultured 
in media containing IL-2 and IL-4. NOG mice (n=60) were injected either i.v. or s.c. with human 
T cells from one of two donors or saline, followed by s.c. injections day 2, 4, 6, 8, and 10 with 
human IL-2 and IL-4 ± human chemokines (mix of CCL5/RANTES, CCL17/TARC, CCL27/CTACK) 
or saline. Mice were euthanized at day 1, 3, 6, and 10. At day 1, a clinical phenotype was visible 
as redness and oedema in 16/24 mice injected s.c. and in 0/24 mice injected i.v. with human 
T cells. At day 6, only faint redness was observed, and no symptoms were observed at day 10. 
Immunohistochemistry confirmed the presence of human T cells in the dermis of mice injected s.c., 
whereas human T cells were not detected in skin biopsies from i.v. injected mice at any time point, 
regardless of s.c. injections with IL-2 and IL-4 ± human chemokines. Thus, s.c. injection of human 
AD derived T cells can induce a clinical phenotype in NOG mice, which might be prolonged by 
more frequent s.c. injections of IL-2 and IL-4.    
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GATA3 is involved in the setup of a functional epidermal barrier and affects the expression 
of differentiation markers and inflammatory cytokines in human keratinocytes
J Zeitvogel, N Jokmin, R Murshidi and T Werfel Division for Immunodermatology and Allergy 
Research, Clinic for Dermatology, Allergy and Venereology, Hannover Medical School, 
Hannover, Germany
GATA3 is an important transcription factor and its role for the differentiation and maintenance of 
the Th2 cell subtype of lymphocytes has been already well described. However, GATA3 is not 
exclusively expressed by T cells but also amongst others by keratinocytes. In contrast to T cells the 
role of GATA3 in keratinocytes is still be poorly explored, especially in regard to inflammatory skin 
diseases like atopic dermatitis and psoriasis. Thus, it was the aim of this study to investigate the role 
of GATA3 in keratinocytes under different inflammatory conditions. For this purpose we silenced 
GATA3 in human primary keratinocytes by lentiviral transduction and performed microarray and 
qRT-PCR. Microarray data indicated that GATA3 is involved in the regulation of several genes 
important for the epidermal barrier like involucrin, loricrin and filaggrin. The silencing of GATA3 
led to a down regulation of these molecules. Furthermore we found an impact on the expression 
of inflammatory cytokines like IL-6 and TNFα. Here GATA3 silenced keratinocytes showed an 
increased expression. Analysis by qRT-PCR confirmed these findings. Of importance, we could 
detect that the effects of GATA3 were dependent on the current micro milieu. The tendency to 
show a reduced filaggrin expression was only detectable in GATA3 silenced keratinocytes that were 
treated with IL-4/IL-13, whereas the effect on involucrin expression was only present under basal 
conditions. In contrast loricrin expression was found to be decreased under all tested conditions in 
GATA3 silenced keratinocytes as compared to controls. Our results demonstrate that GATA3 seems 
to be involved in the signal transduction during inflammatory conditions in the skin and that the 
modulation of its expression affects a broad range of different molecules which are of importance 
for the balance of an intact immunity in the skin.    
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IgA, IgG1 and IgG4 harbor clonally distinct desmoglein 3 autoreactive repertoires in pem-
phigus vulgaris 
CT Ellebrecht, EM Mukherjee, EJ Choi and AS Payne Dermatology, University of Pennsylvania, 
Philadelphia, PA
Pemphigus vulgaris (PV) is a potentially fatal autoimmune disease of the skin and mucous mem-
branes characterized by autoantibodies (autoAbs) to desmoglein (Dsg) 3. During active disease, 
the majority of PV autoAbs belong to the IgG4 and less so the IgG1 subclass. However, >50% of 
patients have serum anti-Dsg3 IgA, the role of which in PV has not been characterized. To better 
understand the clonal relationships among isotype-specific autoreactive B cells in PV, we cloned 
anti-Dsg3 IgA1, IgA2, IgG1, and IgG4 repertoires from a mucocutaneously affected PV patient by 
antibody phage display. We screened >8x108 combinatorial B cell clones per antibody subclass 
and characterized 55, 20, 40 and 88 clones from the IgA1, IgA2, IgG1, and IgG4 libraries after Dsg3 
selection, which identified 17, 5, 15, and 29 unique anti-Dsg3 heavy chain sequences comprising 
5, 4, 4, and 7 CDR3 clonal families, respectively. One clonal family was shared between IgA1 
and IgA2. None were shared between IgA1/2, IgG1 and IgG4. Also, by CDR3-specific RT-PCR, 
we found no evidence of the IgA clones in the IgG4 repertoire. No anti-Dsg3 IgA were found in an 
unaffected individual. Interestingly, an expanded IgA1 family was identified that used the VH3-15 
gene segment, the predominant VH gene used in the natural and vaccine induced response to 
Haemophilus influenzae type B capsular polysaccharide (HIB PRP). The VH3-15 anti-Dsg3 mAb 
specifically crossreacted to HIB PRP, but not other self-antigens such as RNA polymerase II or BP180 
glycoprotein. This crossreactivity was encoded by the heavy chain and was lost after reversion of 
somatic mutations to the germline VDJ sequence. Additionally, a VH3-15 anti-HIB PRP IgA1 clone 
isolated by heterohybridoma from an adult after HIB infection showed crossreactivity with Dsg3 by 
ELISA and immunofluorescence. In summary,we find that anti-Dsg3 IgA, IgG1 and IgG4 repertoires 
in PV are clonally unrelated and that anti-Dsg3 IgA can harbor pathogen cross-reactivity. Our results 
suggest independent evolution of anti-Dsg3 isotype-specific B cell lineages in PV.    
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Tolerance break by immunoglobulin class switch recombination induces pemphigus vulgaris 
in mice
N Wada,1 H Fujii,2 T Ishikura,3 H Koseki,3 M Amagai1 and S Koyasu4 1 Department 
of Dermatology, Keio University School of Medicine, Tokyo, Japan, 2 Department of 
Immunology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan, 
3 Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences, 
Yokohama, Japan and 4 Laboratory for Immune Cell System, RIKEN Center for Integrative 
Medical Sciences, Yokohama, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease induced by IgG autoantibodies against 
desmoglein 3 (Dsg3). We previously isolated a pathogenic mouse monoclonal antibody against 
Dsg3, AK23 IgG1, which is able to induce blisters by binding to the adhesive interface of Dsg3. In 
this study we generated a knock-in mouse expressing AK23 immunoglobulin which can undergo 
class switch recombination and analyzed the fate of the Dsg3-specific B cells and the mechanisms of 
the disease onset. Although Dsg3-reactive knock-in B cells producing AK23 IgM in the serum were 
detected in the peripheral lymphoid organs, the mice neither produced AK23 IgG1 nor developed 
PV phenotype spontaneously under normal conditions up to 40 weeks. No in vivo binding of IgM 
on keratinocytes suggested that IgM was too large in size to bind Dsg3 in the core of desmosomes. 
IL-4 and LPS induced the class-switch from IgM to IgG1 in vitro, and the class-switched B cells 
were able to induce PV phenotype when adoptively transferred to Rag2-/- mice. The immunization 
of AK23 knock-in mice with recombinant Dsg3 in complete Freund’s adjuvant induced the IgG1 
class switch in vivo with the development of PV phenotype. Furthermore, the presence of contact 
dermatitis to 1-fluoro-2,4-dinitrobenzene also induced the class switch and PV phenotype. These 
observations indicate that Dsg3-reactive IgM+ B cells can escape central tolerance mechanism and 
enter the periphery but do not exert pathogenicity until class-switching is induced. These findings 
suggested that the class-switching of self-reactive antibodies is one of the important checkpoints 
in the development of PV.    
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Screen and Identification of HLA-A*0201 Restricted CTL Epitope in Chinese Han Vitiligo 
Patients
Y Yang, F Zhou, C Li, T Gao and G Wang Department of Dermatology, Xijing Hospital, 
Xi’an, China
Vitiligo is a common depigmentation disorder resulted from the destruction of epidermal melano-
cytes by cytotoxic T lymphocytes (CTL). The identification of melanocyte-specific CTL epitopes is 
of great importance for understanding the pathogenesis and treatment of this disease. The aim of 
this study is to screen and identify the melanocyte-specific CTL epitopes of HLA-A*0201 Chinese 
Han vitiligo patients. PBMC samples were separated from 278 progressive vitiligo patients. HLA 
typing was performed to identify the HLA*0201 genetic candidates. We then synthesized melano-
cyte-specific T cell epitopes according to the predicting results of BIMAS and SYFPEITHI. Using 
ELISPOT, we identified the specific synthetic peptides from the selected synthetic peptides pools 
by HLA*0201 PBMCs. A transgenic human HLA-A*0201 mouse model was employed to confirm 
the immune effects of such identified melanocyte- specific epitopes. Six new positive melanocyte- 
specific peptides in HLA-A*0201 Chinese Han vitiligo patients were identified, including Gp100 
P-112 QILKGGSGT, tyrosinase P-41 AMVGAVLTA, Gp100 P-118 QLIMPGQEA, tyrosinase P-24 
SSADVEFCL, tyrosinase P-28 TLEGFASPL and Gp100 P-119 TLEGFASPL. After subcutaneous and 
intraperitoneal injection with selected positive peptides, the spleens and lymph nodes of HLA*0201 
transgenic mice model were enlarged. Moreover, the number of CD8+ T lymphocytes in mice 
spleens and lymph node increased though in a moderate degree. In conclusion, our experiments 
identified 6 new auto-antigenic peptides in Chinese Han HLA-A*0201 vitiligo patients. We found 
that synthesized melanocyte- specific peptides can cause T cell proliferation and activation. Further 
studies are needed to confirm the downstream effects by CD8+ T lymphocytes using the synthesized 
melanocyte- specific peptides in HLA*0201 transgenic mice. Such observations may contribute to 
the understanding of the pathogenesis of vitiligo and provide potential targets for new treatments.   
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Genetic markers predictive for the outcome of anti-interleukin-12/23 therapy in psoriasis 
A Boca,2 M Talamonti,1 M Galluzzo,1 E Botti1 and A Costanzo1 1 Dermatology, Tor Vergata 
University of Rome, Rome, Italy and 2 Pharmacology, Toxicology and Clinical Pharmacology, 
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
Recent studies agree on the need for pharmacogenetic data predictive for the outcome of the vari-
ous therapeutic approaches in psoriasis. Following this direction, we sought to assess the potential 
of genetic variants of interleukin (IL) genes in predicting the outcome of anti-IL-12/23 therapy in 
psoriasis. In this study we included 64 psoriasis patients. All were put on an anti-IL-12/23 therapy 
due to failure of at least two conventional systemic therapies, or anti-tumor necrosis factor agents. 
We genotyped all patients for SNPs present in genes encoding for IL6 by restriction fragment length 
polymorphism PCR, for p40 and for IL23R using real-time PCR and for HLACw6 by allele specific 
PCR. All data was statistically assessed using SPSS. The response to therapy was evaluated using 
the PASI, which we recorded at baseline and weeks 4, 12, 28 and 40. The primary endpoint was 
considered reaching PASI 75. Results showed that a significantly higher percentage of HLACw6 
carriers (p=0.004-0.005) reached the primary endpoint at the various intervals assessed, Statisti-
cal significance was present also for p40 SNP (p=0.002-0.004). Correlating IL6 and IL23R to the 
treatment outcome did not meet statistical significance. Such pharmacogenetic markers could be 
integrated in the daily therapeutic management of psoriasis.    
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Laser capture microdissection followed by next-generation sequencing identifies disease-re-
lated microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis
MB Løvendorf,1 H Mitsui,2 JR Zibert,1 M Røpke,1 M Hafner,3 B Dyring-Andersen,4 
C Bonefeld,5 JG Krueger2 and L Skov4 1 LEO Pharma A/S, Ballerup, Denmark, 2 The 
Rockefeller University, The Laboratory for Investigative Dermatology, New York, NY, 3 The 
Rockefeller University, Howard Hughes Medical Institute, Laboratory of RNA Molecular 
Biology, New York, NY, 4 Gentofte Hospital, Department of Dermato-Allergology, Hellerup, 
Denmark and 5 University of Copenhagen, Department of International Health, Immunology 
and Microbiology, Copenhagen, Denmark
Psoriasis is a systemic disease with cutaneous manifestations. MicroRNAs (miRNAs) are small 
non-coding RNA molecules that are differentially expressed in psoriatic skin, however, only few 
miRNAs have been localized to specific cells or regions of psoriatic lesions. Using laser capture 
microdissection (LCM) and next-generation sequencing (NGS) we aimed to investigate the specific 
miRNA expression profiles in the epidermis (Epi) and dermal inflammatory aggregates (RD) of 
psoriatic skin (N=6). We identified 24 deregulated miRNAs in the Epi and 37 deregulated miRNAs 
in the RD of lesional psoriatic skin compared with non-lesional psoriatic skin (FCH>2, FDR<0.05). 
Among the identified miRNAs several have not previously been described in psoriatic skin. Inter-
estingly, 9 of the 37 miRNAs in RD, including miR-193b and miR-223 were recently described as 
deregulated in circulating peripheral blood mononuclear cells (PBMCs) from patients with psoriasis. 
Using flow cytometry and qRT-PCR, we found that miR-193b and miR-223 were expressed in Th17 
cells. In conclusion, we demonstrate that LCM combined with NGS provides a robust approach to 
explore the global miRNA expression in the epidermal and dermal compartments of psoriatic skin. 
Furthermore, our results indicate that the altered local miRNA changes seen in the RD are reflected 
in the circulating immune cells, suggesting that miRNAs may contribute to a systemic component 
in the pathogenesis of psoriasis.    
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PGD2-DP signaling facilitates the development of imiquimod-induced mouse psoriasis-like 
dermatitis by promoting IL-23p19 production by dendritic cells
T Honda, T Fujita, Y Miyachi and K Kabashima Kyoto University, Kyoto, Japan
Psoriasis is a common chronic inflammatory skin disorder characterized by epidermal hyperplasia. 
Although it has been revealed that cytokines such as IL-23, TNF-alpha and IL-17 play pivotal roles 
in its development, the role of lipid mediators in its pathogenesis remains unclear. Prostaglandin D2 
(PGD2) is a lipid mediator and exerts various physiological effects through two G protein-coupled 
receptor receptors, DP and CRTH2. Although the role of PGD2-DP signaling in allergic disease such 
as asthma or atopic dermatitis have been well studied, the role of DP signaling in the development 
of psoriasis remains unclear. In this study, we examined the role of PGD2-DP signaling in psoriasis 
using imiquimod-induced mouse psoriasis-like dermatitis. Firstly, we observed that the mRNA 
expression of H-PGDS, a PGD2 synthase, was up-regulated in the skin of psoriasis-like dermatitis. 
Mice lacking DP exhibited significantly reduced epidermal hyperplasia and dermal edema in skin 
than did WT mice. The cytokine mRNA expressions such as IL-23p19 and IL-17 in skin of DP 
deficient mice were significantly lower than those of WT mice. Immuno-histochemical analysis 
revealed DP was strongly expressed on dermal DCs. Stimulation of DP on bone-marrow derived DCs 
increased IL-23p19 mRNA expression in a cyclic AMP dependent manner. These results indicate 
that PGD2-DP signaling facilitates the development of mouse psoriasis-like dermatitis via inducing 
IL-23p19 production by dermal DCs, suggesting its involvement in the pathogenesis of psoriasis.   
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Blockade of Syk Ameliorates the Development of Sclerodermatous Chronic Graft-Versus-
Host Disease. 
T Matsushita,1 D Le Huu,4 H Kimura,1 M Date,1 Y Hamaguchi,1 M Hasegawa,2 M Fujimoto3 
and K Takehara1 1 Dermatology, Kanazawa University, Kanazawa, Japan, 2 Fukui University, 
Yoshidagun, Japan, 3 Tsukuba University, Tsukuba, Japan and 4 Hanoi Medical University, 
Hanoi, Viet Nam
Murine sclerodermatous chronic graft-versus-host disease (Scl-cGVHD) is a model for human Scl-
cGVHD and systemic sclerosis (SSc). Syk is a protein tyrosine kinase that has an important role in 
transmitting signals from a variety of cell surface receptors, and is expressed in most of hematopoietic 
cells, fibroblasts, and endothelial cells. This study aims to investigate the effect of a Syk inhibitor, 
R788, on Scl-cGVHD. R788 was orally administered twice a day to allogeneic recipients from day 
14 to day 42 after bone marrow transplantation (BMT). The proliferation of GVHD-derived CD4+ T 
cells and CD11b+ cells were analyzed by R406 in vitro. Allogeneic BMT increased Syk phosphory-
lation in T, B, and CD11b+ cells. The administration of R788 attenuated severity and fibrosis of Scl-
cGVHD. The elevated expressions of CXCR4 on T cells, B cells, and CD11b+ cells were significantly 
down-regulated by R788 treatment. R788 reduced memory CD4+ T cells (CD44hiCD62L-CD4+). 
R406 inhibited proliferation of GVHD CD4+ T cells and CD11b+ cells in vitro. In addition, R788 
treatment inhibited proliferation of CD11b+ cells in Scl-cGVHD mice. R788 treatment also reduced 
skin mRNA expressions of MCP-1, MIP-1a, IFN-g, IL-13, IL-17A, and TGF-b1, but not influenced 
RANTES, CXCL12, and TFN-a. Blockade of Syk suppressed migration factor of immune cells and 
antigen-specific memory CD4+ T cells and proliferation and activation of GVHD CD4+ T cells and 
CD11b+ cells. The current studies suggested that Syk inhibitor is a potential candidate for use in 
treating patients with Scl-cGVHD and SSc.    
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Contact hypersensitivity reactions are abrogated by Treg -mediated degradation of ATP
K Mahnke, J Kersyte, R Koch and AH Enk Univ. of Heidelberg, Heidelberg, Germany
Application of contact sensitizers to the skin can stimulate danger signals such as release of ATP that 
activate T-cells and subsequently lead to sensitization of the affected individuals. In a murine model 
of TNCB-induced contact hypersensitivity (CHS) we found that injection of regulatory T-cells (Treg) 
blocks sensitization against haptens and we also noted increased size and cellularity of the skin 
draining lymph nodes (LN). This led us to hypothesize that Treg may regulate the egress of T-cells 
from LN. When analyzing the LN 2-3h after sensitization, we found that the LN homing receptor 
CD62L is normally downregulated in T-cells, facilitating egress of effector T cells. In contrast, after 
injection of Treg CD62L downregulation was prevented and increased numbers of effector T cells 
in LN could be recorded. As for the mechanism of CD62L regulation we found that ATP released 
into the extracellular space at the site of antigen exposure is inducing the sheddase ADAM17, which 
then removes CD62L from the surface of the effector T cells. Treg express the ectonucleotidases 
CD39 and CD73 that degrade ATP into adenosine. Thus, in the presence of Treg extracellular ATP 
is removed from the tissue and shedding of CD62L is abrogated. These results were confirmed by 
experiments using CD39-/- Treg. These Treg failed to prevent CD62L shedding in vivo and were 
unable to block the sensitization phase. In summary these data indicate that the regulation of ATP 
turnover by Treg and other cells in skin is an important regulator for immune responses.    
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The leukotriene B4 receptor BLT1 acts as gatekeeper of neutrophil recruitment into the skin 
in autoantibody-induced dermatitis 
T Sezin, R Ludwig, D Zillikens and CD Sadik Department of Dermatology, Allergy, and 
Venereology, University of Lübeck, Lübeck, Germany
Recruitment of neutrophils into the skin is a hallmark of skin inflammation, but the molecular mech-
anisms mediating early neutrophil recruitment into the skin are still elusive. We set out to elucidate 
the mechanisms of early neutrophil recruitment into the skin in autoantibody-induced sterile skin 
inflammation using a mouse model of epidermolysis bullosa acquisita, a prototypical example of 
an autoimmune blistering skin disease caused by autoantibodies directed to collagen VII (COL7). 
Here we found that early neutrophil recruitment into the skin is dependent on the lipid mediator 
leukotriene B4 (LTB4) and its receptor BLT1. Thus, deficiency in 5-lipoxgenase, a key enzyme in 
the biosynthesis of leukotrienes, or in BLT1, the high-affinity receptor for LTB4, conferred dramatic 
resistance to anti-COL7-induced, neutrophilic skin inflammation. While wild-type mice developed 
severe clinical signs of EBA, including skin blistering, erythema, and erosions, and histopathologi-
cally displayed massive dermal infiltration predominantly with neutrophils, 5-lipoxygenase- (Alox5-/-) 
and BLT1-deficient (Ltb4r1-/-) mice did not develop signs of disease, neither clinically, nor histo-
pathologically. Remarkably, the skin remained devoid of neutrophils, suggesting a severe defect in 
the recruitment of the very first neutrophils into the skin in Alox5-/- and Ltb4r1-/- mice. Intradermal 
injection of LTB4 into Alox5
-/- mice restored disease. Similarly, adoptive transfer of either wild-type 
or Ltb4r1-/- neutrophils into the dermis of Ltb4r1-/- mice restored disease, albeit to a lesser extent. 
These findings suggest that LTB4 is required to recruit specifically neutrophils into the skin, but that it 
is dispensable for neutrophil activation within the skin. Altogether, our results hint at a role of LTB4/
BLT1 as critical gatekeeper of neutrophil egress into the skin in organ-specific autoantibody-induced 
inflammation, thus identifying LTB4/BLT1 as promising pharmacological targets for the treatment of 
autoimmune blistering skin diseases.    
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“Identification of antigen-presenting cell profile in inflammatory skin diseases using flow 
cytrometry”
A Seghers,1 S Lim,2 A Shin,2 C Theng,1 M Tang1 and F Ginhoux2 1 Dermatology, National Skin 
Centre, Singapore, Singapore and 2 SIGN, Biopolis, Singapore, Singapore
Antigen-presenting cells (APCs) are a heterogenous population and consists of multiple subsets with 
different functional specializations that play an important role in activation of both the innate and 
adaptive immunity. There is a gap in knowledge about the influence of the inflammatory signals 
on the phenotype of the APCs in inflammatory skin diseases. The aim of this pilot study was to 
determine the various subtypes of APCs in 3 clinically important but distinct T-cell mediated inflam-
matory skin diseases, namely atopic eczema, psoriasis and lichen planus. The APC composition 
of each disease was studied using flow cytometric analysis of lesional, non lesional skin biopsy 
specimens and blood from 13 atopic dermatitis, 9 chronic psoriasis and 8 lichen planus patients. 
There were no significant differences in CD14 / CD141 dendritic cell concentrations in lesional, 
non-lesional and peripheral blood of patients in all conditions. A high concentration of CD1c+ 
dendritic cells and macrophages were found in the lesional skin of atopic dermatitis compared to 
non lesional skin and peripheral blood. Lesional skin from patients with psoriasis was found to have 
an increased number of plasmacytoid (CD123+) dendritic cells. Lichen planus was found to be a 
dendritic cell poor disease as no specific changes in the APC profile in lesional and non-lesional 
skin were seen. In conclusion, we found that CD1c+ dendritic cells and macrophages are raised 
in diseased skin of patients with atopic dermatitis. We confirmed previous findings who showed 
that plasmacytoid dendritic cells are elevated in psoriatic skin. These findings highlight the disease 
specific differences in APC composition which may have prognostic and therapeutic implications 
in the management of these conditions.    
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A Case and Review of Autoimmune Progesterone Dermatitis
J Millsop,1 F Lui,2 K Young2 and K Gamson2 1 Dermatology, University of California, Davis, 
Sacramento, CA and 2 Internal Medicine, California Pacific Medical Center, San Francisco, 
CA
Autoimmune progesterone dermatitis is a rare disease where a rash develops in response to rising 
progesterone levels during the luteal phase of the menstrual cycle. A healthy 28 year old female 
presented with a pruritic rash over the chest, abdomen, and extremities. This rash recurred monthly 
since her last pregnancy and typically lasted a week at a time. Physical examination was signifi-
cant for erythematous plaques consistent with wheal and flare reactions over the upper and lower 
extremities and abdomen. Laboratory tests were significant for an elevated erythrocyte sedimentation 
rate (33 mm/hr). C4 complement was normal (15.7 mg/dl). Allergy skin testing was positive only 
for the histamine control. On further questioning, it appeared that the patient’s rash was related 
to her menstrual cycle, consistently occurring 4 to 5 days prior to menstruation. The patient was 
diagnosed with progesterone-induced urticaria. She was prescribed cetirizine, fenofexadine, and 
a combined estrogen-progesterone oral contraceptive pill with improvement in her rash. Autoim-
mune progesterone dermatitis is a rare spectrum of diseases occurring during the second half of 
the menstrual cycle. Manifestations may include urticaria, angioedema, eczema, papulovesicular 
lesions, targetoid lesions, deep gyrate lesions, or anaphylaxis. These manifestations occur 3 to 10 
days prior to the onset of menstruation and resolve 2 days into menstruation. Diagnosis is made 
clinically and confirmed by skin testing with intradermal progesterone injections. Treatment for 
progesterone-induced dermatitis is suppression of ovulation. Although there are no randomized con-
trolled trials, combined estrogen-progesterone oral contraceptives are considered first line therapy. 
Alternatives are gonadotropin-releasing hormone agonists, tamoxifen, and danazol. Autoimmune 
progesterone dermatitis is an important diagnosis to consider in a pre-menopausal female with 
cyclical rash or cyclical angioedema.    
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A crucial role of L-selectin in C protein-induced experimental polymyositis of mice
K Oishi, Y Hamaguchi, T Matsushita, M Hasegawa, K Takehara and M Fujimoto 
Dermatology, Kanazawa University, Kanazawa, Japan
Polymyositis (PM) is a chronic autoimmune inflammatory myopathy and the pathogenesis of PM 
has not been elucidated. Recently, the C protein-induced myositis (CIM) model was established as 
an animal model for PM. Adhesion molecules that include L-selectin and ICAM-1 play major roles 
in leukocyte recruitment into inflammatory site. However, the relative contributions of adhesion 
molecules vary among different models of inflammation and the role of L-selectin and ICAM-1 in 
the CIM model remains unknown. Therefore, we assessed the role of L-selectin and ICAM-1 in 
the development of CIM. CIM was induced in wild type mice, L-selectin-deficient (L-selectin-/-) 
mice, ICAM-1-deficient (ICAM-1-/-) mice, and both L-selectin- and ICAM-1-deficient (L-selec-
tin-/-ICAM-1-/-) mice. The severity of myositis and inflammatory cell infiltration in the muscles 
were examined. In addition, we performed adoptive transfer experiments to confirm the importance 
of L-selectin expression on T cells. The effect of dendritic polyglycerol sulfates (dPGS), which is an 
inhibitor that suppress the function of L-selectin and P-selectin, was also examined. L-selectin-/- mice 
and L-selectin-/-ICAM-1-/- mice developed significantly less severe myositis compared to wild type 
mice, while ICAM-1 deficiency did not inhibit the development of myositis. Immunohistological 
staining revealed that CD3+, CD4+, and CD8+ T cells, F4/80+ macrophages, and MPO+ neutrophils 
were all significantly reduced in L-selectin-/- mice compared to wild type mice. L-selectin-/- mice 
transferred with T cells from naïve, unimmunized wild type mice developed myositis. Wild type 
mice treated with dPGS significantly diminished the severity of myositis compared to control-treated 
wild type mice. Conclusion. These data indicate that L-selectin plays a major role in the devel-
opment of CIM, whereas ICAM-1 plays a lesser, if any, role in development of CIM. Furthermore, 
L-selectin-targeted therapy may be a candidate for the treatment of PM.    
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A genome-wide association study reveals two new susceptibility loci for atopic dermatitis 
H Schaarschmidt,2 H Baurecht,1 E Rodríguez,1 D Ellinghaus,2 W Lieb,3 N Novak,4 J Esparza-
Gordillo,5 Y Lee,5 A Franke2 and S Weidinger1 1 Department of Dermatology, Allergology 
and Venereology, University Hospital Schleswig-Holstein, Kiel, Germany, 2 Institute of 
Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany, 3 Institute of 
Epidemiology and Biobank popgen, Christian-Albrechts-University of Kiel, Kiel, Germany, 4 
Department of Dermatology and Allergy, University of Bonn Medical Center, Bonn, Germany 
and 5 Max-Delbrück-Centrum (MDC) for Molecular Medicine, Berlin, Germany
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases with a 
multifactorial background including environmental as well as genetic factors. Apart from filaggrin 
null mutations, genome-wide association studies (GWAS) have identified several susceptibility 
loci, which, however, explain only a small fraction of the total heritability. In order to increase our 
understanding of the genetic background of AD we conducted a GWAS using imputed data based 
on the Affymetrix 6.0 Gene Chip dataset from 870 German tertiary care cases and 5,293 population 
controls. The 98 most significant loci were subsequently investigated in a replication study on 1,415 
independent German cases and 1,748 controls. 12 out of 20 AD loci previously identified through 
GWAS in European and Asian populations could be confirmed. Of these ZNF365 and CYP24A1/
PFDN4 initially identified in Asians could for the first time be replicated in Europeans. In addition, 
two novel susceptibility loci at 2q24.3 (XIRP2, rs6720763, OR = 1.29) as well as at 9p21.3 (73 kb 
upstream of DMRTA1, rs10738626, OR = 0.81) were identified with genome-wide significance 
(P ≤ 5 × 10-8). Immunohistochemistry showed expression of both proteins in the epidermis, and 
electrophoretic mobility shift assays demonstrated allele-specific DNA-protein binding at both new 
loci. Our analysis increases the number of known AD susceptibility loci in Europeans to 14, which 
together explain 18.5% of the total heritability.    
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A method for rapid and simple extraction of cells from small skin samples for subsequent 
flow cytometric analysis
L Gurzulidis, K Skak and A Hald LEO-Pharma, Ballerup, Denmark
Aberrant immune reactions are an intrinsic part of common skin diseases such as psoriasis and atopic 
dermatitis. In order to expand the knowledge of the inflammatory mechanisms underpinning these 
diseases, it is fundamental to be able to isolate viable skin immune cells in a rapid and reproduc-
ible manner. This is hampered by the resilient nature of skin, which generally requires extensive 
enzymatic treatment for degradation and cell release. In an effort to increase cell yield from minute 
skin samples, we optimized a protocol for extracting skin cells from murine skin samples down to 
25mm2 for subsequent flow cytometric analysis. Using this approach we were able to characterize 
the immunological environment in naïve and challenged mice in a medium-throughput manner.   
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Acetate, a principle metabolite of ethanol, potentiates pro-inflammatory responses to TNFα/
IL-17 in keratinocytes: a potential role for acetate in alcohol-provoked psoriasis 
KC Wu,1 MA Morse,2 SF Kendrick,1 M Donaldson3 and NJ Reynolds1 1 Institute of Cellular 
Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, 2 Epinova 
Discovery Performance Unit, GlaxoSmtihKline, Stevenage, United Kingdom and 3 Stiefel, 
GlaxoSmithKline, Uxbridge, United Kingdom
Alcohol is implicated as a risk factor for the development and exacerbation of psoriasis. To under-
stand how alcohol might contribute to pathogenesis, we examined the effects of clinically relevant 
concentrations of ethanol and acetate, a principle metabolite of ethanol, on the cellular metabolism 
and total protein of primary human keratinocytes (KC) and responses to pro-inflammatory stimuli. KC 
were incubated with ethanol (86mM) or acetate (1mM) prior to stimulation with pro-inflammatory 
cytokines (TNF α and/or IL-17, key cytokines in the pathophysiology of psoriasis), ultraviolet B (UVB) 
or polyinosine-polycytidylic acid (a toll-like receptor 3 agonist). 48h after stimulation effects on 
keratinocyte metabolism, measured by 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium-bro-
mide [MTT] assay; total protein, measured by sulforhodamine B [SRB] assay (which correlates 
with cell number); and secretion of IL-6/-8 cytokines, measured by ELISA, were determined. Ace-
tate potentiated IL-6 response to TNF α and/or IL-17 (~55% enhancement with TNF α plus IL-17 
compared to control, p<0.01) as well as UVB (p<0.01). Acetate also potentiated IL-8 responses to 
TNF α (p<0.05) and UVB (p<0.01). Ethanol did not significantly potentiate IL-6 or IL-8 responses. 
Acetate alone did not affect MTT/SRB, but did impair the SRB endpoint in cells stimulated with TNF 
α plus IL-17 (by ~30%, p<0.01). Acetate’s enhancement of IL-6 KC response to pro-inflammatory 
TNF α plus IL-17 may explain how alcohol predisposes patients to development or exacerbation of 
psoriasis. Previous work in macrophages suggests acetate potentiates pro-inflammatory responses 
by an epigenetic mechanism, through hyperacetylation of histones at promoter regions of target 
genes; a similar mechanism may exist in KC and may explain how exogenous factors interact with 
the genome to influence the psoriasis phenotype.    
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Aldara-induced psoriasis-like skin inflammation - studies of psoriasis patients
H Vinter,1 L Iversen,1 T Steiniche,2 K Kragballe1 and C Johansen1 1 Department of 
Dermatology, Aarhus University Hospital, Aarhus, Denmark and 2 Department of Pathology, 
Aarhus University Hospital, Aarhus C, Denmark
Application with Aldara cream containing 5% imiquimod stimulates toll-like receptor 7/8 on plasma-
cytoid dendritic cells thereby producing a potent immune-modulatory effect. This has been reported 
to trigger psoriasis. Our aim was to establish a human model of Aldara-induced psoriasis-like skin 
inflammation in psoriatic patients. Non-lesional psoriatic skin of 13 patients was treated with Aldara 
under occlusion for two (10 patients) or seven (3 patients) days. The skin was evaluated clinically 
and histologically on days two, four and seven. Cytokine mRNA expression levels in Aldara-treated, 
lesional and non-lesional psoriatic skin were compared using RT-qPCR. Nine out of the ten patients 
receiving application with Aldara under occlusion for two days developed redness, induration and 
scaling. Histological analysis revealed focal parakeratosis, acanthosis and perivascular mononuclear 
infiltration. On days four and seven both clinical and histological signs of inflammation subsided. 
Two out of the three patients treated with Aldara for seven days developed erosions, evolving 
into psoriasis on day 21. In six patients receiving Aldara for two days, the mRNA profile in skin 
biopsies obtained on days two, four and seven was studied. Initially, cytokine markers of activation 
of the innate immune system such as IFN-α, IRF-7 and IL-1β were equally expressed in lesional 
and Aldara-treated skin. IL-6 and TNFα were preferentially expressed in Aldara-treated skin. Acti-
vation of the adaptive immune system occurred only partially. IL-23p19 and IL-22 were similarly 
overexpressed in Aldara-treated and lesional psoriatic skin, whereas IL-17A and IL-12p40 were 
significantly lower expressed in Aldara-treated skin compared with lesional psoriatic skin. Finally, 
IL-10 was significantly overexpressed in Aldara-treated skin. We were able to induce psoriasis-like 
skin inflammation although typical psoriasis did not develop. Possibly due to incomplete adaptive 
immune system recruitment, and induction of IL-10 counter-regulation.    
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Alterations induced by IL-4, IL-13 and IL-25 in a reconstructed human epidermis are remi-
niscent of atopic dermatitis
E De Vuyst,1 S Giltaire,1 C Lambert de Rouvroit,1 A Chrétien,2 M Salmon2 and Y Poumay1 1 
URPHYM-Narilis, University of Namur, Namur, Belgium and 2 StratiCell, Les Isnes, Belgium
The etiology of atopic dermatitis (AD) is still puzzling but data accumulate to suggest that AD 
results from an interplay between an alteration of the epidermal barrier and abnormal activation 
of a T helper type 2 (Th2) immune response, creating a vicious circle that initiates this chronic 
pruritic inflammatory skin disease. The present study intends to understand and reproduce such 
interactions using human tissues in vitro. Indeed, challenging keratinocytes induces epidermal 
reactions that typically include cytokines production and release, interleukin-8 (IL-8) and thymic 
stromal lymphopoietin (TSLP) for instance. However, in absence of cells from the immune system 
the epidermal reaction cannot initiate the suspected interplay. Thus, in a first trial to circumvent 
the absence of immune cells, a reconstructed human epidermis (RHE) was treated with cytokines 
highly expressed in AD: IL-4, IL-13 and IL-25. After 48h of treatment, the histological analysis of 
RHE revealed multiple alterations including spongiosis as well as disappearance of the granular 
layer, two characteristics found in AD epidermis. These alterations were confirmed by the analysis 
of late epidermal differentiation markers. Indeed, the expression of filaggrin (FLG) and loricrin 
(LOR) was strongly down-regulated. Simultaneously, the expression of claudin-4, a tight junction’s 
component, was also reduced. Furthermore, the expression levels of two genes specifically over-ex-
pressed in keratinocytes from AD patients, carbonic anhydrase II and neural growth factor-like 2, 
were increased after treatment with the cytokines. Altogether data suggest that, whereas challenged 
keratinocytes in a RHE can produce cytokines (TSLP) likely able to initiate a Th2 immune response, 
combined addition of AD-specific cytokines to the RHE medium induce morphological and func-
tional alterations of the tissue that are similar to those seen in AD. A more integrated approach will 
include activated T lymphocytes in co-culture with RHE.    
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Analysis of cytokine profile in delayed type hypersensitivity to penicillin in a setting of 
infectious mononucleosis: a case study
E Netchiporouk1 and M Ben-Shoshan2 1 Dermatology, McGill University, Montreal, QC, 
Canada and 2 Allergy and Clinical Immunology, McGill University, Montreal, QC, Canada
Hypersensitivity reactions are divided into 4 classes, including the classic immediate IgE mediated 
(type 1) and T-cell mediated delayed reactions (DTH) (type 4). The last type has been recently 
further subdivided in categories based on the type of T-cell and cytokines involved. The most 
frequent delayed allergy, the maculopapular exanthema (MPE), has been hypothesized to result 
from an aberrant activation of drug specific CD4+ lymphocytes and implication of Th1 cytokines. 
In practice, skin testing appears to be less sensitive than previously reported for DTH. The drug 
provocation test is still necessary for diagnosis. We report a case of a 17 year-old boy, who was 
referred to our center for allergy testing in context of MPE that occurred after taking Amoxicillin for 
sore throat, which later proved to be due to infectious mononucleosis. The skin prick tests were 
negative. Upon an open challenge to amoxicillin, a MPE occurred 8 hours following the exposure 
to the drug. Challenges to cefixime and clindamycin were negative, eliminating a multiple drug 
hypersensitivity profile. We have analyzed the serum lymphocytic cytokine profile before and after 
the challenge and compared results to a healthy control. Unstimulated, serum levels of IL-10, INF-γ, 
TNF-α, and IL-17 were comparable to those of the control. However, during the MPE, there was 
a significant up regulation of TNF-α, INF- γ and Th-17, simultaneously with a down regulation of 
IL-10. In vitro stimulation of patient lymphocytes with pure amoxicillin did not show a dose-ef-
fect relation. Levels of IL-2, IL-4 and IL-6 were comparable to those of the control and remained 
unchanged after the challenge. MPE may represent a true ampicillin hypersensitivity, even in the 
setting of a viral illness. Our findings are consistent with the proposed stipulation of CD4/TH1 
involvement in drug induced MPE.    
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Analysis of Interleukin-21 in peripheral blood of patients with psoriasis under treatment 
with ustekinumab
EN Hadaschik, X Wei and A Enk Dermatology, University Heidelberg, Heidelberg, Germany
The IL-23/Th17 pathway is activated in psoriatic skin: IL-17-producing T helper cells (Th17 cells) are 
present in lesional psoriatic skin and IL-23 is crucial for maintenance of Th17 cells. The importance 
of Th17 cells for pathology of psoriasis has been proven by the therapeutic effect of the biologic 
Ustekinumab, which effectively blocks both cytokines, IL-23 and IL-12, by targeting their common 
p40 subunit. Interestingly a recent report has shown that IL-21, one of the main effector cytokines 
secreted by activated Th17 cells, is highly expressed in psoriatic lesions. In addition intracutaneous 
injection of IL-21 induced epidermal hyperplasia and blockade of IL-21 completely resolved inflam-
mation and epidermal changes in psoriatic skin lesions in the human xenograft model of psoriasis. 
Since IL-21 is mainly produced by Th17 cells, we investigated whether the therapeutic effect of 
ustekinumab is also mediated by downregulation of IL-21. Therefore we analyzed the development 
of the Th17 effector cytokine IL-21 in peripheral blood of 10 psoriasis patients before and during 
treatment with ustekinumab. We found that 8/10 patients showed clinical response to ustekinumab 
as measured by psoriasis activity and severity index (PASI) reduction and PASI reaching 0 within a 
period of 40 weeks. Before treatment, peripheral blood of psoriasis patients contains significantly 
more CD4+ T cells, which express the skin homing marker CLA (IL21+ CLA+ CD4+ T cells), than 
peripheral blood of healthy donors. The number of IL21+ CLA+ CD4+ T cells in peripheral blood 
of psoriasis patients diminishes over time under treatment with ustekinumab in the majority of 
patients. In summary we found a reduction of IL21+ T cells in peripheral blood of psoriasis patients 
under treatment with ustekinumab, indicating that reduction of IL21 might represent an additional 
mode of action of ustekinumab.    
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Analysis of possible mechanisms in atopic dermatitis model induced by topical application 
of Dermatophagoides farinae extract in NC/Nga mice
Y Yamada, K Hashimoto, Y Ueda, H Kido and R Ishii Research Laboratories, Kyoto R&D 
Center, Maruho Co., Ltd., Kyoto, Japan
Atopic dermatitis (AD) is a chronic inflammatory skin disease accompanied by severe itching and 
eczematous lesion. In NC/Nga mice, repeated topical application of an ointment containing Der-
matophagoides farinae extract (Df) can induce early onset and chronic AD-like skin lesions with 
scratching behavior. The aim of the study was to clarify the possible mechanisms, especially the 
characteristics of scratching behavior and change in endogenous pruritogens and axonal guidance 
molecules, in this AD-like model. To induce AD-like dermatitis, Df was applied twice-weekly onto 
the shaved dorsal skin with barrier disruption for 2 weeks. Following repeated topical application 
of Df for 2 weeks, the dermatitis score was gradually elevated and the cell number in axillary 
lymph nodes was significantly increased. Interestingly, the scratching behavior was increased in 
a biphasic fashion; a transient increase in the early phase (0 to 1 hr after Df application) was fol-
lowed by a persistent increase in the later phase (4 to 24 hr after Df application). The expression 
of endogenous pruritogens such as interleukin 31, thymic stromal lymphopoietin and endothelin 1 
was significantly increased in the lesional skin. More PGP9.5-positive nerve fibers were observed in 
the epidermis, which was accompanied by a significant increase in nerve growth factor expression 
and a significant decrease in semaphorin 3A expression in the lesional skin. Elevated expression of 
protease-activated receptor-2 (PAR-2) was also observed in the epidermis. Chlorpheniramine and 
cromoglycate reduced the scratching in the early phase but not that in the later phase. In contrast, 
a protease inhibitor and anti-PAR2 reduced both of them. In conclusion, these observations suggest 
that this AD-like model exhibits the pathological conditions of dermatitis similar to those of human 
AD and PAR-2 activation is involved in the scratching in this model.    
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Analysis of the clinical and immunopathological characteristics and treatment outcomes in 
306 epidermolysis bullosa acquisita patients
H Iwata,1 A Vorobyev,1 H Koga,1 Y Gupta,1 A Recke,1 D Zillikens,1 T Hashimoto2 and 
R Ludwig1 1 Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, 
Germany and 2 Institute of Cutaneous Cell Biology, Kurume University, Kurume, Japan
Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Several clinical phenotypes 
have been described, but subepidermal blistering is characteristic of all variants. Limited data on 
clinical and immunopathological characteristics and treatment outcomes in EBA is available. To 
fill this gap, we collected this information from EBA cases, meeting current diagnostic criteria, 
published between 1971 and 2012. The analysis of 306 cases indicated that EBA affects all age 
groups (median: 47 years, range: 1 to 94 years) at an equal gender distribution. The inflamma-
tory phenotype (INF-EBA) was observed in 56% of patients, whereas the mechanobullous variant 
(MB-EBA) or a combination of both variants was described in 32% or 12% of patients, respectively. 
COL7-specific autoantibodies were primarily of the IgG isotype, but anti-COL7 IgA, IgM and IgE 
were also documented. Mucous membrane involvement was observed in 44% of patients, and 
12% of cases were associated with other chronic inflammatory diseases. Our analysis indicated 
that EBA is difficult to treat and that the choice of treatment varies widely. Fisher’s exact test 
was applied to identify single medications, independent of combination treatments, associated 
with complete remission (CR). High-dose intravenous immunoglobulin (IVIG) and methotrexate 
were associated with CR. Subgroup analysis demonstrated that IVIG, rituximab and azathioprine 
(MB-EBA), or IVIG and methotrexate (INF EBA) were associated with CR. We here document the 
clinical and immunopathological characteristics and treatment outcomes in a large cohort of EBA 
patients. The observed associations of single drugs with treatment outcomes may serve as a guide 
the development of clinical trials.    
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Anti  -inflammatory and antibacterial pro-drug as a new anti-acne active ingredient 
M Aries,2 S Daunes-Marion,1 C Jacques,2 C Viodé,3 H Duplan,2 J Luc,4 N Castex-
Rizzi,2 C Casas,3 S Bessou-Touya2 and D Redoulès3 1 R&D, Pharmacochimie, Pierre 
FABRE DermoCosmétique, Toulouse, France, 2 R&D, Pharmacologie In Vitro, Pierre 
FABRE DermoCosmétique, Toulouse, France, 3 R&D, Biochimie Cutanée, Pierre 
FABRE DermoCosmétique, Toulouse, France and 4 R&D, Microbiologie, Pierre FABRE 
DermoCosmétique, Toulouse, France
Acne is a chronic skin disorder with multifactorial process including inflammation and colonization 
of the pilo-sebaceous unit by P.acnes (Propionibacterium acnes). In order to restore this balance 
we proposed to take advantage of the lipase activity of P. acnes to release from a pro-drug both 
antibacterial and anti-inflammatory active ingredients. So we undertook the synthesis of mono-
glyceride analogues coupling by enzymatic esterification an alkane diol having anti-P.acnes activity 
with alpha-linolenic acid (ALA) showing anti-inflammatory properties. The enzymatic synthesis fits 
with the sustainability requirements and respects green chemistry principles. Combined diol-ALA 
compounds led to hydrolysis reaction under the action of the recombinant lipase of P.acnes after 
recognition as pseudo-substrate. At physiological pH, a decay greater than 99,9% of the P.acnes 
population was observed after 1 hour diol contact time. ALA had significant inhibitory effects on 
keratinocyte arachidonic acid mobilization (58%), cyclooxygenase (56%) and 5-lipoxygenase (60%) 
pathways, and on keratinocyte IL-8 chemokine release (52%). Free radiolabeled ALA was detected 
in the ex vivo tissue model after topical application of 1% radiolabeled pro-drug emulsion, further 
to endogenous enzymatic lipase activity. For the first time in the cosmetic field, the development of 
a pro-drug releasing both anti-inflammatory and anti-P.acnes ingredients has been reported. On the 
top of that, we showed the regulator properties of alpha-linolenic acid with respect to inflammatory 
response and the bactericidal efficacy of the diol on P.acnes, attesting the real interest of our pro-drug 
in acne cutaneous inflammatory disorders. Furthermore, the search for a selective and local action 
by targeting only the infected pilosebaceous follicle is an innovative approach.    
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CD271 Regulates Human Dermal Fibroblast Differentiation and Migration Through Phos-
phodiesterase 4 Binding 
A Marconi, F Truzzi, R Lotti, A Saltari, P Morandi and C Pincelli University of Modena and 
Reggio Emilia, Modena, Italy
The phosphodiesterase 4 (PDE4) isozyme family encoded by 4 genes (PDE4A, B, C, D) selectively 
degrades cyclic adenosine monophosphate (cAMP) and constitutes the predominant phosphodi-
esterases in immune and inflammatory cells. Evidence indicates that PDE4A4/5 interacts with the 
CD271 receptor (p75 neurotrophin receptor) to enhance cAMP degradation. After injury, various 
factors, including neurotrophins, promote dermal fibroblast (DF) differentiation into myofibroblasts 
(DM), characterized by the expression of α-smooth muscle actin (α-SMA). These cells are predom-
inantly responsible for connective-tissue contracture and extracellular matrix reorganization. We 
analyzed the role of the CD271/PDE4 complex in DF and DM. We first demonstrated that all PDE4 
isoforms co-immunoprecipitate with CD271 in DM. Conversely, CD271 formed weak complexes 
with PDE4A and PDE4B in DF and no complex with PDE4C or PDE4D. Using the PDE4 inhibitor, 
apremilast, the CD271/PDE4 complex failed to significantly affect proliferation both in DF and 
DM, as shown by MTT and BrdU assay. Moreover, the PDE4 inhibition did not exert any effect 
on apoptosis in either DF or DM, as shown by TUNEL and propidium iodide staining. However, 
cAMP degradation mediated by beta-amyloid (CD271-specific ligand) appeared to be reduced 
by the addition of the PDE4 inhibitor in DM. Finally, PDE4 inhibition reduced migration and 
differentiation mediated by nerve growth factor, as shown by scratch-wound assay and the down 
regulation of α-SMA expression. These results suggest that CD271 may signal through PDE4 to 
induce fibroblast differentiation and migration and that the CD271/PDE4 complex may be involved 
in wound healing and fibrotic processes.    
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Characterization of peripheral blood dendritic cells in atopic dermatitis 
A Kapitány,1 G Béke,1 G Nagy,1 M Doan-Xuan,3 Z Bacsó,3 K Gáspár,1 G Boros,5 T Bíró,4 
ÉVA Rajnavölgyi2 and A Szegedi1 1 Division of Dermatologial Allergology, Faculty of 
Medicine, University of Debrecen, Debrecen, Hungary, 2 Department of Immunology, 
University of Debrecen, Debrecen, Hungary, 3 Department of Biophysics and Cell Biology, 
University of Debrecen, Debrecen, Hungary, 4 DE-MTA “Lendület” Cellular Physiology 
Research Group, University of Debrecen, Debrecen, Hungary and 5 Department of 
Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
Dendritic cells (DCs) as the main antigen presenting cell type play crucial role in the pathogenesis of 
atopic dermatitis (AD). Characteristics of the DCs located in the skin of patients are well defined but 
less is known about their peripheral blood DC precursors. Therefore we aimed to characterise the 
myeloid pre-DCs separated from the blood of patients with AD, to examine their phenotypical fea-
ture, cytokine and chemokine production in order to determine if they differ from myeloid pre-DCs 
separated from the blood of healthy persons. Peripheral blood myeloid DCs were separated from 
the blood of 12 AD patients and 10 healthy controls using CD1c+/BDCA1+ magnetic separation 
kit. Cell surface markers were examined with Flow Cytometry, cytokine levels with Laser Scan-
ning Cytometry, while chemokine production was investigated with Chemokine Antibody Array. 
Focusing on CD1c+ and CD11c + cells we found, that cells separated from the blood of patients 
with AD expressed more FceRI (56,23% vs. 27,48%) and less CD206-mannose receptors (45,8% 
vs. 66,2%) than the controll cells. The levels of the Th2 (IL-2) and Th22 (IL-6, TNF-alfa) polarizing 
cytokines were also found to be elevated in AD patients compared to the control group. In the 
case of chemokines we have found, that CCL3, CCL4, CCL5, CCL19, CCL20, CXCL5, CXCL10 and 
CXCL11 were produced only by AD DC-s, while the Th2 polarising CCL17 was produced by both 
AD and healthy DC-s, but DC-s from AD patients produced it in a significantly higher amount. Our 
results indicate that circulating pre-DCs deriving from AD patients are more matured than the cells 
that derive from healthy persons, and are characterized by a Th2 and Th22 polarizing capacity.   
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Cutaneous hemorrhage during thrombocytopenia depends on Gαi2-mediated neutrophil 
activation 
C Hillgruber,1 B Pöppelmann,1 C Weishaupt,1 WE Berdel2 and T Goerge1 1 Dept. of 
Dermatology, University Hospital of Münster, Münster, Germany and 2 Dept. of Hematology 
and Oncology, University Hospital of Münster, Münster, Germany
Platelets have been recognised as important mediators not only of hemostasis but also of vascular 
integrity during inflammation. It has been reported that in the absence of platelets inflammation 
leads to hemorrhage. In the present project we observed UVB-induced bleeding (Purpura solaris) in 
thrombocytopenic patients phototested for UVB tolerance (30200 mJ/cm2). In analogy, thrombocy-
topenic mice (anti-GPIbα) subjected to UVB-radiation developed cutaneous bleeding that occurred 
time- and dose-dependent and was strictly limited to the sites of irradiation. Moreover, UVB-ra-
diation (100 mJ/cm2) induced a significant influx of neutrophils as confirmed by analysis of the 
neutrophil-specific enzyme myeloperoxidase and intra-vital microscopy. To further understand the 
role of neutrophil recruitment in Purpura solaris, mice were treated with a neutrophil-depleting anti-
body (anti-Gr-1) prior to platelet depletion and UVB-radiation. Interestingly, under leukocytopenic 
conditions skin bleeding was virtually absent. In two additional models of cutaneous inflammation, 
immune complex-mediated vasculitis (ICV) and irritative contact dermatitis (ICD), thrombocytopenic 
mice developed petechial bleeding as well. Despite profound tissue damage reduced neutrophil 
recruitment was observed during both ICV and ICD. By gradual interference with single steps of 
leukocyte extravasation, we finally identified neutrophils as the key inducer of thrombocytopenic 
bleeding during cutaneous inflammation in general. In particular, in Gαi2
-/- mice we observed a 
significant reduction of infiltrating leukocytes and hemorrhage during cutaneous inflammation. In 
conclusion, cutaneous hemorrhage in the absence of platelets depends on Gαi2-mediated neutrophil 
activation during inflammation.    
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CXCL10, a relapse marker in bullous pemphigoid 
M Riani,1 S Le Jan,1 J Plee,1 A Durlach,2 P Bernard1 and F Antonicelli1 1 Dermatology, 
University of Reims, Reims, France and 2 Histopathology, Laboratory Pol Bouin, CHU, 
Reims, France
Bullous pemphigoid (BP) is an autoimmune bullous disease associated with an inflammatory 
response involving cytokines and proteases in the dermal-epidermal cleavage ending with blister 
formation. The objectives of our study were to investigate the expression of the chemokine CXCL10 
along BP progress and to determine the relationship linking CXCL10 expression to the production 
of the protease MMP-9. CXCL10 concentrations were measured by ELISA, and MMP-9 quantified 
using ImageJ solfware after gel zymography separation. We found that CXCL10 levels were higher 
in serum (n=31) and in the blister fluid (n=23) of BP patients, compared to age- and sex- matched 
controls (n=16). IHC study on BP skin biopsy specimens (n=16) showed that inflammatory cells at 
lesional site expressed CXCL10 and its receptor CXCR3. Compared to baseline, serum CXCL10 con-
centrations increased at day 60 in the serum of patients who relapsed within the first year of treatment 
(p=0.005, n=25), although BP patients were under treatment (topical superpotent corticosteroids). 
An increased secretion of MMP-9 was observed in PBMC and PMN of BP patients after stimulation 
by CXCL10 versus controls. From isolated monocytes and lymphocytes, only monocytes from BP 
patients (n=7) expressed MMP-9 in response to CXCL10. The ratio of CXCR3A/CXCR3B (isoforms of 
CXCL10 receptor) was reversed in monocytes compared to lymphocytes from BP patients. Finally, 
the use of specific inhibitors involving the signaling pathways ERK1/2, P38, PI3K (monocytes) and 
P38, PI3K (PMN) reduced the expression of MMP-9 after stimulation by CXCL10. In conclusion, our 
results show an increase of 1) the expression of CXCL10 in serum and blister fluid of BP patients, 
and 2) an increased sensitivity of monocytes and PMN from BP patients to respond to CXCL10 
stimuli. Finally, the serum overexpression of CXCL10 could help in detecting patients that might 
relapse within the 1st year of treatment. According to the role of CXCL10 in MMP-9 expression, 
this chemokine could also be a promising target for those patients.    
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Defective expression of GADD45a and GADD45b in Psoriasis
H de la Fuente,3 E Rivas-Garcia,2 MJ Concha,1 Y Delgado,1 A Sanguino,2 F Sanchez-Madrid2 
and E Dauden1 1 Dermatología, Instituto de Investigación Sanitaria del Hospital de la 
Princesa, Madrid, Spain, 2 Inmunología, Instituto de Investigación Sanitaria del Hospital 
de la Princesa, Madrid, Spain and 3 Biologia Vascular e Inflamacion, Centro Nacional de 
Investigaciones Cardiovasculares CNIC Carlos III, Madrid, Spain
There is increasing evidence that GADD45 (growth arrest and DNA damage-inducible genes) family 
members have important functions in T cells. Deficiency of Gadd45b in CD4+ T cells impairs their 
responses to TCR stimulation or inflammatory cytokines and is involved in IFN-gamma production 
by dendritic cells (DCs). GADD45a has been described as a negative regulator of activation-induced 
T cell proliferation, Gadd45a(-/-) mice spontaneously develop an autoimmune disease, similar to 
human systemic lupus erythematosus. The aim of this work is to study the putative role of Gadd45a 
and Gadd45b in human Psoriasis. Gadd45a and Gadd45b expression was analyzed by RT-PCR, 
immunofluorescence and/or immuno-histochemical assays in skin and samples from 30 psoriasis 
patients and 20 healthy controls. GADD45 expression was also studied in peripheral CD4+ T cells 
and monocyte-derived DCs (moDCs). In T cells, GADD45a negatively modulates the alternative 
pathway of p38 activation. Thus, we have analyzed the expression of p38 phosphorylation on 
Tyr323 and Thr180 -Tyr182 in CD4+ T cells. Lesional skin from psoriasis patients expressed very 
low levels of Gadd45a and Gadd45b mRNA compared with non-lesional skin and healthy donors. 
Immunohistochemical staining showed that keratinocytes are the main cell subset expressing low 
levels of Gaddd45a. In addition, expression of Gadd45b was decreased in moDCs from psoriasis 
patients compared to healthy controls. However, in response to LPS, moDCs from psoriasis patients 
showed a higher induction of Gadd45b expression compared to controls. CD4+ T cells from psoria-
sis showed a higher phosphorylation on pTyr323 compared to control subjects, indicating activation 
of the alternative pathway of p38. Defective expression of Gadd45a and Gadd45b in Psoriasis 
patients could have a role in the immunopathogenesis of this disease.    
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Deletion of the major bullous pemphigoid epitope region of collagen XVII induces blistering, 
spontaneous autoimmunization and itching in mice
T Hurskainen,1 N Kokkonen,1 R Sormunen,2 J Jackow,3 S Löffek,3 R Soininen,2 C Franzke,3 
L Bruckner-Tuderman3 and K Tasanen1 1 Dermatology, University of Oulu, Oulu, Finland, 2 
Biocenter Oulu, Oulu, Finland and 3 University of Freiburg, Freiburg, Germany
Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease with a characteris-
tic of pruritus and subepidermal blistering. BP patients carry inflammation-triggering autoantibodies 
against the hemidesmosomal transmembrane protein, collagen XVII (ColXVII). The immunodom-
inant region is the juxtamembraneous extracellular NC16A domain that is also involved in ecto-
domain shedding of ColXVII. Deletion of the corresponding NC14A region in a genetically modified 
mouse model (ΔNC14A) decreased the amount of ColXVII in skin, but did not prevent ectodomain 
shedding. Newborn ΔNC14A mice had no visible phenotypic changes. However, subepidermal 
microblisters, rudimentary hemidesmosomes, and loose basement membrane zone were observed 
by microscopy. ΔNC14A mice grow normally, but at around three months of age start to scratch 
themselves and develop crusted erosions. Furthermore, perilesional eosinophilic infiltrations in the 
skin, eosinophilia and elevated serum IgE levels are detected. Despite the removal of the major BP 
epitope region, ΔNC14A mice develop IgG and IgA autoantibodies with subepidermal reactivity 
indicating autoimmunization against a dermo-epidermal junction component, causing pruritus and 
scratching. Our newly developed ΔNC14A mice provide a novel and highly reproducible BP related 
mouse model with spontaneous breakage of self-tolerance and development of autoantibodies. 
Therefore, ΔNC14A mice are an excellent model to study the early stages and the development of 
autoimmune blistering skin disease.    
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Diabetes mellitus induces alterations in insulin sensitivity, release of pro-inflammatory cyto-
kines and antioxidant capacity of epidermal keratinocytes
O Reichert, L Terstegen, F Staeb, H Wenck, G Neufang, L Kolbe and D Roggenkamp R&D, 
Beiersdorf AG, Hamburg, Germany
Type 2 Diabetes is associated with an increased susceptibility to develop skin manifestations such as 
cutaneous infections, itching and impaired wound healing. However, the direct impact of diabetes 
mellitus on skin homeostasis in humans remains unknown. Hence, we investigated the influence 
of diabetes on keratinocyte biology. For in vitro studies, human skin cells were isolated from skin 
punch biopsies. Skin punch biopsies were obtained from healthy and type 2 diabetic subjects with an 
average HbA1c of 7,6%. As insulin resistance is a common feature of type 2 diabetes, we investigated 
whether isolated diabetic keratinocytes are affected by impaired insulin signaling. A reduced mRNA 
expression of the insulin receptor and insulin receptor substrate 2 (IRS-2), both essential for insulin 
signaling, was observed in diabetic keratinocytes. These alterations were accompanied by a reduced 
insulin-induced glucose transport capacity, suggesting that keratinocytes from diabetic donors are 
insulin resistant and maintain this status in vitro for a prolonged time. For further analyses, we 
developed a diabetic organotypic skin model, comprising diabetic keratinocytes and fibroblasts. As 
systemic inflammation and oxidative stress have been implicated in the development of insulin resis-
tance, we investigated the inflammatory and cytoprotective state in diabetic skin models. Our studies 
demonstrate that expression of pro-inflammatory cytokines (e.g. IL1β, IL6, CCL5 and CXCL10) was 
significantly increased in diabetic skin models. Additionally, epidermal mRNA expression of the 
cytoprotective Nrf2- and AhR-system was significantly decreased in diabetic models, indicating 
that diabetic keratinocytes might be more sensitive towards oxidative stress. Taken together, these 
data strongly suggest that epidermal keratinocytes are affected by diabetes mellitus and display 
long-lasting alterations in insulin signaling, inflammatory state and cytoprotective potential.    
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Diagnostic performance of the Anti-skin Profile ELISA Kit
M Sardy,1 O Horvath,1 M Kaneda,2 E Schmidt3 and T Ruzicka1 1 Dept. of Dermatology and 
Allergology, Ludwig Maximilian University, Munich, Germany, 2 MBL, Woburn, MA and 3 
Department of Dermatology, Allergology and Venerology, Univ. of Lubeck, Lubeck, Germany
The newly developed Anti-skin Profile ELISA Kit (MBL), which is designed for the diagnosis of 
pemphigus foliaceus, pemphigus vulgaris, bullous pemphigoid, and epidermolysis bullosa acquis-
ita, allows testing of five different autoantibodies in one plate at the same time without the need 
for prior indirect immunofluorescence. The diagnostic value of Anti-skin Profile ELISA Kit (MBL) 
was assessed in a retrospective study testing the sera from 25, 40, 51, 21, and 40 patients having 
pemphigus foliaceus, pemphigus vulgaris, bullous pemphigoid, epidermolysis bullosa acquisita, 
and various non-autoimmune skin diseases, respectively. Sensitivities for desmoglein 1, desmoglein 
3, BP180, BP230, and collagen VII ELISAs were 88.0%, 92.5%, 58.82%, 62.75%, and 80.95%, 
respectively. The specificities for desmoglein 1, desmoglein 3, BP180, BP230, and collagen VII 
ELISAs were 100%, 100%, 97.5%, 100%, and 97.5%, respectively. The results from the anti-skin 
profile ELISA were concordant with those from other ELISAs in 92% of sera. The Anti-skin Profile 
ELISA had similar performance compared to previously produced ELISAs. This kit can be used for 
very rapid diagnosis of most common autoimmune blistering diseases, and it is especially suitable 
to identify overlapping disorders.    
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Diagnostic value of a new IgA staining pattern system in the small bowel of patients with 
dermatitis herpetiformis and celiac disease 
A Görög,2 P Silló,2 M Juhász,1 D Kocsis,1 K Preisz,2 D Kuzmanovszki,2 Z Tulassay1 and 
S Kárpáti2 1 2nd Department of Internal Medicine, Semmelweis University, Budapest, 
Hungary and 2 Department of Dermatology, Venereology and Dermatooncology, 
Semmelweis University, Budapest, Hungary
A pathological transglutaminase-(TG2)-targeted IgA staining has been described in the small bowel, 
in both manifestations of gluten-sensitive enteropathy (GSE), i.e. dermatitis herpetiformis (DH) and 
celiac disease (CD). These tissue deposited “celiac antibodies” bind along the villous and cryptal 
basement membrane, around capillaries and lymphatics in the lamina propria. Here we present 
characteristic IgA staining patterns (IGASP) of diagnostic value in normal, differently damaged or 
even structurally re-organized duodenal tissues received from 111 DH, 51 CD and 42 non-GSE 
(control) patients, who were either under normal diet, or under strict or intermittent gluten-free 
diet (GFD). While 88 DH patients (79%) showed IGASP, 37 of the IGASP positives had no GSE 
on histology and 14 of them were either TG2-IgA or EMA negative, 17 were completely seroneg-
ative. Out of the 23 IGASP negative DH patients 9 showed other GSE features, like seropositivity 
(n=3), histological pathologies (n=3) or both (n=3). Totally 128 GSE (DH and CD) patients (79 %) 
presented IGASP, while 17 DH patients out of them were completely seronegative, and 42 had no 
histological changes indicating GSE. 11 out of these 17 seronegative, IGASP positive patients were 
under GFD. When IGASP analysis was performed before GFD, we identified it in 73/88 (83 %) 
DH patients, in 36/40 (90%) CD patients and in none of the non-GSE patients. Among 17 (23%) 
completely seronegative DH patients before GFD 5 (29%) showed IGASP positivity. These data 
indicate that the new IGASP analysis is a useful and sensitive additive diagnostic method in mild 
GSE pathologies with borderline or absent seropositivity, or missing morphological characteristics.   
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Diminished expression of the complement regulation proteins CD46,CD55 in Bullous 
Pemphigoid 
P Qiao, E Dang and G Wang Department of Dermatology, Xijing Hospital,Fourth Military 
Medical University, Xi’an, China
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. Binding 
of autoantibodies against BP180 in the dermal–epidermal junction (DEJ) and activation of the com-
plement system are the most important events in the pathogenesis of BP. Complement regulatory 
proteins (CRPs) are the negative–regulators in the complement activation pathways. Deficiency of 
CRPs may be associated with lower protection of healthy cells from complement mediated lysis. The 
aim of this study was to analyze the expression of the main CRPS(CD46 and CD55) in BP patients. 
A total of 20 BP patients were enrolled. Real–time PCR and flow cytometric analysis indicated that 
CD46 was significantly lower on leukocytes from BP patients compared with control (p<0.01 and 
p=0.0334). Meanwhile, we found that CD46 and CD55 expression were obviously lower in the 
epidermal keratinocyte of BP patients by immunohistochemistry and western blot analysis. Further-
more, by inhibition ELISA and immunofluorescence study we found that CD46 and CD55 could 
inhibit the complement activation and C3 deposition induced by the pathogenetic antibody from BP 
patients in vitro. These results suggest that altered CD46 and CD55 might play an important role in 
the pathogenesis of BP and protein CD46 and CD55 have a potential role in the future therapy of BP.   
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Double membrane structures in pemphigus revealed by advanced imaging techniques
E Sokol,1 D Kramer,2 M Nijenhuis,2 J Kuipers,3 GF Diercks,2 MF Jonkman,2 BN Giepmans3 
and HH Pas2 1 Department of Dermatology and Department of Cell Biology, UMCG, 
Groningen, Netherlands, 2 Department of Dermatology, UMCG, Groningen, Netherlands 
and 3 Department of Cell Biology, UMCG, Groningen, Netherlands
Pemphigus is a life-threatening disease where autoantibodies against desmogleins (Dsgs) cause 
loss of cell-cell adhesion, and blistering of the skin and/or mucous membranes. Dsgs (1-4) are 
transmembrane proteins of desmosomes that link keratin filaments of neighboring cells. The most 
prominent reported finding in pemphigus tissue is the redistribution of targeted Dsgs into large 
clusters. The pathomechanism of blistering and the role of pemphigus autoantibodies herein are 
poorly understood. We aim to define the exact subcellular changes in pemphigus tissue using newly 
developed large scale electron microscopy (EM) which we term as nanotomy, as well as correlated 
fluorescence microscopy and EM in a keratinocyte monolayer model. In patient skin and mucosa 
we found intercellular widening, loss of cell-cell adhesion, reduction in number of desmosomes 
and double membrane structures in form of interdigitations between cells. Double membrane 
structures are at the positions of the IgG/Dsg clusters. In the monolayer model we observed that 
pemphigus antibodies against Dsg3 cause its redistribution together with other desmosomal com-
ponents, but not of adherens junction components, leaving Dsg2 containing desmosomes. Dsg3 
and desmosomal components organized into arrays perpendicular to the cell membrane. Correlated 
microscopy revealed that these arrays are protrusions of one cell into another. Membranes at these 
positions are closely aligned and resemble the double membrane structures in patient tissue. In 
double membrane structures small electron dense structures are present, which most likely present 
dismantling desmosomes. We conclude that the double membrane structures both in patient tissue 
and cell model are induced by pemphigus IgG, most likely trough crosslinking of opposite Dsgs, 
and as such represent ‘glued together’ membranes.    
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Drugs responsible of DRESS syndrome regulate IL-10 and TNFα intracellular production 
and secretion 
B Sabbah,1 B Janela,2 D Picard,1 M Maho-Vaillant,1 P Joly,1 SF Calbo1 and P Musette1 1 
Rouen University Hospital, Department of Dermatology, INSERM U 905, Normandie Univ, 
Rouen, France and 2 Singapore Immunology Network, Agency for Science, Technology and 
Research (A*STAR), Singapore, Singapore
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug-induced reaction 
that involves both the skin and the viscera. Several herpesvirus family members including EBV 
or HHV-6 can be detected coincidently with various clinical symptoms in DRESS. In addition, 
we have previously identified activated EBV specific cytotoxic CD8+ T cells as major actors in 
the pathophysiology of DRESS. Furthermore, gene expression profiling of DRESS patients’ PBMC 
revealed that IL-10 and TNFα were two of the most upregulated mRNA. Interestingly, IL-10 plays 
a key role in the immunomodulation and EBV replication while TNFα is highly implicated in the 
inflammation process during DRESS. However, drug effect on cytokines secretion has not been stud-
ied. We thus measured IL-10 and TNFα secretion levels in DRESS patients’ serum and B-LCL lines 
following incubation with DRESS inducer drugs for 72 hours. EBV-B cell lines were obtained after 
incubation of B cells from DRESS patients or healthy donors with EBV virus. Also, DRESS patients 
and healthy donors PBMC and serum were included in the study. We analyzed the presence of IL-10 
by ELISA, FACS and QPCR, and the presence of TNFα by ELISA and FACS. We show that DRESS 
patients have an increase of IL-10 and TNFα in their serum at the onset of the disease. In vitro, we 
demonstrate that some DRESS inducer drugs reduce significantly the IL-10 secretion in B-LCL from 
DRESS patients but not from healthy donors by sequestering IL-10 in the cytoplasm. Interestingly, 
the same observation was obtained for TNFα in DRESS patients and healthy donors B-LCL, with 
however differential effect depending of the drugs regarding the sequestering of TNFα also in the 
cytoplasm of B cells. The balance between IL-10 and TNFα is affected by DRESS inducer drugs 
specifically in DRESS patient. These findings allow a better understanding of the physiopathology 
of the DRESS syndrome.    
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Effects of UVB Irradiation on Cytokine Profile of Normal Human Keratinocytes Under 
Osmotic Stress Conditions
I Krolikiewicz-Renimel, O Jeanneton, M Dumas, R Kurfurst and S Schnebert LVMH 
Recherche, Saint Jean de Braye, France
Cytokines are secreted by keratinocytes under certain conditions such as age, osmotic stress and 
UV irradiation. These molecules influence keratinocyte proliferation and differentiation and could 
contribute to dysfunctions of the epidermal barrier. The aims of this study were: firstly to develop 
a cellular model of osmotic stress induced by sorbitol and identify specific cytokines involved; 
secondly to study the effects of a moderate UVB irradiation on this model by the quantification of 
these cytokines. In accordance with ethical rules, skin samples obtained after abdominal surgery 
from Caucasian women were used to isolate normal human keratinocytes (NHK). After seeding, 
cells were cultivated for a 24h period in a medium containing sorbitol 200mM to induce an osmotic 
stress. Then, the cells were irradiated by 12.5mJ/cm2 of UVB. 8 hours later, the supernatants from 
irradiated and untreated cells were collected for the cytokines quantification using a multiplexing 
tool. In our model, the pro-inflammatory status induced by a hyperosmotic environment was con-
firmed in NHEK cultures by an increase of IL-4, IL-6, IL-8, TNF-α, MCP-1 and VEGF release, the 
last two cytokines being well described in the inflammatory phase of atopic dermatitis. After UVB 
irradiation, the secretion of IL-4 and IL-6 is mainly induced by the UVB exposure. In contrast, for 
IL-8, TNF-α, VEGF and MCP-1, a synergistic stimulation was observed between osmotic and UVB 
stress. The most remarkable synergistic induction was relevant for MCP-1 (18pg/mg of proteins with 
UVB irradiation; 31pg/mg of proteins with osmotic stress and 108 pg/mg of proteins for both). Our 
epidermal model of osmotic stress seems able to mimic the cytokinic response triggered in atopic 
dermatitis. This response is distinct from that obtained with UVB. Our results highlight the synergy 
between UVB irradiation and osmotic stress in the pro-inflammatory response of epidermal kerati-
nocytes, indicating that these cytokines could be amplified in the case of dry skin.    
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Efficacy of astaxanthin in a murine model of atopic dermatitis 
Y Yoshihisa,2 T Andoh,1 K Matsunaga2 and T Shimizu2 1 Applied Pharmacology, University of 
Toyama, Toyama, Japan and 2 Dermatology, University of Toyama, Toyama, Japan
Atopic dermatitis (AD) is a common chronic inflammatory skin disease associated with various 
factors, including immunological abnormalities and exposure to allergens. Astaxanthin (AST) is a 
xanthophyll carotenoid that has recently been demonstrated to have anti-inflammatory effects. Thus, 
we investigated whether AST could improve the clinical skin severity and pruritus in a murine model 
of AD using male NC/Nga mice. In addition to a behavioral evaluation, the effects of AST on the 
AD were determined by serum IgE level, histological analyses of skin, and by RT-PCR and Western 
blotting analyses for the expression of inflammation-related factors. AST (100 mg/kg) or vehicle (olive 
oil) was orally administered three times a week for 26 days. When compared with vehicle-treated 
group, the administration of AST significantly reduced the clinical skin severity score. In addition, 
the spontaneous scratching in AD model mice was reduced by AST administration. Moreover, the 
serum IgE level was markedly decreased by the oral administration of AST compared to that in 
vehicle-treated mice. The number of eosinophils, total and degranulated mast cells all significantly 
decreased in the skin of AST-treated mice compared with vehicle-treated mice. The mRNA and 
protein levels of eotaxin, MIF, IL-4, IL-5 and L-histidine decarboxylase were significantly decreased 
in the skin of AST-treated mice compared with vehicle-treated mice. These results suggest that AST 
improves the dermatitis and pruritus in AD via the regulation of the inflammatory effects and the 
expression of inflammatory cytokines.    
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Epicutaneous   sensitization with protein antigen is impaired by oral tolerance 
J Baek, Y Jung, E Lee and J Roh Gachon university, incheon, Republic of Korea
Atopic dermatitis is a chronic inflammatory skin disease that has shown a global increase over 
the past few decades. The pathomechanism of atopic dermatitis is still unknown, but abnormal 
immuno-inflammatory pathway such as impaired skin barrier, environmental and neurocutaneous 
factors have been suggested. Impaired oral tolerance can induce allergic reaction and anaphylaxis, 
but the effect of oral tolerance in atopic dermatitis was not revealed yet. We observed the differences 
of histopathologic changes, inflammatory mediators (IL-1β, IL-4, IL-5, IFN-γ, IL-9, IL-10, IL-13, 
IL-12p35, IL-17, TNF-α) and cell profiles (T cell, eosinophil, neutrophil, mast cell) in epicutaneous 
sensitized mouse model after inducing oral tolerance to reveal the influence of ovalbumin-induced 
oral tolerance in atopic dermatitis.    
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Epidermal Langerhans Cells and Dendritic Cells Produce Distinct and Complementary Cyto-
kines that Sustain the Skin Inflammation in Active Psoriasis
E Martini, M Wikén, M Ståhle and L Eidsmo Dermatology and Venerology Unit, Department 
of Medicine, Solna, CMM, Karolinska University Hospital, Karolinska Institutet, Stockholm, 
Sweden
In this study we aim to clarify the inflammatory properties of epidermal Dendritic cells (DCs) and 
Langerhans cells (LCs) in psoriasis. Skin biopsies from healthy skin and active psoriasis lesions 
were taken and sectioned for Confocal and Electron microscopy. Dermal DCs (dDCs), epidermal 
infiltrating DCs (iDCs) and LCs from dermal and epidermal skin suspensions from biopsies were 
sorted for gene expression profiling. Cell suspensions were stimulated with LPS (TLR4 ligand) and 
R848 (TLR7/8 ligand) in presence of BFA and cytokine expression was measured by FACS. LCs 
and iDCs were identified in epidermis in active psoriasis lesions by confocal imaging and electron 
microscopy. iDCs expressed more CCR2 and less CCR6 and CCR7 than epidermal LCs and dDCs 
respectively and thus comprised of a distinct cell population. Both in epidermis and dermis, LCs and 
DCs were localised in the immediate vicinity of T cells, suggesting local T cell-DC interactions. In 
line with the T cell activation profiles, epidermal LCs were the main producers of the Th17 driving 
cytokine IL-23, measured both by RNA expression and flow cytometry. In contrast, epidermal iDCs 
produced IL-10 and less IL-23 in comparison to LCs. Both LCs and DCs produced IL-1β and IL-6, 
both cytokines with a multitude of effects on both T cells and keratinocytes. Our results highlight 
the complexity of tissue inflammation in the skin and we propose that local IL-23 production in 
epidermis may serve as extra-lymphoid stimulation resulting in the high proportion of IL-17 and 
IL-22 producing epidermal T cells.    
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Epidermal plasmacytoid dendritic cells and disease severity in patients with psoriasis
Y Uchida,1 K Kawai2 and T Kanekura1 1 Department of Dermatology, Kagoshima University 
Graduate School of Medical and Dental Sciences, Kagoshima, Japan and 2 Department of 
Dermatology, Kido Hospital, Niigata, Japan
Plasmacytoid dendritic cells (pDCs) are a dendritic cell subset that produces large amounts of type 
I interferon (e.g. IFN-a). There is evidence supporting the role of dermal pDCs in the pathogenesis 
of psoriasis, but it is unknown whether epidermal pDCs are involved. In this study, we investigated 
the presence of epidermal pDCs during the exacerbation phase of psoriasis and examined their 
relationship with disease severity using the PASI score. We enrolled 12 psoriasis and 6 atopic 
dermatitis (AD) patients and 6 healthy controls. In all patients the diagnosis of psoriasis or AD was 
confirmed histopathologically. All psoriasis lesions were in the exacerbating phase. We performed 
immunohistochemistry using both anti CD123 and BDCA-2 antibodies for pDCs. Psoriatic skin 
biopsy specimens showed infiltration of CD123+ and BDCA-2+ cells into the thickened epidermis 
and papillary dermis. Normal skin showed no CD123+ or BDCA-2+ cells in the epidermis. These cells 
were hardly detectable in the normal dermis. Although CD123+ or BDCA-2+ cells were absent in the 
atopic epidermis, they significantly increased in the dermis of AD as well as psoriasis patients. Both 
epidermal and dermal pDCs significantly increased in psoriatic lesions as compared with normal 
skin. The number of epidermal CD123+ and BDCA-2+ cells was correlated with the PASI score. 
These findings suggest that epidermal pDCs potentially contribute to the pathogenesis of psoriasis.   
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Evaluating morbidity and association with autoimmune thyroiditis of chronic urticaria in 
children
E Netchiporouk1 and M Ben-Shoshan2 1 Dermatology, McGill University, Montreal, QC, 
Canada and 2 Allergy and Clinical Immunology, McGill University, Montreal, QC, Canada
Chronic urticaria (CU) is defined when hives occur for at least 6 weeks. When no identifiable cause 
for CU can be found, this condition is classified as chronic spontaneous urticaria (CSU). Recent 
studies suggest that autoimmunity including targeting either the mast cell IgE receptor, the IgE 
molecule or auto-antigens (i.g. thyroid antigens) may account for almost 50 % of CSU cases. The 
pathogenesis of CU and its effect on quality of life (QoL) are not well established in children. We 
aimed to establish a registry of CU in children to assess autoimmunity and factors affecting QoL. 
Between January 2013 and 2014, we recruited 35 children from our urticaria clinic. Participants 
were queried on demographics, clinical history, QoL through a validated questionnaire (CU-Q2oL) 
and the urticaria activity score (UAS). Blood tests were drawn to assess basophile activation, thy-
roid autoimmunity and confirmatory tests were performed when applicable to diagnose inducible 
forms. Our findings reveal that the majority of children were males (57%) presenting at a median 
age of 8 years (IQR: 3.75-12.0). Thyroiditis was reported in 17.1% of family members, but TSH 
and anti-thyroid peroxidase IgG were normal in all patients. Physical forms occurred in 17.1 % of 
patients (mostly cold induced CU). Autoimmune urticaria, demonstrated by high CD63 expression, 
occurred in 15.7% patients. The mean weekly UAS score over 3 months was 6.5 on a scale of 42, 
indicating a mild disease. Increased age at onset (odds ratio, OR=2.2, 95%CI,1.51,2.87) was asso-
ciated with decreased QoL in the functionality domain and UAS (2.16, 0.48,3.85) with worse sleep 
domain. CU in our initial sample of children was not associated with thyroiditis and the incidence 
of autoimmune CU was lower compared to that reported in the adult literature. Older age of onset 
and higher UAS may affect the quality of life in pediatric population.    
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Experimental bullous pemphigoid in adult mice is a suitable model to test potential pharma-
cological inhibitors of tissue destruction
FS Schulze,1 T Beckmann,1 S Goletz,1 F Nimmerjahn,2 D Zillikens,1 R Ludwig3 and 
E Schmidt1 1 Department of Dermatology, University of Lübeck, Lübeck, Germany, 2 
Department of Biology, University of Erlangen-Nuremberg, Erlangen, Germany and 3 Lübeck 
Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
Bullous pemphigoid (BP) is a subepidermal blistering disease of the elderly mediated by autoanti-
bodies against the structural skin proteins type XVII collagen (BP180) and BP230. The importance 
of Fcgamma receptors (FcγR) for the disease development in subepidermal autoimmune blistering 
diseases has been shown in the neonatal mouse model of BP as well as in the passive transfer model 
of epidermolysis bullosa acquisita (EBA). We have recently developed a novel experimental model 
for BP by repeated injection of rabbit anti-murine BP180 IgG into adult mice replicating major 
clinical and immunopathological characteristics of the human disorder. Tissue destruction in this 
model depended on FcγRIV and, to a lesser extent, on FcγRIII while FcγRIIB was protective. Here, the 
value of the novel model to explore anti-inflammatory mediators was investigated. Pharmacological 
inhibition of FcγRIV in a prophylactic setting greatly suppressed disease induction while application 
in a quasi therapeutic approach, i.e. in mice with initial skin lesions, no significant clinical effect 
was seen. These data suggest that FcγRIV-mediated effects are more important in the initiation of 
the inflammatory reaction rather then when skin inflammation is already established. In contrast, 
depletion of neutrophils and macrophages by an anti-Gr-1 antibody resulted in significantly less 
tissue destruction, in both the prophylactic and the quasi therapeutic approach. In conclusion, we 
show that the novel experimental BP mouse model is suitable to investigate potential anti-inflam-
matory strategies in a quasi therapeutic setting.    
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Expression of the alarmin HMGB1 in psoriasis vulgaris 
SM Lund Andersen,2 S de Fønss,2 K Stenderup,2 T Norman Dam1 and C Rosada2 1 Dept. of 
Dermatology, Roskilde Hospital, Roskilde, Denmark and 2 Dept. of Dermatology, Aarhus 
University Hospital, Aarhus, Denmark
High Mobility Group protein B1 (HMGB1) is a nuclear protein that, in response to inflammatory 
stimuli, is released in the cytoplasm and extracellular space and functions as an alarmin. The 
role of HMGB1 in psoriasis is still not understood, but translocation of HMGB1 to the cytoplasm 
has been shown in lesional skin and serum levels are increased in psoriatic patients. This study 
aims to describe HMGB1 expression in psoriasis and the cellular origin of released HMGB1. The 
expression levels of HMGB1 protein and mRNA were investigated by western blot and RT-qPCR in 
biopsies from plaque psoriasis, non-lesional and healthy skin. HMGB1 localisation in the skin was 
assessed by immunohistochemistry. HMGB1 protein and mRNA levels were also investigated in 
peripheral blood mononuclear cells (PBMC) isolated from blood collected from psoriasis patients 
and healthy donors and in primary human keratinocytes (NHEK) isolated from healthy donors. A 
psoriasis-like phenotype in NHEK was induced by stimulation with TNFα, IL-17 and IL-22 and 
HMGB1 release was assessed by ELISA. Translocation of HMGB1 from the nucleus was confirmed 
in lesional compared to non-lesional and healthy skin. Protein expression was increased in skin 
biopsies from psoriatic patients compared with healthy controls; however, mRNA expression level 
was decreased. No difference in HMGB1 protein or mRNA expression was observed in PBMC. 
Induction of a psoriasis-like phenotype in NHEK did not alter the protein expression level or the 
release of HMGB1, yet mRNA expression level increased after 2 hours and returned to control level 
after 24 hours suggesting a more subtle regulation of HMGB1 expression in a chronic inflammatory 
status. These data are the first attempt to clarify the role of HMGB1 in psoriasis and suggest that 
TNFα, IL-17 and IL-22 alone are not sufficient for HMGB1 release from NHEK. As no difference 
in HMGB1 expression is found in PBMC isolated from psoriasis or healthy donor blood, it can be 
suggested that the skin may be the source of serum HMGB1 in psoriasis.    
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Filaggrin null mutations in humans are associated with Langerhans cell maturation 
C Leitch,2 S Ghaffar,2 N Madarasingha,3 Z Venables,3 E Natafji,3 R Chu,2 I McLean,1 
J Schwarze,3 S Howie3 and RB Weller2 1 Centre for Dermatology and Genetic Medicine, 
University of Dundee, Dundee, United Kingdom, 2 Department of Dermatology, Royal 
Infirmary of Edinburgh, Edinburgh, United Kingdom and 3 Centre for Inflammation Research, 
University of Edinburgh, Edinburgh, United Kingdom
Filaggrin null mutations are the strongest risk factor yet identified for the development of atopic 
dermatitis, but the mechanism linking filaggrin deficient epidermis and inflammatory skin disease 
has not yet been elucidated. We have previously shown that there is no difference in skin barrier 
function between healthy individuals with and without filaggrin null mutations. The purpose of 
this study was to investigate the relationship between filaggrin null mutations and epidermal anti-
gen presenting cell maturation in individuals with and without atopic dermatitis. Additionally we 
investigated whether cis-urocanic acid, a filaggrin breakdown product, exerted immunmodulatory 
effects on dendritic cells in vitro. Epidermal antigen presenting cells in suction blister roofs from 
non-lesional skin were assessed by flow cytometry and confocal microscopy. Monocyte derived 
dendritic cells generated from peripheral blood from healthy volunteers were used to assess the 
effects of urocanic acid on dendritic cell phenotype by flow cytometry. Flow cytometry of suction 
blister roofs indicated that epidermal antigen presenting cells from filaggrin null individuals with 
and without atopic dermatitis had increased CD11c expression (p=0.006). Confocal microscopy 
confirmed this (p=0.04), and additionally revealed an increased number of CD83+ Langerhans cells 
in filaggrin-null individuals (p=0.01). Cis-urocanic acid reduced the expression of co-stimulatory 
molecules CD86 and PDL-1 in monocyte-derived dendritic cells. Individuals with filaggrin-null 
mutations have more mature Langerhans cells in non-lesional skin whether or not they have atopic 
dermatitis. A relative deficiency of cis-urocanic acid in filaggrin null subjects is a possible mechanism 
leading to increased Langerhans cell maturation.    
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Further characterization of crocin anti-inflammatory activity 
D Fagot,1 M Verdier,1 L Guerin2 and S Cheilian2 1 Research and Innovation, L’Oréal, Aulnay-
sous-bois, France and 2 Research and Innovation, L’Oréal, Chevilly-Larue, France
Crocus sativus Linn is a flowering plant from the Iridaceae family, commonly known as saffron. 
Considering that aqueous and ethanolic extracts of saffron stigmas were reported to possess acute 
and chronic anti-inflammatory activity, the present in vitro study aimed at further characterizing the 
anti-inflammatory properties of crocin (crocetin di-gentiobiose ester), one of the major biologically 
active ingredients of saffron together with crocetin. In the presence of crocin (0.3 and 1 mM), the 
release of inflammatory mediators (PGE2, IL-8, IL-6, TNF-a and LTB4) from 10 ng/ml Phorbol Myri-
state Acetate (PMA)-treated human keratinocytes in culture was significantly inhibited. Moreover, 
1 mM crocin treatment of normal human keratinocytes for 24 h resulted in the modulation of a 
number of genes, involved in NF-kB signaling pathway. Among these, the down-regulation of CSF2, 
CSF3, CXCL1, CXCL2, IL-1A, LI1RN, IL1R2, TNF, STAT1, PDGFB, PLAU and MMP9 gene expression 
underlined a decreased inflammatory response and hence an increased defense against chronic acti-
vation of inflammatory response (inflamm-aging). On the other hand, the up-regulation of NQO1, 
and SOD2 genes, among others, reflected an increased cell defense response to stress. Altogether 
these results highlighted the beneficial of crocin with respect to key processes involved in skin aging.   
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High expression of ADAMs are involved in the pathologic process of bullous pemphigoid
H Fang and G Wang department of dermatology, xijing hospital, xi’an, China
BP180 (also referred to as collagen XVII) is a collagenous transmembrane protein, which exists 
as a full-length transmembrane protein or as a soluble 120kd ectodomain that is shed from the 
cell surface by ADAM9, ADAM10 and ADAM17(proteins with a disintegrin and metalloprotease 
domain). Although ADAMs family has been implicated in the control of BP180 shedding, the 
expression levels and role of ADAMs on bullous pemphigoid were still largely unknown. In the 
present study, We investigated the three ADAMs expression in BP patient compare with healthy 
people. We also detected the relationship between ADAMs and BP180 in the process of HaCaT 
keratinocytes proliferation. The function of ADAMs proteolysis were observed through the proin-
flammatory cytokines stimulation on HaCaT keratinocytes. Our results reveal that the ADAM9, 10 
and 17 were upregulated in lesions of BP patients when compared with healthy control by immuno-
histochemistry and Western Blot analysis. Meanwhile, BP180 cell-surface expressions were related 
with the three ADAMs in HaCaT in vitro. More importantly, we found that the proinflammatory 
cytokines including interferon–γ (IFN-γ) and tumor necrosis factor–α (TNF–α) and transforming 
growth factor–β (TGF–β), could increased the level of the active protease and release of soluble 
120kDa fragment in HaCaT keratinocytes, then leading to loss of BP180 from the cell surface and 
decreased keratinocyte cohesion. Collectively, these findings indicate that the ADAM9, ADAM10 
and ADAM17 were overexpressed in BP patients and may play an important role in the pathological 
process of bullous pemphigoid.    
052
High prevalence of cryofibrinogenemia in dermatitis herpetiformis
P Bognár, A Görög and S Kárpáti Department of Dermatology, Venereology and 
Dermatooncology, Semmelweis University, Budapest, Hungary
Cryofibrinogen (CF) is a form of cryoprotein which precipitates in cold (4C°) plasma but not in 
serum, and redissolves upon increasing the temperature back to 37C°. The cryoprecipitate consist 
mainly of fibrinogen, fibrin, fibronectin, and factor VIII. Cryofibrinogenemia (CFE) is an uncommon 
finding with a prevalence of 0-7% in healthy population, and 8-13% among hospitalized patients. 
The condition can be primary or secondary to various conditions. CFE may exist asymptomatically, 
but subtle skin findings such as purpura, cold intolerance, Raynaud-phenomenon may develop. 
Since in early dermatitis herpetiformis (DH) skin lesions the papillary IgA, C3 and TG3 precipitates 
also contain deposits of fibrin and fibronectin, and acral purpura is a common symptom in the 
disease, we studied DH patients for the presence of CF and cryoglobulin. 88 DH patients, 60 men 
and 28 women, mean age 36.5±17.4 have been involved in the study. The overall prevalence of 
CFE in the screened DH population was 57.95% (51 out of 88 patients), while the prevalence of 
cryoglobulinemia revealed 11.36% (10 out of 88 patients). CFE was detectable in 37 out of 55 DH 
patients before gluten free diet (GFD), reaching the prevalence of 67.27%, while in patients already 
under strict GFD the prevalence was lower, 42,42% (14 out of 33 patients). On the contrary cryo-
globulinemia was detected in 9.09 % of patients without GFD (5 out of 55 patients), and this value 
was 15.15% (5 out of 33) in patients on GFD. In the group of DH patients on GFD and concomitant 
dapsone treatment the prevalence of CFE was significantly reduced to 6.06% (2 out of 33), while 
the prevalence of cryoglobulinemia did not changed. These data provide evidence for the unusually 
high prevalence of CFE in DH patients, and suggest that the well established treatments (GFD and/
or dapsone) reduce the frequency of the otherwise usually latent CFE.    
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Human monocyte-dermal fibroblast co-cultures as in vitro models that reflect macrophage 
behavior in human skin 
A Winiski, S Wang, S Olt, F Kalthoff, E Kriehuber and B Wolff-Winiski ATI/dermatology, 
Novartis Institutes for BioMedical Research, Vienna, Austria
Since fibroblasts are a dominant cell type in the dermis, we wanted to explore their effects on human 
macrophage behavior under co-culture conditions. Co-cultures of primary human monocytes with 
human dermal fibroblasts in 2D culture on plastic, as well as monocytes on fibroblast-derived matri-
ces (FDM) in 3D were established. They were incubated for up to a week to allow for macrophage 
differentiation in the presence or absence of M-CSF followed by overnight stimulation with IL-4, 
IFN-γ, LPS or combinations thereof. Surface markers and secreted proteins indicative of macrophage 
differentiation and M1/M2 polarization were evaluated by FACS and ELISA, respectively. In the 
presence of fibroblasts in 2D co-culture, surface expression of the M2 markers CD206, CD209 and 
CD200 receptor was increased compared to monocyte monoculture and further enhanced by the 
presence of IL-4. The expression of the macrophage differentiation marker CD163 expression was 
also increased by the presence of fibroblasts. Interestingly, the surface expression of the M1 markers 
CD38, CD64 and CD197 was also increased by the presence of fibroblasts and further enhanced by 
IFN- γ. The highest levels of CD163, CD206 and CD209 expression (tissue macrophage phenotype) 
were obtained after co-culture of monocytes with FDM, independent of the presence or absence 
of M-CSF. The secreted M1 markers CXCL10 and IL-23p19 were up-regulated by IFN- γ alone and 
in combination with LPS, respectively, while the secreted M2 markers CCL22 and CCL18 were 
up-regulated by IL-4 alone and in combination with LPS. The expression of a tissue macrophage 
phenotype (CD163, CD206, CD209) on macrophages in monocyte-fibroblast co-cultures, as well 
as the polarizability toward M1 and M2 phenotypes by IFN- γ and IL-4 respectively, support their 
relevance as in vitro models of macrophages in human skin.    
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IL-17A Negatively Correlated with Serum C1q/TNF-Related Protein-3(CTRP3) Levels in 
Patients with Psoriasis: Implications for Cardiovascular Co-morbidities
K Xue, D Li, C Li and G Wang Dermatology, Xijing Hospital, Fourth Military Medical 
University, Xi’an, China
Epidemiological investigations suggest patients with psoriasis have a high prevalence of metabolic 
disorders and an increased risk of developing cardiovascular consequences.IL-17A is the common 
inflammatory mediator between psoriasis and cardiovascular disease whereas the molecular mech-
anistic link between the two diseases is not fully characterized. C1q/TNF-related proteins-3 (CTRP3) 
is a newly identified adipokine as a cardioprotective factor and regulator of glucose homeostasis. 
Our research focus on the CTRP3 variation in psoriasis patients and the correlation between CTRP3 
and IL-17A levels. We conducted a case-control study including 28 adult patients with plaque type 
psoriasis during March to May 2014 at a dermatology inpatient department and 47 healthy age- and 
sex-matched controls. Serum levels of CTRP3, IL-17A and TNF-α were detected using commercial 
ELISA kits. We found that CTRP3 levels of psoriasis were decreased significantly compare to health 
controls (237.7±98.8 pg/mL vs. 650.8±309.2 pg/mL, P<0.0001). Spearman’s correlation test was 
performed to determine the relationships of serum CTRP3 levels with study variables. Circulating 
CTRP3 levels were significantly negatively correlated with BMI (r=-0.5638, P=0.0018), triglycer-
ide (r=-0.5292, P=0.0065) and fasting glucose levels (r=-0.4020, P=0.0418). More importantly, 
we observed a significant negative correlation between CTRP3 and IL-17A levels in cases group 
(r=-0.5320, P=0.0036). On the other hand, CTRP3 levels had no significant correlations with var-
ious psoriatic parameters including PASI and TNF-α levels. In summary, we detected a significant 
decrease of serum CTRP3 levels and a negative correlation with IL-17A in psoriasis patients. We 
concluded that IL-17A may have an influence on CTRP3 expression in psoriasis and this IL-17A/ 
CTRP3 interactive mechanism offers an implication for cardiovascular co-morbidities in psoriasis.   
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IL-17A secreted from CpG-stimulated keratinocytes can induce IL-22 production in CD4+ T 
cells: implication of keratinocytes in the pathogenesis of psoriasis 
H Lee,1 Z Li,2 C Kim2 and J Lee1 1 Dermatology, Chungnam National University Hospital, 
Daejeon, Republic of Korea and 2 Chungnam National University, School of Medicine, 
Daejeon, Republic of Korea
Interleukin-17A (IL-17A) is secreted mainly from Th17 cells activated by several stimuli including 
Toll-like receptor 9 (TLR9) ligand CpG. Recently, the role of keratinocytes in the pathogenesis of 
psoriasis has been re-emphasized. To elucidate the role of keratinocytes in psoriasis, we investi-
gated whether CpG induces expression of IL-17A in keratinocytes using Q-PCR and ELISA. We also 
checked whether CpG induces IL-17A production via the NF-κB-mediated pathway. When HaCaT 
keratinocytes were treated with CpG, IL-17A expression was significantly increased, together with 
increase of other cytokines such as TNF-α and CCL20. The CpG-induced IL-17A expression was 
via the NF-κB pathway, evidenced by the fact that inhibitor for NF-κB pathway markedly blocked 
the CpG-induced IL17A production in HaCaT keratinocytes. Finally, IL-17A secreted from kerati-
nocytes can stimulate CD4+ T cells, leading to strong induction of IL-22 production. As IL-22 is an 
important regulator for psoriatic inflammation, our data suggest that keratinocytes can contribute 
to the pathogenesis of psoriasis by TLR9-dependent production of IL-17A.    
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IL-1beta promotes atopic dermatitis phenotype in 3D reconstructed normal human epidermis 
M Bernard,1 B Guiraud,2 M Vocanson,1 S Bessou-Touya,2 H Duplan,2 A Rozieres,1 
C Goujon,3 J Nicolas1 and M Galliano2 1 U1111 CIRI, INSERM, Lyon, France, 2 Pierre Fabre 
Laboratory, Toulouse, France and 3 Unité de Recherche Clinique en Immunologie Lyon Sud, 
CHU Lyon Sud, Pierre Benite, France
Atopic dermatitis (AD) is a common T-cell mediated skin inflammatory disease characterized by 
production of thymic stromal lymphopoietin (TSLP) by epidermal cells, a marked Th2 polarization 
with production of IL-4 and IL-13 and a profound alteration in epidermal barrier function. In this 
study, we explore a possible contribution of IL-1b to the development of AD skin inflammation. We 
investigated the impact of IL-1b signalling on the epidermal homeostasis of both healthy subjects 
and AD patients [with functional filaggrin (FLG) alleles] with particular attention on TSLP produc-
tion and epidermal barrier function. We generated 3D-reconstructed human epidermis (RHE) and 
exposed them to graded doses of IL-1b and/or to a mixture of inflammatory stimuli (TLR2/TLR3 
ligands or IL-4/IL-13 cytokines) known for their ability to activate epidermal cells and induce an AD 
phenotype. Production of inflammatory mediators and alteration of skin barrier function was then 
analysed at molecular, cellular and tissue level. IL-1b, comparatively to TLR2/3 ligands or IL-4/13 
cytokines, promoted in normal RHE: (i) a robust secretion of TSLP in a NFkB-dependant manner, 
and (ii) a significant decrease in epidermal barrier function, as illustrated by reduced filaggrin 
and claudin-1 expression and increased dye penetration through the epidermis. Interestingly, RHE 
generated from AD donors behaved like those of normal individuals: at the steady state, they did 
not display skin barrier dysfunction and showed comparable responses to IL-1b signals. Our data 
strongly supported that IL-1b is a key mediator for the acquisition of AD phenotype through induction 
of TSLP and alteration of epidermal barrier function. However they exclude a correlation between 
AD susceptibility of FLG+/+ allergic individuals and epidermal responsiveness to IL-1b signals.   
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Immunomodulatory Effects of Heat Shock Protein 90 Inhibition on Humoral Immune 
Responses
S Tukaj,1 B Tiburzy,1 R Manz,1 A de Castro Marques,1 A Orosz,2 RJ Ludwig,1 D Zillikens1 and 
M Kasperkiewicz1 1 University of Lübeck, Lübeck, Germany and 2 Anticancer Drug Research 
Foundation, Budapest, Hungary
Heat shock protein 90 (Hsp90) inhibition affects inflammatory disease pathways and exhibits ther-
apeutic activity in autoimmune disease mouse models, including the blistering disease epidermol-
ysis bullosa acquisita. However, how Hsp90 blockade exerts its immunomodulatory activity on 
components of humoral immunity is not yet fully understood. Therefore, in the present study, in 
vitro and in vivo effects of Hsp90 inhibition on (auto-)antibody responses in humans and mice were 
investigated. The Hsp90 inhibitor 17-DMAG inhibited proliferation of activated total B cells and their 
IgG secretion in cultures of human peripheral B cells from healthy subjects. 17-DMAG treatment was 
associated with induction of nuclear and cytoplasmic heat shock factor 1 and Hsp70 in stimulated 
human B cells, respectively. Type VII collagen (epidermolysis bullosa acquisita)-immunized mice 
early treated with 17-DMAG had reduced total B cells in spleens, a relative increase in splenic 
regulatory B cell fractions, higher serum IL-10 concentrations, and lower levels of circulating auto-
antibodies compared to vehicle-treated immunized mice. Autoantibody production was blunted in 
isolated and autoantigen-restimulated lymph node cells from immunized mice by either 17-DMAG 
or purified autologous splenic regulatory B cells. Thus, pharmacological Hsp90 blockade potently 
modulates humoral immune responses at the B cell level, further supporting the introduction of 
Hsp90 inhibitors into the clinical setting for treatment of autoantibody-mediated disorders.    
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Immunosuppressive effects of 1,25-dihydroxyvitamin D3 in human peripheral blood mononu-
clear cells and keratinocytes are additively increased by the combination with betamethasone
K Hashimoto, H Uratsuji, T Matsumoto and R Ishii Research Laboratories, Kyoto R&D Center, 
Maruho Co., Ltd., Kyoto, Japan
Activated vitamin D3 analogues and corticosteroids have been widely used for topical treatment 
of psoriasis. A combination therapy of the two drugs is more useful than monotherapy because of 
earlier and stronger therapeutic effects onset. Both drugs have been reported to elicit the immunosup-
pressive effects such as the suppression of lymphocytes proliferation and reduction of inflammatory 
cytokines production in the therapy of psoriasis. However, the non-clinical data regarding the 
combined immunosuppressive effects of both drugs are still insufficient. Therefore, we investigated 
the immunosuppressive effects of 1,25-dihydroxyvitamin D3 (VD3) in the presence of betamethasone 
(Bet) in human peripheral blood mononuclear cells (PBMCs) and human epidermal keratinocytes 
(KCs) in vitro. In PBMCs, the uptake of bromodeoxyuridine (BrdU) was dose-dependently sup-
pressed by VD3 and Bet at 10
-9 to 10-6 mol/L, indicating the inhibition of PBMCs proliferation. The 
suppression of BrdU uptake by Bet was additively increased in the presence of VD3 (10
-6 mol/L). 
The productions of tumor necrosis factor-α and interferon (IFN) -γ from PBMCs stimulated with 
phytohemagglutinin were dose-dependently reduced by VD3 and Bet at 10
-9 to 10-6 mol/L. Further 
reduction in those cytokines levels were induced by the combination of both drugs when compared 
to each drug alone. In KCs, interleukin (IL) -6 and IL-8 productions induced by stimulation with IFN-γ, 
were dose-dependently decreased by VD3 and Bet at 10
-9 to 10-6 mol/L. The combination of VD3 
and Bet showed further decrease in the production of those mediators when compared to each drug 
alone. In conclusion, our study demonstrated the additive immunosuppressive effects of combined 
treatment with VD3 and Bet in PBMCs and KCs, supporting the usefulness of combination therapy 
involving activated VD3 analogues and corticosteroids in the treatment of psoriasis.    
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Impact of rituximab on auto-reactive B cell repertoire in Bullous Pemphigoid
N Berkani,1 N Colliou,2 F Caillot,1 SF Calbo,2 P Joly1 and P Musette1 1 Dermatology, Rouen 
University Hospital, Rouen, France and 2 Normandy University, Inserm U905, Rouen, France
Bullous Pemphigoïd (BP) is the most common auto-immune sub-epidermal blistering disease 
characterized by the production of auto-antibodies directed against 2 major components of the 
hemidesmosome: BP180 and BP230. B cell depletion by rituximab (Mabthera®)(RTX) has shown 
efficacy against relapsed forms of pemphigus. We performed a clinical trial evaluating RTX in 
treatment to 18 relapsing BP patients for 2 years. B cell subsets, BP180 and BP230 antibody titers, 
BP180 specific B cells number and repertoire were monitored in blood. Five patients died, 3 
patients exit the trial caused by uncontrolled disease or severe side effects. Six patients relapsed 
during the trial and are still in minimal treatment and 4 patients are in complete remission weaned 
for corticoids. B cell depletion was observed until 6 to 9 months after RTX injection. We found that 
the balance between naïve and memory B cells is affected even 2 years after treatment (1.5 at D0 
to 4 at D720). Anti-BP180 and anti-BP230 antibodies titers showed a long-term decrease after RTX 
for all patients except during relapses which is consistent with the disappearance of IgG+BP180+ 
specific B cells whereas IgM+ B cell BP180+ specific were still detectable after treatment implying an 
inhibition of class switching of BP180+IgM+ B cells to pathogenic IgG+ B cells. Repertoire analysis 
of BP180+IgG+ cells before RTX showed a specific usage of VH1 and VH5 family and their CDR3 
sequences present a Glycine in 114 position (IMGT numerotation) for 60% of them. Comparatively 
this specific pattern is not present in BP180+IgM+ CDR3 sequences. Our study describe the BP180 
specific B cell repertoire and the impact of RTX on auto-reactive B cells re-population after treat-
ment characterized by the blockage of isotypic commutation to pathogenic IgG selected by their 
auto-reactive CDR3 motifs on BCRs.    
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Increased expression of CD93 in skin in patients with chronic plaque psoriasis
A Duvetorp,2 R Slind Olsen1 and O Seifert3 1 Division of Drug research, Deparment of 
medical and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, 
Sweden, 2 Department of Dermatology, Futurum, - academy for Health and Care, Jönköping 
Conuty Council, Jönköping, Sweden and 3 Department of Dermatology, Ryhov Hospital, 
Futurum, -academy for health and Care, Jönköping County Council, Jönköping, Sweden
CD93 and the pathogenesis of psoriasis is an unexplored field in research. Human CD93 is an 
epidermal growth factor (EGF) – like domain containing transmembrane protein which appears 
in two forms; a cell-associated full-length form and a truncated soluble form. Expression of CD93 
is seen on a variety of cell types involved in the inflammatory cascade and hematopoiesis, and is 
predominantly expressed in vascular endothelium. CD93 acts as a possible angiogenetic factor and 
may play a role in T-cell homing in human skin. This suggests that CD93 may play a role in psoriasis 
pathogenesis. In this study we investigated the gene expression and the localization of CD93 in 
lesional and non-lesional skin in patients with chronic plaque type psoriasis (n=14) compared to 
healthy controls (n=15). Subjects had all undergone medical care at the Department of Dermatol-
ogy at the Ryhov Hospital, Jönköping, Sweden. Our results showed significantly increased mRNA 
expression of CD93 in skin from patients with psoriasis compared with skin from healthy controls. 
Immunohistochemical analysis showed an increase in CD93 protein levels in vascular endothelial 
cells located in the dermis of psoriasis lesional skin but was not present in non-lesional skin or 
healthy controls. This is the first study to show an increased gene expression of CD93 in psoriasis 
skin. The increased levels of CD93 in endothelial cells in lesional skin suggests that CD93 might 
play a role in the pathogenesis of psoriasis. Further studies to determine this role and the potential 
of CD93 as a possible target in future treatment options should be encouraged.    
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Increased expression of the Wnt signaling inhibitor Dkk-1 in non-lesional skin and peripheral 
blood mononuclear cells of patients with chronic plaque type psoriasis 
O Seifert,1 J Söderman,2 M Skarstedt2 and O Dienus2 1 Division of Dermatology, 
Ryhov Hospital, Jönköping, Sweden and 2 Department of Laboratory Services, Clinical 
Microbiology, Ryhov Hospital, Jönköping, Sweden
Psoriasis is a common inflammatory skin disease characterized by abnormal keratinocyte prolif-
eration, increased dermal angiogenesis and systemic inflammation with increased cardiovascular 
mortality. The cell signaling cascades provoked by Wnt proteins and their inhibitors as Dickkopf-1 
play a crucial role to maintain homeostasis of a variety of tissues such as blood, intestine and skin 
and they are involved in epidermal regulation, angiogenesis and innate immunity. This study was 
designed to investigate the distribution of Dickkopf-1, a secreted protein inhibiting the Wnt signaling 
pathway, in lesional and non-lesional skin, in serum and in peripheral blood mononuclear cells of 
patients with chronic plaque type psoriasis compared with healthy controls. Our results showed sig-
nificantly increased mRNA and protein expression of Dickkopf-1 in non-lesional skin from patients 
with psoriasis compared with lesional skin and healthy control skin. Dickkopf-1 protein expression 
was significantly increased in peripheral blood mononuclear cells of patients with psoriasis com-
pared with healthy controls. No significant differences of Dickkopf-1 serum levels were observed. 
Increased levels of Dickkopf-1 in peripheral blood mononuclear cells, which are key actors in 
systemic inflammation, suggest a possible role of Dickkopf-1 in the chronic systemic inflammation 
recognized in psoriasis and increased levels of Dickkopf-1 in non-lesional psoriasis skin offers 
new insights in the local inflammatory processes in psoriasis skin since Wnt signaling regulates 
angiogenesis. In conclusion, Dickkopf-1 might be a possible target for new future treatment options   
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Increased level of circulating anti-alpha 6 integrin autoantibodies in patients with psoriasis 
vulgaris and psoriatic arthritis 
B Gál,1 S Dulic,2 M Kiss,3 G Groma,1 L Kovács,2 L Kemény1 and Z Bata-Csorgo1 1 
Dermatology and Allergology, University of Szeged, Szeged, Hungary, 2 Rheumatology, 
University of Szeged, Szeged, Hungary and 3 Dermatological Research Group, Hungarian 
Academy of Sciences, Szeged, Hungary
Alteration in laminin integrity described in the psoriatic skin could lead to insufficient laminin 
integrin interactions leaving the integrin exposed and accessible which may trigger the production 
of anti α6-integrin autoantibodies. Therefore, in this cross-sectional clinical study we aimed to 
investigate the presence of anti-α6 integrin autoantibodies in psoriasis vulgaris (Ps) and psoriatic 
arthritis (PsA). Serum samples were collected from 62 patients with Ps, 46 patients with PsA, 52 
healthy donors and 54 patients with rheumatoid arthritis (RA) that served as an additional control 
group. Collected sera from all four groups were subjected to determine the presence of circulating 
anti-α6 integrin antibodies by ELISA using three α6 integrin fragments predicted to have high 
immunogenic properties. Antibodies against at least one recombinant epitope of α6 integrin were 
found in 30.65% and 28.26% of patients with Ps and PsA, respectively. In contrast, in case of RA 
the frequency of the development of anti-α6 integrin antibodies was similar to the healthy controls. 
About 71% of the psoriatic patients received some form of systemic treatment. However, there was 
no correlation between the occurrence of these autoantibodies and the ongoing treatment. In early 
onset psoriasis the positivity for anti-α6 integrin antibodies was significantly more frequent than 
in those of late onset psoriasis. Our study provides evidence for the presence of anti-α6 integrin 
antibodies in Ps and PsA but not in RA, which could indicate ongoing abnormal processes in the 
skin. Anti-α6 integrin autoantibodies are unlikely to be part of the pathomechanism. Alternatively, 
autoantibodies could contribute to the formation of micro-wounds in the skin and to the charac-
teristic wound healing phenotype in psoriasis.    
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Inhibitory effect of selected plant extracts on IL-6 secretion in HaCaT cells exposed to UVB
K Bazela, R Debowska, K Rogiewicz and I Eris Centre for Science and Research, Cosmetic 
Laboratories Dr Irena Eris, Piaseczno, Poland
Inflammation is an important part of the pathologic changes in a number of skin diseases as well as 
in skin aging. Solar radiation, being a key factor accelerating skin aging, induces the formation of 
proinflammatory mediators such as TNF-α, IL-1ß, IL-6 initiating the inflammatory reaction cascade. 
Aging of human skin has been the subject of a profound interest for cosmetic industry which attempts 
to counteract this process. The use of anti-inflammatory cosmetic ingredients seems to be an effective 
approach to prevent symptoms related to photo-induced aging of the skin. The present study was 
aimed at evaluating the effect of selected plant extracts (A, B, C) on UVB-induced production of one 
of the inflammation mediators, interleukin (IL) 6, in skin cells. HaCaT cells (immortalized human 
keratinocyte cell line, Cell Line Service), used as a model resembling human keratinocytes, were 
grown in standard culture media and conditions. UVB irradiation was carried out using fluorescent 
bulb Midrange Tube, 15W (UVP) (emission peak at 302 nm). Confluent HaCaT cells were exposed 
to UVB (30 mJ/cm2) in phosphate buffered saline. Cell viability was evaluated with MTS assay. The 
concentration of IL-6 secreted to the cell culture media was assessed with BD OptEIATM Human IL-6 
ELISA. Results of in vitro study on HaCaT cells demonstrated the inhibitory effect of extract A and C 
on IL-6 secretion whereas extract B had no effect. Extract A (0,001-0,1%) decreased the IL-6 concen-
tration by 20%. Extract C (0,01-0,5%) inhibited the IL-6 concentration in a dose dependent manner. 
The ED50 parameter determining the concentration of tested substance for which 50% decrease of 
IL-6 secretion was assessed by log (agonist) vs. response – Variable slope (four parameters) model 
(GraphPad Pris 5.0, GraphPad Software, CA, USA). ED50 for extract C was 0,033%. In view of our 
results extract A and C could be an effective skin care and anti-photoaging ingredients. However, 
further studies are required to assess the full-spectrum of tested extracts anti-inflammatory activity.   
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Intranuclear changes of lymphoid cells in patients with atopic dermatitis
I Khamaganova,3 N Potekaev,4 M Savina,2 S Khromova1 and A Simonova2 1 department of 
microbiology&virology, Russian national research medical university named after N.I.Pirogov, 
Moscow, Russian Federation, 2 department of clinical laboratory diagnistics, Russian 
national research medical university named after N.I.Pirogov, Moscow, Russian Federation, 
3 department of skin diseases&cosmetology, Russian national research medical university 
named after N.I.Pirogov, Moscow, Russian Federation and 4 Moscow scientific &practical 
centre for dermatology &cosmetology, Moscow, Russian Federation
Atopic dermatitis is characterized by miscellaneous immune changes.The objective of this study 
was to examine lysine- rich,arginine- rich histone fractions & DNA in lymphocytes of peripheral 
blood in patients with atopic dermatitis.60 patients (29 males & 31 females) aged 14 to 36 years 
were examined.The duration of atopic dermatitis was about 13,5 to 35,5 years. Histone fractions 
were obtained by stepped extraction.The level of lysine- rich histone fraction was 20,7±1,8% what 
is lower than normal 37,0±1,5,p≤0,01.The level of arginine- rich histone fraction was 64,7±1,9% 
what is higher than in controls 44,0±1,7,p≤0,01.The ratio lysine/arginine was 0,32±0,07 what is 
lower than normal 0,84±0,01,p≤0,01.The ratio histone/DNA was 0,82±0,13 what is higher than in 
controls 0,63±0,06,p≤0,01.The findings showed intranuclear changes of lymphoid cells in patients 
with atopic dermatitis.We can assume that the intranuclear changes may depend upon the activity 
of the atopic dermatitis & functional activity of lymphocytes.    
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Kinetics of IL-17F and IL-22 in a 3 Days Imiquimod-Induced Dermatitis Model in Mice 
M Mortensen,1 G Olsen,1 P Lovato,1 L Svensson,2 L Martoft3 and L Veng1 1 Skin Inflammation 
Pharmacology, LEO Pharma A/S, Ballerup, Denmark, 2 NME Ideation, LEO Pharma A/S, 
Ballerup, Denmark and 3 Skin PK & Safety Pharmacology, LEO Pharma A/S, Ballerup, 
Denmark
A single, topical application of Imiquimod (IMQ) 5% cream, a ligand for Toll-like receptor (TLR) 
7 and 8, can elicit and aggravate flares in psoriasis patients. Daily topical applications of IMQ on 
murine skin can induce a skin phenotype resembling characteristics of psoriasis, e.g. inflammation 
with erythema and scaling, development based on the IL-23/IL-17 axis, resulting in increased 
epidermal expression of IL-17F and IL-22. Here, we present a short term, mechanistic model fea-
sible to i) investigate the expression of key cytokines in skin and ii) evaluate drugs intended to 
down-regulate the expression of IL-17 for treatment of psoriasis. We investigated the expression 
of IL-17A, IL-17F and IL-22 in our model, in which skin inflammation was induced by topical 
administration, once daily, of IMQ for 3 consecutive days. Skin and serum samples were collected 
1, 3, 5, 7 and 24 hours after the last application of IMQ. Skin protein levels of IL-17F and IL-22, 
but not IL-17A, were detected at all time-points investigated. Levels of IL-17F were significantly 
increased 1, 3, 5 and 7 hours after the last provocation with IMQ. Similarly, levels of IL-22 in skin 
were significantly increased 3 and 5 hours after the last provocation. Furthermore, the expression 
was attenuated upon treatment with relevant anti-inflammatory treatments. In addition, IL-17F and 
IL-22 were also detected in serum at all time-points investigated; however, no significant increases 
were identified. Gene expression of Il17f was unaffected by IMQ provocation, while expression 
of transcription factor genes Rorc and Rora were significantly down-regulated at the time-points 
investigated. In conclusion, the data show that our model is fast and feasible to investigate key - and 
psoriasis related pro-inflammatory cytokines expressed in the skin. However, it is not suitable gene 
expression analysis or protein analysis in serum.    
066
Kinetics of the expression of dopamine receptors 1 and 2 in allergic contact dermatitis 
H El-Nour Department of Medicine Solna, Dermatology and Venereology Unit, Karolinska 
Institutet, Stockholm, Sweden
The aim of this study was to investigate the kinetics of expression of dopamine (D) receptors (R) 
1 and 2 in skin biopsies obtained at 0, 48 and 72 h after antigen challenge, from allergic contact 
dermatitis patients. Skin biopsies (3 mm) were obtained from 10 female nickel allergic patients, at 
the designated time-points, and fixed in Bouin fixative for 2 h before being rinsed in 0.1 M phosphate 
buffer containing 10% sucrose for at least 24 h. The samples were stained using immunohistochem-
istry and a streptavidin-biotin method. Fluorescent microscopy and semiquantification (1 = low, 2 
= medium, 3 = high) were performed to analyse DR1 positive cell number or DR2 immunoreactive 
signal intensity, and DR2 epidermal fraction (1 <= 25%, 2 <= 50% and 3 <= 75%). DR1 expression 
was observed on dermal mononuclear cells. The number of DR1 positive cells was increased at 72 h 
(2.6±0.5 cells/section) compared to both 0 (1.0±0.1, p<0.001) and 48 h (2.1±0.4, p<0.05). Also the 
number of these positive cells was significantly increased at 48 in contrast to 0 h (p<0.001). While 
few mononuclear cells expressed DR2, the receptor expression was evident on basal keratinocytes 
where the signal intensity was noted to differ at the studied time-points. The highest immunoreactive 
signal was seen at 0 h (2.9±0.2) compared to 48 (2.0±0.3, p<0.001) and 72 h (1.5±0.4, p<0.001). 
The difference in signal intensity was significant between 48 and 72 h (p<0.002). DR2 epidermal 
fraction was lesser at 0 h (1.2±0.3) compared to both 48 (1.8±0.3, p<0.001) and 72 h (1.7±0.3, 
p<0.001). Our findings demonstrate the contribution of dopamine receptors 1 and 2 to the allergic 
contact dermatitis reaction and an altered expression of these receptors during the different stages 
of this disorder. DR2 may play a role in skin barrier integrity.    
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Leptin induces CXCL-1 expression in the dermal fibroblast – a possible link between obesity 
and psoriasis
PO Andersen, T Stjernholm, K Stenderup, L Iversen and C Rosada Department of 
Dermatology, Aarhus University Hospital, Aarhus, Denmark
Leptin, an adipokine secreted by the adipose tissue, plays both immune and endocrine roles. In 
obesity the adipose tissue sustains a low-grade systemic inammation, which is suggested to predis-
pose to psoriasis. Leptin is found at elevated levels in serum of both obese individuals and psoriasis 
patients compared to healthy controls; in psoriasis patients the level is reduced by treatment. Also, an 
activated state of the subcutaneous adipose tissue underneath psoriasis plaques has been described. 
Yet, the link between obesity and psoriasis is still unknown. The aim of this study was to investigate 
the response of dermal fibroblasts to leptin as the epidermis is physically separated from the subcuta-
neous adipose tissue by the intermediate dermis where the dermal fibroblast explicates its functions. 
Furthermore, we investigated whether this response may stimulate keratinocyte hyperproliferation, 
a characteristic of psoriatic epidermis. Cultured primary human dermal fibroblasts, isolated from 
normal (n=4) or psoriatic skin (n=4), were stimulated with leptin (300nM) and screened for secreted 
pro-inflammatory cytokines using a proteome profiler array. CXCL-1 was found to be induced more 
than 10 fold upon leptin stimulation of fibroblasts from both normal and psoriatic skin. These data 
were confirmed by ELISA. Increased proliferation of keratinocytes was observed after seven days 
of exposure to CXCL-1 suggesting an indirect effect of CXCL-1; indeed, in other cell lines, CXCL-
1-induced proliferation has been described to be associated with transactivation of the epidermal 
growth factor receptor. This study proposes a role for leptin in the pro-inflammatory events that occur 
at the dermal fibroblast level in psoriasis, suggesting CXCL-1 as a possible link between obesity and 
psoriasis. Even more, these data suggest that the fibroblast may play a not yet appreciated role in 
the pathogenesis of psoriasis and possibly of psoriasis comorbidities.    
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Leptin stimulates proliferation and augments secretion of inflammatory cytokines in primary 
human keratinocytes 
T Stjernholm, PO Andersen, C Rosada, C Johansen, L Iversen and K Stenderup Department 
of Dermatology, Aarhus University Hospital, Aarhus, Denmark
Leptin is a peptide hormone secreted by the adipose tissue and increased body fat mass leads to 
increased levels of secreted leptin. Obesity is a known risk factor in psoriasis. Obese patients are 
more disposed to severe psoriasis and are less likely to respond to therapy. Patients with severe 
psoriasis have elevated serum levels of leptin and lesional psoriasis skin shows elevated leptin 
expression levels. Whether leptin plays a role in the psoriasis pathogenesis and could help explain 
the correlation between obesity and psoriasis is still unknown. Previous studies have shown that 
leptin stimulates proliferation and secretion of inflammatory cytokines in T-cells. However, the effect 
of leptin on human keratinocytes has only been investigated sparsely. As keratinocyte hyper-prolif-
eration and secretion of inflammatory cytokines are hallmarks of psoriasis we aimed to investigate 
the effect of leptin on keratinocytes. Primary human keratinocytes (NHEKs) were isolated from 
healthy individuals undergoing corrective surgery. NHEKs were cultured until 80% confluence and 
stimulated with leptin for 48 hours. The effect of leptin on keratinocyte proliferation was evaluated 
by a viability assay (n = 4) and demonstrated a significant 2 fold stimulation of proliferation. The 
effect of leptin on secreted inflammatory cytokines was measured at protein level by ELISA (n = 5) 
and demonstrated significantly augmented secretion of IL-6 (50 fold), IL-8 (5 fold), CCL20 (MIP-3α, 
11 fold), CXCL1 (GRO-α, 4 fold), hBD2 (7 fold), and MMP-9 (3 fold). The stimulated proliferation 
and augmented secretion of inflammatory cytokines by leptin in human keratinocytes suggest that 
the adipose tissue, especially the underlying adipose tissue in the skin, may play an active role 
in the psoriasis pathogenesis and may help explain the correlation between psoriasis and obesity. 
The present results predict that future design of novel therapeutic interventions in psoriasis may be 
developed based on targeting the leptin axis.    
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Lupus-like systemic autoimmunity in wild-type mice by treatment with topical TLR7 agonist 
is accelerated by ultraviolet B irradiation
K Ohko, R Kamijima, C Fujimoto, S Kataoka, M Takaishi, K Nakajima and S Sano Depatment 
of Dermatology, Science Research Center, Kochi University, Nankoku, Japan
SLE is an autoimmune disease characterized by the production of autoantibodies and inflammatory 
pathologies such as glomerulonephritis. A number of studies have demonstrated that altered Toll-like 
receptor 7 (TLR7) signaling contributes to the initiation of SLE in humans and murine models. Indeed, 
introduction of Tlr7 null mutation in lupus-prone mice resulted in amelioration of lupus nephritis 
and reduction of autoantibodies, clearly indicating the contribution of TLR7 to lupus phenotype. 
We have recently demonstrated that epicutaneous application of TLR7 agonists, imiquimod (IMQ) 
or R848, leads to systemic autoimmunity in wild-type mice. Following topical treatment with 
TLR7 agonists, but not by intraperitoneal injection, wild-type mice developed lupus-like systemic 
autoimmunity, showing elevated autoantibodies to double-stranded DNA and glomerulonephritis, 
hepatitis, carditis and photosensitivity. This finding clearly renders the skin as the primary organ 
that allows TLR agonists to initiate lupus. Since ultraviolet (UV) irradiation is a worsening factor in 
SLE, we investigated the effect of UVB on TLR7 agonist-induced lupus. Strikingly, UVB irradiation of 
Balb/c mice resulted in earlier emergence of R848-induced anti-sm autoantibody, and higher titers 
of anti-double stranded DNA, than those treated with R848 alone. Simultaneously, UVB irradiation 
facilitated the development of renal disease with glomerular immunocomplex deposition. Results 
of the present study recapitulates the clinical feauture of SLE in that UV irradiation exabarates the 
systemic autoimmunity, and strongly suggests that the skin provides the specific platform where 
SLE initiates and develops    
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Macrophage migration inhibitory factor in the stratum corneum: A marker of the local severity 
of atopic dermatitis 
C Yasuda,1 A Enomoto,1 S Ishiwatari,1 N Mori,2 K Matsunaga,2 Y Yoshihisa,2 S Matsukuma1 
and T Shimizu2 1 Advanced Technology Research Center, Fancl Research Institute, 
Yokohama, Japan and 2 Dermatology, University of Toyama, Toyama, Japan
Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with various factors, 
including immunological abnormalities and exposure to allergens. Although various biomarkers 
are used to evaluate the severity of AD, it remains difficult to evaluate the severity of localized 
skin lesions. Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine that plays an 
essential role in the pathophysiology of skin inflammation, including AD. To establish whether the 
MIF level in stratum corneum (SC) can serve as a marker to evaluate the severity of AD lesions, we 
examined the SC MIF (scMIF) levels in AD patients. The SC of the cheek, neck and upper arm skin 
were collected using a tape-stripping method, and the scMIF level was measured in the patients with 
AD (n=43) and healthy subjects (n=20). The scMIF level was significantly higher in involved skin 
lesions than in uninvolved areas from the same patient or in healthy controls (p<0.01). Moreover, 
the scMIF level was significantly correlated with the severity of local skin lesions (p=0.0001). Our 
findings suggest that the scMIF level can serve as a useful marker to evaluate the local severity of AD.    
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Maximal Use Systemic Exposure Study of AN2728, a Novel Boron-Based Small Molecule for 
Treating Children and Adolescents with Mild-to-Moderate Atopic Dermatitis
L Kircik,2 R Call,3 E Tschen,4 Z Draelos,5 M Van Syoc,1 L Zane1 and A Hebert6 1 
Anacor Pharmaceuticals, Inc, Palo Alto, CA, 2 DermResearch, PLLC, Louisville, KY, 3 
Richmond Allergy & Asthma Specialists, Henrico, VA, 4 Academic Dermatology Associates, 
Albuquerque, NM, 5 Dermatology Consulting Services, High Point, NC and 6 University of 
TX Health Science Center, Houston, TX
AN2728 is a boron-based compound that inhibits phosphodiesterase-4 activity and reduces pro-in-
flammatory cytokines production that may be associated with atopic dermatitis (AD). AN2728 Oint-
ment, 2% was applied twice daily for 28 days to children and adolescents (N=34) with mild-to-mod-
erate AD, defined as mild or moderate on the Investigator’s Static Global Assessment (ISGA) scale. 
Subjects were grouped based on age and minimum percent of treatable body surface area (%BSA) 
affected: 2-5 yo (≥35%), 6-11 yo (≥35%) and 12-17 yo (≥25%). Subjects were dosed in the clinic 
during the first 8 days for pharmacokinetic (PK) studies and at home thereafter. Disease severity 
was measured using the ISGA scale, signs/symptoms score and %BSA affected. At Day 29, 65% 
of subjects achieved ISGA scores of clear or almost clear and 47% of subjects achieved scores of 
clear or almost clear with a >2-grade improvement from baseline. Marked reductions were observed 
across individual baseline AD signs and symptoms (pruritus, erythema, lichenification, excoriation, 
exudation) throughout the study. Notably, mean pruritus scores improved by approximately 60% 
from baseline after 5 days of treatment and mean %BSA affected decreased by a mean of 78% across 
groups after 4 weeks. Common treatment-related adverse events were mild or moderate application 
site reactions in 12 subjects which resolved spontaneously. One patient withdrew from the study 
due to application site pain. Pharmacokinetic results demonstrated low blood levels of AN2728 
similar to those previously observed in adults after adjusting for %BSA treated. These maximal use 
condition results suggest that AN2728 Ointment, 2% may be safe and effective in subjects 2 years 
of age and older with mild-to-moderate AD.    
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Modulation of hyperseborrhea by targeting inflammatory pathways involved in acne patho-
genesis: in vitro and in vivo studies
S Bredif,2 N Lachmann,2 S Leclère-Bienfait,2 J Rocheteau,2 H Talbot,2 A Moga,3 B Chadoutaud,4 
C Baudouin,2 T Biro1 and P Msika2 1 UNIVERSITY OF DEBRECEN, DEBRECEN, Hungary, 
2 INNOVATION, R&D DIRECTION, LABORATOIRES EXPANSCIENCE, Epernon Cedex, 
France, 3 SYNELVIA, LABEGE, France and 4 CLINREAL, TOULOUSE, France
Inflammation plays a central role in acne pathogenesis, indeed, it represents an early event and may 
be further amplified by both sebum lipid alteration and P. acnes proliferation. Sebum is not only 
produced in excess in acne, but its composition is also altered with an accumulation of oxidized 
squalene and a deficit in linoleic acid, creating an inflammatory ground. We have developed a plant 
extract, enriched in polyphenols, according to an optimized, secured and eco-designed process, in 
compliance with our sustainable policy. We investigated its capacity to target different pathways 
involved in acne in vitro and in vivo. The extract had a strong and direct inhibitory effect on P. 
acnes growth; it highly and significantly stimulated gene expression of anti-microbial peptides thus 
enabling keratinocytes to fight against microbial colonization. Moreover it was able to significantly 
inhibit IL8 production induced by P. acnes. Besides, the extract had an important anti-seborrhea 
potential as shown by the decreased sebaceous glands lipid content and the anti-oxidant capacity. 
We conducted a double-blind randomized placebo-controlled study on 34 women with mild 
to moderate acne during 60 days. A non-invasive sampling method was used to collect the skin 
surface lipids on forehead. Neutral lipids as well as squalene oxidized were quantified respectively 
by GC/MS and LC/MS. We observed highly significant differences between a 5% active formula 
and placebo on squalene (-28%), glycerides (+32%) and squalene oxidized (-39%). These results 
underlined the capacity of the extract to modulate the main inflammatory-related pathways of acne 
pathogenesis, regulate sebum secretion, improve sebum quality by protecting bounded fatty acids 
and limit oxidative alterations of the skin in vivo. Thus, this new cosmetic active ingredient offers 
a global solution for the management of oily and acne prone skin.    
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Modulation of the IL-17/IL-23 axis via inhibition of RORγt suppresses imiquimod induced 
cutaneous inflammation 
E Jaspers,2 SB Nabuurs1 and PE van Erp2 1 Lead Pharma Medicine B.V., Oss, Netherlands and 
2 Dermatology, Radboud university medical center, Nijmegen, Netherlands
The imiquimod (IMQ) model, in which mice receive a daily topical dose of IMQ on the shaved 
back, is a useful skin inflammatory model. The induced dermatitis closely resembles psoriasis, and 
is mediated by the IL-17/IL-23 axis. To evaluate the IMQ model for testing of potential therapeutic 
agents we tested two public domain reference inhibitors of RORγt, a master regulator of the IL-17/
IL-23 axis (CMP_01 and CMP_02). Clinically it was confirmed that topical application of IMQ 
induced redness (erythema), scaling and thickening of the skin (induration) in the IMQ treated 
skin compared to control. For the evaluation of therapeutic efficacy a scoring system analog to 
a clinical scoring system (SUM score) for psoriatic patients was used. Furthermore, the treated 
skin was evaluated (immuno)histochemically. Oral treatment was well tolerated for both reference 
compounds. In the clinical scores a significant decrease in scaling was observed in mice treated 
with CMP_01 compared to IMQ alone, whereas erythema and induration seemed to have changed 
only slightly. In the HE histological analysis the three specific clinical features for psoriasis were 
also recognizable. An increased infiltrate of leukocytes characteristic for erythema was observed 
together with desquamation and a marked increase in thickening of the epidermis (induration). When 
measuring the epidermal thickness from the HE histology, a significant and dose dependent decrease 
was observed for both CMP_01 and CMP_02. Immunohistochemical analysis using Ki67, filaggrin, 
involucrin, ly6g, cytokeratin 6, CD3, MPO, and Gr-1 confirmed the clinical and histological find-
ings. In conclusion, a skin inflammatory mouse model was established for testing and evaluation 
of potential therapeutic agents targeting the IL-17/IL-23 axis. The effect of two orally administered 
reference RORγt inhibitors was tested and evaluated. Besides clinical evaluation, histological and/
or histochemical evaluation seems necessary to proof therapeutic effect in this model.    
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Neuroanatomical evidence of descending inhibitor control of itch
E Karabulut,2 M Cayirli,1 M Seyrek,2 O Yesilyurt,2 F Kecilioglu3 and A Dogrul2 1 Dermatology, 
Mevki Hospital, Ankara, Turkey, 2 Pharmacology, Gulhane Academy of Medicine, ankara, 
Turkey and 3 Student, Gulhane Faculty of Medicine, Ankara, Turkey
Recent studies indicate the importance of spinal cord for processing and modulation of itch. It has 
been well known that descending pathways modulate the nociception, via axons that run from 
supraspinal sites through mainly the dorsolateral funiculus (DLF), which control spinal dorsal horn 
neuronal activity. We hypothesized that the descending modulatory mechanism for pain would 
also work for itch. We used intradermal pruritic substance-induced straching model to evaluate 
pruritus. Serotonin (25 μg) or histamine (250 μg) was injected intradermally (i.d.) in a volume of 
50 μl into the rostral part of skin on the back of Male Balb-C mice (25-32 gr) and scratches were 
counted for a 30-min observation period. Under anesthesia with ketamine (80 mg/kg) and xylazine 
(7 mg/kg) (i.p.), bilateral surgical lesions of DLF or sham surgery were performed at the T8–10. We 
assessed i.d. serotonin or histamine-induced stcratches in DLF lesioned and sham animals after 5 
days surgery. Data are expressed as mean and SEM (n=7-9) and Unpaired t-test was used to com-
pare the sham and DLF groups. As consistent with previous studies, total scratches of serotonin 
and histamine were found to be 23.4 ± 4.7 and 18.5 ± 5.4, respectively, in sham animals. While 
serotonin-induced stcratches significantly increased to 73.60 ± 7.4 (p<0.01), histamine-induced 
scratches did not alter significantly ( 15.25 ± 3.7, p=0.2) in DLF lesioned mice when compared 
to sham groups. Although the mostly descending fibers through DLF are serotonergic, but there 
are some non-serotonergic axons.Thus, not only descending serotonergic pathways but also other 
neurotransmttters may contribute descending control of pruritus. Our results confirm the importance 
modulatory role of spinal cord in the pruritic events and the targeting central nervous system in the 
treatment of pruritus. We provide neuroanatomical evidence that descending pathways through 
dorsolateral funiculus inhibit non-histaminergic peripheral pruritic stimuli.    
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Neutrophil inhibitory factor from Ancylostoma caninum binds to neutrophils and inhibits 
C5a-induced and anti-human type VII collagen autoantibody-induced neutrophil activation 
A Kemmer,2 K Bieber,1 J Köhl,3 K Seeger,4 C Kauderer,1 D Zillikens2 and A Recke2 1 
Lübeck Institute of Experimental Dermatology (LIED), Lübeck, Germany, 2 Department 
of Dermatology, University of Lübeck, Lübeck, Germany, 3 Institut für Systemische 
Entzündungsforschung (ISEF), Lübeck, Germany and 4 Department of Chemistry, University 
of Lübeck, Lübeck, Germany
Subepidermal blistering dermatoses are prototypic autoimmune diseases caused by autoantibodies 
to structural proteins of the skin which activate neutrophils and induce tissue damage at the der-
mal-epidermal junction. Since systemic immunosuppression leads to severe side effects, there is 
a need for development of novel treatments with fewer adverse effects. For this purpose, we engi-
neered a protein containing neutrophil inhibitory factor (NIF) derived from Ancylostoma caninum. 
Scalable protein expression was achieved by cloning NIF into a pMIB/V5-HisC expression vector 
for stable transfection of Sf21 insect cells. NIF was purified from the supernatant of the insect cell 
shaking culture by Strep-Tactin affinity chromatography and binding of NIF to neutrophils was 
verified by flow cytometry. The biological activity of NIF was evaluated in in vitro disease models 
that mimic the cascade of pathogenic events in the effector phase of epidermolysis bullosa acquisita 
(EBA). Since activation of the complement system significantly contributes to tissue injury in EBA, 
we investigated the effect of NIF on C5aR-mediated chemoattraction of neutrophils. We showed 
that C5a-stimulated neutrophil transwell migration was strongly inhibited by NIF. As release of 
reactive oxygen species (ROS) is a precondition for blistering in EBA, we measured ROS release by 
neutrophils from healthy volunteers stimulated with immobilized immune complexes and treated 
with different NIF concentrations. We found a dose-dependent inhibition of ROS production by NIF. 
Although very effective, toxicity of NIF on neutrophils proved to be low (AnnexinV/Propidium iodide 
staining). We conclude that NIF is a good candidate for future selective inhibition of neutrophil 
functions in EBA and related neutrophil-mediated autoimmune diseases.    
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Novel therapeutic strategy to control atopic dermatitis using a newly generated JAK inhibitor 
JTE-052 via promoting skin barrier functions 
W Amano, S Nakajima, Y Miyachi and K Kabashima Dermatology, Kyoto University 
Graduate School of Medicine, Kyoto, Japan
Barrier disruption and continuous percutaneous exposure to allergens presumably initiate and drive 
the development of atopic dermatitis (AD). In fact, majority of AD patients exhibit impaired barrier 
dysfunction due to genetic, environmental, and immunological factors. Th2 milieu is known to 
impair keratinocyte terminal differentiation; however, its underlying mechanism remains unclear. 
In the present study, we initially demonstrated that Th2-STAT3 and Th2-STAT6 signaling are crucial 
for keratinocyte terminal differentiation and inflammatory mediators, such as CCL26, respectively. 
Therefore, we evaluated a therapeutic potential of a JAK inhibitor by generating a novel JAK inhibitor 
JTE-052. Using normal human keratinocytes and a reconstructed human skin equivalent model, we 
found that JTE-052 promoted the production of terminal differentiation proteins such as filaggrin 
(FLG) and loricrin (LOR) in the presence of Th2 cytokines. In addition, using NC/Nga mice as an 
AD model, we revealed that topical administration of JTE-052 improved TEWL in accord with 
increased FLG and natural moisturizing factor (NMF) productions. Similar findings were obtained 
in an acetone-induced dry skin model, which excluded a possibility that improved barrier function 
is merely as a result of control of immune responses by the JAK inhibitor. We prepared immu-
no-compromised mice grafted with human skin to obtain human relevance, and found that JTE-052 
promoted productions of FLG and NMFs consistently. Taken together, our findings suggest that 
JAK-STAT signaling is critical for keratinocyte terminal differentiation in mice and human, which 
may open new therapeutic avenues in the treatment of AD.    
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Plasmin but not neutrophil elastase nor MMP9 primarily cleaves the juxtamembranous NC16A 
domain of collagen XVII
W Nishie, W Mayumi, K Natsuga, K Izumi and H Shimizu Department of Dermatology, 
Hokkaido University Graduate School of Medicine, Sapporo, Japan
Bullous pemphigoid (BP) is a common autoimmune blistering disease in which autoantibodies target 
epidermal transmembrane collagen XVII (COL17) and BP230. Autoimmunity to COL17 is thought 
to be mainly involved in the pathogenesis of BP; however, the role of any protease(s) in cleaving 
COL17 in lesional skin is still uncertain. This study aims to investigate the protease(s) responsible for 
blister formation in BP. Based on the knowledge that 120kD and 97kD COL17 ectodomains cleaved 
within the juxtamembranous NC16A domain are present in BP blister fluids, which suggests that 
lesional protease(s) preferentially targets the NC16A domain, we hypothesize that a key protease(s) 
also cleaves native COL17 within the NC16A domain in vitro. Recombinant full-length native human 
COL17 was used for limited digestion by candidate cleaving proteases including MMP9, neutrophil 
elastase and plasmin. MMP9 mainly targets the central region of the COL17 ectodomain and not the 
NC16A domain. Although high concentrations of neutrophil elastase cleaves the NC16A domain of 
COL17, it preferentially digests other parts of the molecule, and the 120-kD ectodomain does not 
appeared to be a main digested fragment. In contrast to MMP9 and neutrophil elastase, plasmin 
preferentially cleaves COL17 within the NC16A domain, and a 120-kD-ectodomain polypeptide 
is stably produced. At high concentrations of plasmin, a 97-kD fragment of the COL17 ectodomain 
with an additional carboxyl-terminal cleavage is observed; notably, mass spectrometry analysis 
reveals that cleavage also occurs within the NC16A domain. These results indicate that plasmin, 
and not neutrophil elastase nor MMP9, preferentially cleaves COL17 within the NC16A domain 
and that the digestion yields 120-kD and 97-kD ectodomains of the molecule, as observed in BP 
blister fluids. In summary, the present study suggests that a plasmin or plasmin-like serine protease(s) 
is the key enzyme in cleaving COL17 in BP lesional skin.    
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Prevalence of pemphigus and pemphigoid autoantibodies in the general population
H Koga, W Jung, J Prüssmann, A Recke, H Iwata, E Schmidt, D Zillikens, S Ibrahim and 
R Ludwig Department of Dermatology, University of Lübeck, Lübeck, Germany
Mucocutaneous blistering is the clinical hallmark of autoimmune bullous dermatoses (AIBD). In 
AIBD, blistering is caused by autoantibodies directed against structural components of the skin. Data 
on prevalence of AIBD autoantibodies in healthy individuals are contradictory. To clarify this, sam-
ples from 7,063 normal healthy blood donors (HD) were tested for presences of anti-BP180NC16A, 
anti-BP230 and anti-Dsg1 and 3 IgG by indirect immunofluorescence (IF) microscopy. IF findings 
were subsequently validated by commercially available ELISA kits. Among the positive samples, 
anti-BP180NC16A-positive samples were analyzed regarding their reactive oxygen species (ROS) 
production after activation with immune complex consisting of BP180NC16A. Furthermore anti-
BP180NC16A reactivity was fine-mapped, and subclasses of anti-BP180NC16A IgG were deter-
mined. Regarding anti-Dsg3 IgG observed in HD, their ability to induce Dsg3 internalization was 
compared to that of pemphigus patients. Cumulative prevalence of these autoantibodies was 0.9% 
(95% CI: 0.7-1.1%) with anti-BP180NC16A IgG being the most prevalent. Validation of IF findings 
by ELISA confirmed presence of autoantibodies in 7/15 (anti-Dsg1), 6/7 (anti-Dsg3), 35/37 (anti-
BP180NC16A) and 2/3 (anti-BP230) cases. Interestingly, anti-BP180NC16A autoantibodies from 
HD formed immune complexes with the recombinant antigen and activated neutrophils dose-de-
pendently. Fine-epitope mapping within BP180NC16A domain showed a different binding pattern 
of anti-BP180NC16A autoantibodies from HD compared to that of bullous pemphigoid patients, 
while IgG subclasses were identical. None of the tested anti-Dsg3 IgG positive samples induced 
an internalization of Dsg3 when incubated with HaCaT cells, as opposed to IgG from a pemphigus 
vulgaris patient. This lack of pathogenicity is most likely due to the low anti-Dsg3 IgG concentrations 
in these samples. Collectively, we report a low prevalence of AIBD autoantibodies in HD. Further-
more, functional analysis shows differences between autoantibodies from HD and AIBD patients.   
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Pro-inflammatory gene expression and its modulation in human macrophages differentiated 
and activated in normoxic or hypoxic conditions
M Stebegg,2 E Foglar,1 C Weishaeupl1 and F Kalthoff1 1 ATI/Dermatology, Novartis Institutes 
for BioMedical Research, Vienna, Austria and 2 Centre for Molecular Biology, University of 
Vienna, Vienna, Austria
Oxygen deprivation is one of the hallmarks of chronically inflamed or diseased tissues due to 
insufficient vascularization or intensive metabolic activity of pathogens. Innate immune cells such 
as macrophages are required to function in hypoxic conditions and adapt to low O2 pressure by 
altering gene expression to maximize their biological functions. In this study, we have compared 
the expression profiles of inflammatory genes in human macrophages cultured under normoxic 
and hypoxic conditions (1% O2, 5%CO2, 37°C). When kept in hypoxia, RT-PCR data confirmed 
up-regulation of well-known hypoxia markers such as VEGFα or miRNA210. Expression levels of 
pro-inflammatory cytokines in macrophages were generally higher when exposed to LPS under 
hypoxic conditions. Interestingly, when monocytes were differentiated to become type 1 mac-
rophages, LPS-stimulation led to a strong enhancement of IL-1α, IL-1β and IL-23. Furthermore, 
inhibitors of mitogen-activated and stress-activated protein kinase pathways showed a differential 
potency to inhibit the expression of inflammatory cytokines in LPS-activated macrophages. Whereas 
an inhibitor of the JNK kinase family (JNK1/2/3) generally failed to inhibit macrophage activation, a 
specific inhibitor of MEK1/2 demonstrated high potency to reduce pro-inflammatory gene expression 
in normoxic and hypoxic macrophages. A specific p38α kinase inhibitor, however, only weakly 
inhibited or even dose-dependently enhanced IL-1α and IL-1β expression in macrophages when 
differentiated by M-CSF under hypoxic conditions. Taken together, our results underscore the sub-
stantial effect of hypoxia to modulate gene expression in inflammatory macrophages and provide 
the rationale to specifically address hypoxia-mediated immune cell conditioning when searching 
for new therapeutic agents against chronic inflammatory diseases.    
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Pro-osteoclastogenesis march is enhanced by cutaneous pro-inflammatory mediators
A Balato, A Raimondo, S Lembo, M Schiattarella, G Caiazzo, R Di Caprio, N Balato and 
F Ayala Dermatology, University of Naples Federico II, Naples, Italy
Up to 30% of psoriasis patients develop psoriatic arthritis: in approximately 80% of cases, arthritis 
follows psoriasis by a mean of 10 years. Common pro-inflammatory mediators are involved: inter-
leukin (IL)-33, osteopontin (OPN) and tumor necrosis factor (TNF)-α are increased in the synovium 
and in the skin; these can also contribute to osteoclastogenesis and bone erosion. The aim of this 
study was to assess the ability of pro-inflammatory mediators to induce skin prompted osteo-
clastognesis. Ex vivo skin organ culture (OC) from healthy donors were stimulated with IL-33, 
OPN and TNF-α at different concentrations and timing; thereafter qRT-PCR was used to analyze 
pro- and anti-osteoclastogenesis mediators gene expression. Similarly, the epidermal sheet and the 
epithelial infiltrating T cells were isolated from skin samples and were separately stimulated with 
IL-33, OPN and TNF-α. Healthy donor monocytes were isolated and seeded with OC supernatants 
to induce differentiation. Thereafter, identification of osteoclasts precursors (OCP) was performed 
through TRAP staining and TRAF and Syk gene expression; moreover, OCP activity was assessed 
through cathepsin-K gene analysis. Subsequently, to assess the role of RANKL, we added the RANKL 
inhibitor oteoprotegerin and performed TRAP staining. Our results showed that pro-osteoclastogen-
esis mediators were overexpressed in stimulated-OC in a time, and not dose, dependent manner. 
Conversely, anti-osteoclastogenesis factors were downregulated respect to unstimulated skin. The 
contribution of epidermal sheet was more significant than that of skin-infiltrating T cells. OCP 
overdifferentiated when healthy monocytes were cultured with supernatants from stimulated-OC. 
Similarly, the activation markers of OCP, such as cathepsin-k, were enhanced. Although RANKL 
inhibition dramatically reduced OCP formation, a significant differentiation was still observed. In 
conclusion, we suggest the possibility of a “pro-osteoclastogenesis march” induced by cutaneous 
pro-inflammatory mediators.    
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Withdrawn    
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Protein phosphatase 2Cδ probably regulates the activity of phospho- p90 Ribosomal S6 kinase 
2 in the lesional Psoriatic skin
M Rasmussen, RB Kjellerup, S Andersen, A Hald, C Johansen, L Iversen and B Gesser Dept. 
of Dermatology, Aarhus University Hospital, Aarhus, Denmark
The p90 ribosomal S6 kinase 1 and 2 (RSK1,2) are serine/threonine protein kinases, activated through 
the ERK1/2 signalling pathway. Known upstream regulators of cell proliferation are macrophage 
migration inhibitory factor (MIF) and epidermal growth factor (EGF) which are both elevated in the 
serum of patients with psoriasis compared with control serum. MIF and EGF phosphorylate RSK1, 2 
in vitro. Protein phosphatase 2Cδ (PP2Cδ) is inactivating RSK1,2 in cancer, but its role in psoriasis is 
not known. We examined the levels of p-RSK1,2 and PP2Cδ in skin from patients with psoriasis. In 
paired biopsies from non-lesional and lesional skin we investigated the expression of p-RSK (T573) 
and (S380) and the two PP2Cδ isoforms, integrin-linked kinase-associated serine/threonine phos-
phate (ILKAP) and wild-type p53-induced phosphatase 1 (Wip1), by immuno-flouresence, Western 
blotting and immuno-precipitation. The induction of Wip1 by MIF and EGF was studied in normal 
keratinocytes. We demonstrated increased level of p-RSK (T573) in lesional skin compared with the 
non-lesional skin, while p-RSK (S380) was reduced in lesional skin compared with non-lesional skin. 
The expression of ILKAP was higher in the lesional then in the non lesional skin. WiP1 was expressed 
more similarly in the lesional and non lesional skin. Co-immuno-precipitation with monoclonal Ab 
for RSK2 showed that WiP1 67 kDa was highly associated with RSK2 in the lesional skin. In normal 
keratinocytes, EGF or MIF induced the association between WiP1 and RSK2 which was inhibited 
by an ERK1/2 inhibitor PD98059. Our results suggest that the association of WiP1 with RSK2 
contributes to the de-phosphorylation of p-RSK2 at (S386) in the lesional skin and thereby inhibit 
RSK2 activity. ILKAP and WiP1 play significant but different role in the pathogenesis of psoriasis.   
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Rapid transition from pemphigus vulgaris to pemphigus foliaceus: correlation with autoan-
tibody profiles
S Shimizu,1 T Ito,1 K Kikuchi,1 W Nishie,2 H Shimizu2 and R Moriuchi1 1 Sapporo City 
General Hospital, Sapporo, Japan and 2 Hokkaido University, Sapporo, Japan
There are two major subtypes in pemphigus, pemphigus vulgaris (PV) and pemphigus foliaceus 
(PF) which differ in clinicopathological features as well as in anti-desmoglein (Dsg) autoantibody 
profile. To further clarify the relationship between the phenotype and the anti-Dsg antibodies, we 
evaluated autoantibody profile of sequential serum samples from a patient whose clinical man-
ifestation rapidly transited from mucocutaneous PV to PF just in 6 weeks. Antibody titer against 
Dsg1 and Dsg3 were measured with antigen-specific enzyme-linked immunosorbent assay (ELISA) 
using recombinant Dsg1 and Dsg3. The 57-year-old man presented erosion on the oral mucosa 
and erosive, crusted scaly erythematous plaques and bullae on the trunk. Histological findings of 
suprabasilar acantholysis and direct immunofluorescence showing IgG deposits in keratinocyte 
cell surface throughout the epidermis are consistent with typical mucocutaneous PV. High titers of 
anti-Dsg1 and 3 autoantibodies (ELISA index, 125, and 57, respectively) were detected. Although 
mucosal lesions completely disappeared after 6 weeks of systemic therapy, the disease flared up 
showing typical PF phenotype confirmed by histopathology. At this point the titer of anti-Dsg1 
autoantibodies selectively increased (index, 1818) while anti-Dsg3 autoantibodies were undetect-
able. Anti-Dsg3 autoantibodies have not been detectable for 12 months since then. These findings 
suggested that the rapid transition from PV to PF occurred in quite short duration in association 
with striking change of anti-Dsg1 and anti-Dsg3 autoantibodies profile. This case clearly showed 
the rapid transition from mucocutaneous PV to PF in both clinical features and autoantibody profile.   
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Reactivity against non disease-specific antigens in autoimmune bullous disease is rare and 
may represent an epiphenomenon 
V Calabresi,1 F Mariotti,1 V Pacifico,1 B Didona,2 G Zambruno1 and G Di Zenzo1 1 Molecular 
and Cell Biology Laboratory, Istituto dermopatico dell’Immacolata (IDI)-IRCCS, Rome, Italy 
and 2 I Dermatology Division, IDI-IRCCS, Rome, Italy
Bullous pemphigoid (BP), mucous membrane pemphigoid (MMP), epidermolysis bullosa (EBA) and 
pemphigus vulgaris (PV) are autoimmune bullous diseases (ABD) associated with an autoantibody 
response to several components of the basement membrane zone and the desmosome (BP180, 
BP230, laminin332, collagen VII, desmoglein 1 and 3) in human skin. The aim of this study was to 
characterize the humoral immune response of 80 ABD patients (20 BP, 20 MMP, 20 EBA, 20 PV) 
against different autoantigens, by commercial available ELISAs and by immunoblotting. ABD sera 
bound to different disease-specific antigens with the expected frequency (PV: 100% desmoglein 3 
and 45% desmoglein 1; BP: 85% BP180 and 75% BP230; MMP: 30% BP180, 30% BP230 and 10% 
laminin 332; EBA: 100% collagen VII). Interestingly, almost half of the patients affected with BP, PV 
and MMP (45%, 55% and 40%, respectively) showed reactivity against multiple autoantigens and 
only 4 of 80 sera (2 PV, 1 BP and 1 EBA) also bound to antigens typically recognized by patients 
affected with a different ABD. In particular, 1 BP and 1 PV of 20 prospectively recruited patients 
reacted against collagen VII (in addition to BP180 and BP230) and BP180 (in addition to desmoglein 
3), respectively, at an early stage of the disease. Of note the reactivity against these two additional 
antigens remained stable during disease course, while in the same patients reactivity against dis-
ease-specific antigens fluctuated in parallel with disease severity as expected. These findings further 
confirm that in ABD patients multiple reactivities to disease-specific antigens frequently occur. On 
the contrary, reactivity against non disease-specific antigens is rare and might represent an epiphe-
nomenon unrelated to the evolution and progression of the autoimmune disease.    
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Refinement of oxazolone and ovalbumin induced skin inflammation models in mice 
H Siller,1 S Knoth Clausen,1 N Svitacheva,1 L Svensson,2 P Lovato,1 A Hald,1 K Moller,1 
A Clauss2 and P Scheipers2 1 Skin Research, LEO Pharma, Ballerup, Denmark and 2 NME 
Ideation, LEO Pharma, Ballerup, Denmark
Focusing on animal welfare and cost-effectiveness of animal studies, the original set-ups of two 
atopic dermatitis (AD) like skin inflammation models were adjusted. The optimized protocols repre-
sent an example of Reduction & Refinement according to the 3Rs. Duration of the chronic oxazolone 
model was shortened from 28 to 24 days; the impact on several end-points were investigated. BALB/
cA mice were sensitised, one week later challenged with oxazolone on the ear. Repeated oxazolone 
challenge was conducted until the day before termination. No differences were observed between 
the two termination days in ear thickness, cytokines (IL-22, IL-17F, TARC, IL-1β, IL-2, IL-4, IL-5, 
IL-12, IFN-γ, IL-10, mKC and TNF-α), or histopathology (acanthosis, edema, hemorrhage). The 
fraction of CD45+, CD3+ and TCRα/β+ cells was constant, the fraction of TCR γ/δ+ decreased 
slightly from day 24 to 28. Treatment efficacy of a topically applied calcineurin inhibitor, PDE4 or 
JAK inhibitor was comparable to previous 28 days long studies. In conclusion, without compro-
mising the results, the 24 days model is a more cost/effective model to be used in future studies. 
In a mouse model of skin inflammation repeated epicutaneous sensitization to ovalbumin (OVA) 
and mechanical skin injury lead to inflammation resembling hallmarks of AD. To avoid severe 
skin wounds, several procedures were optimized – induction and area of skin injury, application 
of the OVA-patch and number of patch periods. Animals were anaesthetized; dorsal skin shaved 
and tape-stripped and an OVA-patch secured to the skin. Mice were exposed to 2 or 3 one-week 
OVA-patch periods, separated by two weeks rest period. Visual inspection showed reduction in 
skin wounds confirmed by histology. Reduction had no impact on the level of OVA-specific IgE in 
serum. In conclusion, a new protocol for tape-stripping and patching was refined resulting in OVA 
penetrating the skin, leading to inflammation and increased OVA-specific IgE in serum without 
inducing severe skin wounds to the mouse    
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RNase 7 promotes the uptake of DNA and the production of IFN-α by human plasmacytoid 
dendritic cells 
V Kopfnagel,1 S Wagenknecht,1 J Harder,2 M Kleine3 and T Werfel1 1 Dermatology and 
Allergy, Hannover Medical School, Hannover, Germany, 2 Department of Dermatology, 
University Hospital Schleswig-Holstein, Kiel, Germany and 3 PLANTON GmbH, Kiel, 
Germany
Plasmacytoid dendritic cells (pDCs) comprise a dendritic cell population highly specialized for 
sensing viral and microbial DNA through endosomal Toll-like receptors to produce type 1 inter-
ferons. pDCs accumulate in the skin of patients with inflammatory skin diseases such as psoriasis. 
Furthermore, activation of pDCs in the skin and subsequent production of IFN-α has been identified 
as important initiator of psoriasis development. RNase 7 is one of the major antimicrobial peptides 
(AMPs) secreted by keratinocytes. It is constitutively expressed in the epidermis of healthy human 
skin and upregulated in chronic inflammatory skin diseases such as atopic dermatitis and psoriasis. 
In the current study we demonstrate that RNase 7 enables sensing of self-DNA by human pDCs 
which leads to strong IFN-α production. Furthermore, RNase 7 promotes rapid sensing of bacterial 
and CpG DNA by human pDCs. The elicited IFN-α response was sufficient to inhibit herpes simplex 
(HSV-1) infection of human keratinocytes in an in vitro infection model. This points to a possible 
role for RNase 7 in antiviral immune defense. Experiments with a ribonuclease-inactive recombinant 
RNase 7 mutant show that RNase 7 ribonuclease activity is dispensable for the uptake of DNA and 
induction of IFN-α production. Our data indicate that RNase 7 has immunmodulatory functions 
and supports the efficient recognition of microbial infection by human pDCs.    
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Serotonergic mechanisms in atopic eczema 
A Rasul,1 H El-Nour,1 S Lonne-Rahm,1 B Johansson,2 O Fransson,1 M Zubeidi,1 C Johansson1 
and K Nordlind1 1 Dermatology and Venereology Unit, Department of Medicine, Karolinska 
University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden and 2 Department of 
Molecular Medicine and Surgery, CMM, Karolinska Institutet, Stockholm, Sweden
Stress and anxiety often worsen atopic eczema (AE). Our aim was to study serotonergic mechanisms 
in AE in relation to extent of the disease, the degree of inflammation, pruritus intensity, and also anx-
iety traits, chronic stress and depression. Twenty-eight patients with AE were studied using SCORAD 
(extent of AE), VAS (pruritus), Swedish Universities Scales of Personality, depression (MADRS-S), and 
salivary cortisol test. Biopsies were taken from lesional and non-lesional AE skin, and investigated 
for expression of serotonin (5-hydroxy-tryptamine; 5-HT), 5-HT1A and 5-HT2A receptors (R), and 
serotonin transporter protein (SERT), using immunohistochemistry. A 5-HT1AR-positive signal was 
found in the apical part of the epidermis and also in mast cell-like cells in the papillary dermis, 
with the highest number in lesional skin. The highest positive 5-HT2AR epidermal fraction and 
number of positive vessels were recorded in lesional skin. A basement membrane 5-HT2AR signal 
was more prominent in non-lesional skin, compared to lesional skin. The highest basal epidermal 
layer SERT immunoreactivity was obtained in lesional skin. A positive correlation between SCORAD 
and number of inflammatory dermal 5-HT1AR-positive cells in lesional skin and 5-HT2AR-positive 
vessels in non-lesional skin was determined. There was a positive correlation between depression 
score and the epidermal 5-HT1AR positive fraction, but an inverse correlation with the number of 
5-HT2AR expressing vessels, both in lesional skin. Moreover, in non-lesional skin a positive correla-
tion between the 5-HT2AR- positive epidermal fraction and the cortisol ratio. The basal epidermal 
SERT immunoreactivity in lesional skin was positively correlated with the degree of acanthosis and 
inversely correlated with stress susceptibility. No correlation was seen for pruritus intensity and the 
serotonergic markers. A complex role for the serotonergic system seems to exist in AE.    
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Sustained IL-17 and IL-23 serum levels are associated with BP outcome 
J Plee,1 S Le Jan,2 J Giustiniani,4 P Joly,3 C Bedane,5 P Vabres,6 F Truchetet,7 F Aubin,8 
F Antonicelli2 and P Bernard1 1 Dermatology, CHU, Reims, France, 2 Dermatology, 
University, Reims, France, 3 Dermatology, CHU, Rouen, France, 4 cancérology, Institut 
Jean Godinot, Reims, France, 5 dermatology, CHU, Limoges, France, 6 Dermatology, CHU, 
Dijon, France, 7 Dermatology, CHR, Thionville, France and 8 Dermatology, CHU, Besançon, 
France
Bullous pemphigoid (BP) relapse during the first year of follow-up has been related to disease extent, 
and to serum autoantibody level at baseline. Although the inflammatory cytokine IL-17 has been 
localized at skin lesional site in BP, the prospects of IL-17 and associated cytokines-based therapeutic 
strategy has not been investigated yet. We conducted a multicenter prospective observational study 
in 8 French dermatology departments to analyze serum level variations of IL-17, IL-23 and TGF-β 
during the first months of treatment in 120 BP patients with newly diagnosed BP and 16 sex- and 
age-matched patients as controls. Baseline and 2 follow-up visits on days 60 and 150 were planned 
for collection of blood samples for cytokine and BP180/BP230 autoantibodies by ELISA. Associations 
of clinical parameters (BP extent at time of diagnosis, BP relapse within the first year of treatment) 
with serum cytokines concentrations were assessed (univariate analysis). High serum levels of 
IL-17, IL-23 and TGF-β were observed at baseline compared to controls. IL-17 was correlated to 
TGF-β (p=0.01) at baseline, but no association could be drawn between cytokines concentration 
and disease extent. A negative correlation was observed between IL-23 and anti-BP180 autoanti-
bodies. IL-17 level did not decrease under therapy, while IL-23 increased between day 0 and day 
60 in serum from BP patients who relapsed (p=0.006). IL-23 increase showed a sensitivity of 76% 
[58-94], a specificity of 33% [21-46], a negative predictive value of 79% [62-95] and a positive 
predictive value of 30% [17-42] for BP relapse occurring during the first year of treatment. This 
longitudinal study revealed that an early serum IL-23 increase helped to discriminate BP patients 
with relapse from patients with ongoing remission. Then, our results propose novel therapeutic 
targets to control BP disease process.    
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Th1/Th17-mediated colitis is diminished after epicutaneous and oral tolerance induction
T Schmidt,1 N Lorenz,1 VK Raker,1 S Reissig,2 A Waisman,2 B Weigmann3 and K Steinbrink1 
1 Department of Dermatology, University Medical Center Mainz, Mainz, Germany, 2 
Institute of Molecular Medicine, University Medical Center Mainz, Mainz, Germany and 3 
Department of Gastroenterology, University Medical Center Erlangen, Erlangen, Germany
The mouse model of TNBS-induced colitis is a Th1/Th17-mediated immune response, resembling 
Crohn’s disease in humans. Previously, we demonstrated that epicutaneous and oral applications 
of subimmunogenic amounts of allergens (e.g. TNCB) result in low zone tolerance (LZT), which 
prevents the development of an allergic skin inflammation (contact hypersensitivity reaction) in 
mice. In the current study, we have analysed the impact of orally and epicutaneously-induced LZT 
on the outcome of the TNBS-colitis and the underlying immune mechanisms. Notably, we found 
that repeated applications of low doses of the hapten TNCB affected the course of colitis resulting 
in a significantly reduced inflammation of the gut, which were evaluated by use of mini-endoscopy 
and histology. These data were confirmed by a diminished hapten-specific T cell-proliferation and 
reduced Th1/Th17-cytokine production (IFN-γ, IL-2, IL-17) after both routes of tolerization, indicat-
ing an inhibition of TNBS-induced colitis by LZT. Furthermore, we put into question the role of 
CD4+CD25+ regulatory T cells (Tregs) in LZT modulation of colitis. Here, mice were either treated 
with anti-CD25 mAb or DEREG mice with diphtheria toxin for Treg depletion prior to repeated 
applications of low doses of contact allergens and subsequent colitis induction. In the absence of 
CD4+CD25+ Tregs, LZT failed to develop but rather a pronounced colitis response was observed, 
indicating a pivotal role for Tregs in colitis prevention by LZT. In addition, we observed an abroga-
tion of LZT and pronounced colitis development if a second unrelated contact allergen (e.g. DNFB) 
was used for tolerization, indicating allergen-specific mechanisms of LZT in colitis prevention. Our 
data demonstrates that LZT inhibits a Th1/Th17-mediated colitis independent of the site of tolerance 
induction in an hapten-specific manner by activation of CD4+CD25+FOXP3+ Tregs.    
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The expression of miR-23b increases during adalimumab treatment despite unaltered expres-
sion in untreated psoriatic skin
L Raaby, A Langkilde, H Vinter, RB Kjellerup, C Johansen and L Iversen Department of 
Dermatology, Aarhus University Hospital, Aarhus, Denmark
MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression and known to 
be dysregulated in psoriasis. miR-23b has been ascribed a role in protecting against autoimmunity 
and is downregulated in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus 
(SLE) and in mouse models of RA and SLE. Anti-TNFα therapy is an effective treatment for moder-
ate to severe psoriasis. The IL-17A mRNA expression is downregulated in psoriasis after 14 days 
of anti-TNFα therapy and IL-17A can decrease mir-23b expression. The aim of this study was 
to investigate miR-23b changes in psoriatic skin before and during treatment with adalimumab 
(Humira). Further, to investigate changes in the miR-23b expression in the early phases of psoriasis 
in an imiquimod (Aldara)-induced psoriasis-like skin inflammation mouse model. Punch biopsies 
from psoriatic patients receiving Humira were collected before and after 4, 14, 42 and 84 days of 
treatment. Biopsies from mice were collected after three days of Aldara treatment. The samples 
were analysed with RT-qPCR and in situ hybridization. No regulation was seen when comparing 
lesional and nonlesional untreated psoriatic skin nor in the mouse model. However, miR-23b 
expression increased 1.6 and 2.0 fold after 14 and 42 days respectively, and it remained high also 
after 84 days. miR-23b was located in the cytosol of the keratinocytes in human psoriatic skin. We 
therefore conclude that no changes in miR-23b expression were seen, neither when inducing skin 
inflammation in the mouse model nor when comparing lesional and nonlesional psoriatic skin. 
These data suggest that the role of miR-23b in psoriasis differs from other inflammatory diseases 
like RA and SLE. In patients, the first clinical improvements were seen after 14 days of treatment 
and after 84 days the psoriasis had almost cleared. However, the miR-23b expression raised during 
treatment and the level remained high even at 84 day. This could indicate that miR-23b protects 
against relapse of the disease.    
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The histamine released from epidermal keratinocytes is involved in the α-melanocyte-stim-
ulating hormone-induced itch-associated response in mice 
K Shimizu,2 T Andoh,1 Y Yoshihisa2 and T Shimizu2 1 Applied Pharmacology, Toyama 
university, Toyama, Japan and 2 Dermatology, Toyama university, Toyama, Japan
Sunburn, wound repair and chronic renal failure with hemodialysis are usually accompanied by both 
pigmentation and itching. Recent studies have shown that the α-melanocyte-stimulating hormone 
(α-MSH) produced from the precursor, proopiomelanocortin, by external stimuli, such as ultraviolet 
irradiation, is involved in cutaneous pigmentation. However, it is unclear whether α-MSH is also 
involved in the itching resulting from these stimuli. In this study, we investigated whether α-MSH 
elicits itching in male ICR mice. In one part of this study, male mast cell-deficient mice (WBB6F1-W/
Wv) and normal littermates (WBB6F1-+/+) were used. An intradermal injection of α-MSH into the 
rostral part of the skin elicited hind-paw scratching, an itch-related behavior, at the injection site. The 
α-MSH-induced scratching was inhibited by treatment with an H1 histamine receptor antagonist, 
terfenadine. In contrast, the mast cell deficiency did not inhibit the α-MSH-induced scratching, 
suggesting that mast cells do not play a role in α-MSH-induced scratching. L-Histidine decarboxylase 
(HDC) is a key enzyme required for the production of histamine. Immunohistochemical analysis 
showed HDC was expressed in not only mast cells, but also keratinocytes. These findings indicate 
that α-MSH may play an important role in itching associated with pigmented cutaneous lesions, 
and that the histamine released from keratinocytes is involved in this α-MSH-induced itching.   
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The inflammatory cytokine TSLP up-regulated by IL-33 induced Egr-1 expression in human 
keratinocytes via MAPK pathways 
W Ryu, H Lee, J Kim, H Bae and S Son Korea University, Seoul, Republic of Korea
IL (Interleukin) -33 is lately identified cytokine, which is belonged in IL-1 superfamily. IL-33 act as 
a pro-inflammatory cytokine and regulates Th2 cell-mediated immune response. Recently, there is 
a report that IL-33 is highly expressed in AD (Atopic dermatitis) which is a chronic inflammatory 
skin disease where T-helper type 2 (Th2)-type immune responses are dominant. IL-33 has been 
described to increase the production of Th2-associated cytokine such as IL-4, IL-5 and IL-13. And 
TSLP (Thymic stromal lymphopoietin), which is known as highly expressed cytokine in the epidermis 
of the lesional skin in AD patients, promotes Th2 cell differentiation and Th2 cell-mediated inflam-
mation in inflammatory disease. However, the regulatory mechanism between IL-33 and TSLP is still 
unknown. To investigate the relevance between IL-33 and TSLP, TSLP expression was upregulated 
by transfection with pcDNA3- Early growth response protein-1 (Egr-1), which is recently known as 
a critical role in the immune response. IL-33 induced TSLP expression in human keratinocytes was 
decreased by mitogen-activated protein kinase inhibitors or Egr-1 small interfering RNAs. The result 
of Chromatin immunoprecipitation assays indicate direct binding of Egr-1 in IL-33 mediated TSLP 
induction. Taken together, these results indicate IL-33 exposure increased TSLP expression through 
an Egr-1-dependent mechanism via the mitogen-activated protein kinase in human keratinocytes.   
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The number of epidermal FcεRI + CD207- cells in lesional and nonlesional bullous pemphigoid 
skin correlates with total serum IgE
B Kwiek,1 A Lesniewska,2 C Kowalewski2 and K Wozniak2 1 Dermatology, Medical 
University of Warsaw, Warsaw, Poland and 2 Dermatology and Immunodermatology, 
Medical University of Warsaw, Warsaw, Poland
Total serum IgE is commonly elevated in bullous pemhigoid (BP) and was found to correlate with 
disease activity. We wanted to evaluate the presence of high affinity IgE receptor (FcεRI) bearing 
cells in lesional and nonlesional epidermis in BP and correlate it with total serum IgE. 13 patients 
with BP confirmed with direct immunofluorescense and the presence of serum anti BP180 IgG, aged 
36-89 (mean 74,6) were included into this study. 4 healthy patients aged 70-78 (mean 73,5) and 4 
patients with atopic dermatitis (AD) aged 19-41 (mean 28,2) served as controls. Skin biopsies were 
taken from perilesional healthy-looking (non-lesional) and from lesional erythematous skin of patient 
with active BP, lesional skin of AD patients and healthy skin of healthy controls. Skin samples were 
double stained with anti anti FcεRI and CD207 and analysed with confocal microscopy. Positive 
cells were enumerated in 10 fields for each sample by blinded investigator and average cell number 
on square mm was calculated. Total IgE was measured in BP patients sera. We have found FcεRI+ 
cells within epidermis of BP patients and majority of these cells were CD207+ Langerhans cells. 
The mean number of epidermal FcεRI+ was 145,8, 75,2, 82 and 61,3 per mm2 for AD lesional, BP 
non-lesional, BP lesional and healhy control respectively. Of these cells 34,9 % were CD207- non 
LC in AD skin and 8,5%, 14,5% and 4,81% for non-lesional BP, lesional BP and healthy control 
respectively. We have found significant positive correlation between the number of FcεRI+CD207- 
cells in both lesional and non-lesional skin and total serum IgE in BP patients (r=0,68 and 0,71 
respectively). No such correlation was found for FcεRI+CD207+ Langerhans cells. These results 
support the hypothesis of the presence of FcεRI+ cells in BP epidermis and proves that LC are the 
major population bearing this receptor. However a minor population of FcεRI + CD207- non LC 
correlates with total serum IgE level.    
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The Reduction of Oxidative Damage after H1 Antihistamine Therapy in Urticaria Patients
L Dinu,2 SR Georgescu,1 C Ene (Nicolae),3 M Tampa,1 I Nicolae4 and J Diaconu1 1 
Dermatology, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania, 2 
Dermatology, MedLife Clinic, Bucharest, Romania, 3 University of Medicine and Pharmacy 
Carol Davila, Bucharest, Romania and 4 Research in Dermatology, Victor Babes Hospital of 
Clinical and Infectious Diseases, Bucharest, Romania
The aim of this study was to evaluate a possible role of oxidative stress markers in the pathogenesis 
of urticaria. The study included 80 acute urticaria (AU) patients and 80 chronic spontaneous urticaria 
(CSU) patients, aged 18 and over. We assessed 8-hydroxy-deoxyguanosine (8-OHdG), malondialde-
hyde (MDA) and carbonylated proteins (CP) serum levels. All the patients were evaluated at baseline 
(T0) and at three moments after the therapy initiation which consisted of H1-antihistamines. The 
monitoring moments were at 1 (T1a), 3 (T2a) and 6 weeks (T3a) for AU and 1 (T1c), 3 (T2c) and 
6 months (T3c) for CSU patients. For AU group the serum levels of oxidative stress markers were: 
6,12±2,10 ng/ml at T0, 5,76±1,74 ng/ml (T1a), 4,67±1,14 ng/ml (T2a) and 3,72±0,46 ng/ml (T3a) for 
8OHdG; 4,7±1,3 nmol/ml at T0, 4,2±0,9 nmol/ml (T1a), 3,9±0,7 nmol/ml (T2a) and 2,6±0,8 nmol/
ml (T3a) for MDA; 3,6±1,1 nmol/mg protein at T0, 3,5±1,4 nmol/mg protein (T1a), 3,1±0,8 nmol/mg 
protein (T2a) and 2,0±0,7 nmol/mg protein (T3a) for CP. For CSU group the serum levels of oxidative 
stress markers were: 7,84±3,12 ng/ml at T0, 6,53±2,05 ng/ml (T1c), 4,47±1,02 ng/ml (T2c) and 
4,12±0,55 ng/ml (T3c) for 8OHdG; 5,1±2,7 nmol/ml at T0, 4,5±1,4 nmol/ml (T1c), 3,4±1,2 nmol/ml 
(T2c) and 2,7±0,8 nmol/ml (T3c) for MDA; 2,5±0,7 nmol/mg protein at T0, 2,3±0,8 nmol/mg protein 
(T1c), 2,0±0,6 nmol/mg protein (T2c) and 1,8±0,7 nmol/mg protein (T3c) for CP. The favorable 
therapeutic response is associated with the reduction of the oxidative damage in urticaria patients.   
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Therapeutic efficacy of a novel selective JAK2 inhibitor (CEP-33779) in organ-specific, auto-
antibody-induced tissue injury 
US Samavedam,1 J Scheuber,1 MM Seavey,2 H Koga,1 M Witte,1 FS Schulze,3 K Matsumoto,1 
D Zillikens1 and RJ Ludwig1 1 Lübeck Institute of Experimental Dermatology (LIED), Lübeck, 
Germany, 2 Teva Pharmaceutical Industries Ltd, West Chester, PA and 3 Department of 
Dermatology, University of Lübeck, Lübeck, Germany
Autoimmune bullous dermatoses (AIBD) are chronic inflammatory, organ-specific (skin) disorders, 
characterized by mucocutaneous blistering and autoantibodies against desmosomal or hemides-
mosomal antigens. AIBDs have become a major medical burden with high morbidity and mortality. 
Janus kinase-2 (JAK-2) is responsible for activation of several inflammatory pathways and inhibi-
tion of JAK-2 signalling is protective in different models of chronic inflammatory diseases, such 
as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). However, the role of JAK-2 
signalling is yet to be evaluated in AIBD. Here, we describe the impact of CEP-33779 , a selective, 
orally active, inhibitor of JAK-2 evaluated in experimental models of epidermolysis bullosa acquisita 
(EBA), an AIBD, caused by autoantibodies to type VII collagen (COL7). JAK-2 blockade inhibited 
immune-complex-induced release of reactive oxygen species (ROS) and elastase release from neu-
trophils in a dose-dependent manner. B-cell proliferation and IgG production were also affected by 
CEP-33779. Inhibition of JAK-2 impaired dermal-epidermal separation induced by the incubation 
of human skin sections with anti-COL7 IgG and neutrophils. To characterize the contribution of 
JAK-2 specifically in the effector phase of EBA, disease was induced by transfer of anti-COL7 IgG 
into mice. Prophylactic treatment with CEP-33779 impaired induction of skin blistering in a dose 
dependent manner. Furthermore, in already established EBA (immunization-induced), blockade of 
JAK-2 significantly attenuated clinical disease progression. This study demonstrates a key contribu-
tion of the JAK-2 signalling pathway in the pathogenesis of autoantibody-induced tissue injury in 
a prototypical organ-specific autoimmune disease. Our results also identified JAK-2 as a potential 
novel therapeutic target for EBA and related AIBD.    
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Thromboxane A2 promotes the development of imiquimod-induced psoriasis-like murine 
model via TP receptor
Y Tanada-Ueharaguchi,3 T Honda,3 T Murata,3 M Arita,1 S Narumiya,2 Y Miyachi3 and 
K Kabashima3 1 Faculty of Pharmaceutical Sciences, Graduate School of Pharmaceutical 
Sciences the University of Tokyo, Tokyo, Japan, 2 Center for innovation in immunoregulative 
technology and therapeutics, Kyoto, Japan and 3 Dermatology, Kyoto University Graduate 
School of Medicine, Kyoto, Japan
Prostanoids are a family of lipid mediators composed of prostaglandins and thromboxane (Tx)A2. 
Prostanoids exert a variety of actions via each specific G protein-coupled receptor. Several prosta-
noids have been reported to abundantly present in human psoriatic skin lesions in 1980’s, suggesting 
the involvement of prostanoid in its pathogenesis. However, the responsible prostanoids for the 
development of psoriasis and the underlying mechanism remain unclear. To address this issue, we 
first used mass spectrometry for metabolomic analysis of the skin samples using an imiquimod-in-
duced mouse psoriasis-like model. We thereby found increased production of TxA2 in the skin 
lesion. Then we evaluated the role of TxA2 in psoriasis using mice lacking the TxA2 receptor (TP). 
TP-deficient mice exhibited significantly less ear-swelling response, dermal edema, and epidermal 
hyperplasia than did wild-type (WT) mice. In addition, flow cytometry analysis revealed a signifi-
cantly reduced number of IL-17- or IL-22-producing cells in the skin of TP-deficient mice. Moreover, 
the significantly reduced numbers of Vg4-positive IL-17 producing gd T cells were observed in the 
skin of TP-deficient mice. Consistently, administration of a TxA2 synthase inhibitor to WT mice 
recapitulated the phenotype of TP-deficient mice in this model. These results indicate that TxA2-TP 
signaling has vital roles in the development of imiquimod induced psoriasis-like skin lesions.   
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Toll-like Receptor 3 Increases Allergic and Irritant Contact Dermatitis
N Nakamura,1 R Tamagawa-Mineoka,1 M Ueta,2 S Kinoshita2 and N Katoh1 1 Dermatology, 
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan 
and 2 Ophthalmology, Graduate School of Medical Science, Kyoto Prefectural University of 
Medicine, Kyoto, Japan
The role of Toll-like receptor (TLR)-3 in non-infectious inflammation has been increasingly rec-
ognized, but the function of TLR3 in inflammatory skin diseases is unclear. We investigated the 
functions of TLR3 in allergic and irritant contact dermatitis. Wild-type (WT), Toll-like receptor 3 
knockout (Tlr3 KO), and TLR3 transgenic mice were sensitized and hypersensitivity was elicited 
in ears with a hapten, 2,4,6-trinitro-1-chlorobenzene (TNCB). In separate experiments, croton oil 
was applied to ears of WT, Tlr3 KO, and TLR3 transgenic mice as a cutaneous irritant. Furthermore, 
migration of cutaneous dendritic cells (DCs) to draining lymph nodes was assessed by FITC skin 
painting in WT and Tlr3 KO mice. Antigen presentation was studied by culturing DCs with allo-
genic lymphocytes. Lymphocyte proliferation was analyzed by CFSE dilution. Chemokines were 
measured in vivo in TNCB-induced inflammatory skin tissues and in vitro in murine keratinocytes 
and fibroblasts after TLR3 stimulation. The contact hypersensitivity (CHS) response was lower in 
Tlr3 KO mice, and was greater in TLR3 transgenic mice, than in WT mice after TNCB challenge. 
Adoptive transfer of immunized lymph node cells from Tlr3 KO mice induced CHS in WT recipients. 
In contrast, adoptive transfer of immunized lymph node cells from WT mice did not fully induce 
CHS in Tlr3 KO recipients. The response following irritant croton oil application was lower in Tlr3 
KO mice, and was greater in TLR3 transgenic mice, than in WT mice. The function of DCs and 
lymphocytes between WT and Tlr3 KO mice were comparable. The CXCL10/IP-10 expression was 
significantly elevated in skin tissue of TNCB-induced CHS in WT mice compared with that in Tlr3 KO 
mice, and TLR3 stimulation of keratinocytes and fibroblasts induced CCL5/RANTES and CXCL10/
IP-10 release. These results suggest that TLR3 enhances antigen-independent skin inflammation by 
inducing chemokine secretion from keratinocytes and fibroblasts.    
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Topical methotrexate is rapidly absorbed into skin processed with ablative fractional laser 
EH Taudorf,4 CM Lerche,4 A Vissing,4 P Alshede Philipsen,4 JT D’Alvise,3 SH Hansen,3 
C Janfelt,3 U Paasch,2 R Anderson1 and M Haedersdal4 1 Wellman Center, Harvard, Boston, 
MA, 2 Dp of Derm, Leipzig Univ, Leipzig, Germany, 3 Dp of Pharmacy, Copenhagen Univ, 
Cph, Denmark and 4 Dp. of Derm, Bispebjerg Univ Hospital, Cph, Denmark
Methotrexate (MTX) is a widely used systemic chemotherapeutic and anti-inflammatory drug, which 
may cause adverse effects. This study investigates transport kinetics of topically delivered MTX 
in ablative fractional laser (AFXL)-processed or intact skin. In vitro passive diffusion of 10 mg/ml 
MTX (1w/v%) was measured at 0.25, 1.5, 7, 18, 21 and 24h in Franz Cells (n=40). Mid-dermal 
700 μm microchannels aligned with 35 μm coagulation zone (CZ) were generated in porcine skin 
by 2,940nm AFXL, 2.4% density, 256 mJ/microchannel and 225 μs pulse duration. MTX concen-
trations were quantified using High Performance Liquid Chromatography (HPLC). UVC-irradiation 
at 254nm induced MTX-specific fluorescence (excitation:405nm/emission:451nm) in order to 
visualize the biodistribution of MTX in skin sections by fluorescence microscopy. Biodistribution 
was further imaged by Desorption Electrospray Ionization Mass Spectrometry Imaging (DESI-MSI). 
HPLC quantification demonstrated a rapid and continuous deposition of MTX in the skin within 
the first 7h of application, where upon a 10-fold increased steady-state compared to intact skin was 
reached (p=0.0022). Beyond 7h, MTX penetration across skin became substantial and increased 
up to 223-fold compared to intact skin (p=0.0022). Maximum penetration was 8% of applied MTX 
dose. Fluorescence microscopy illustrated a rapid lateral distribution of MTX across the thermal 
CZ. MTX fluorescence in the surrounding tissue increased continuously and reached saturation 
at 7h of application. DESI-MSI visualized and confirmed lateral distribution of MTX in an entire 
skin section of AFXL-processed skin 24h after application. In conclusions, topically applied MTX 
is rapidly delivered and mainly restricted to AFXL-processed skin in the first 7h of application, 
which raises a clinical perspective for new topical treatments of non-melanoma skin cancers and 
inflammatory skin diseases.    
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Unrelated cutaneous expressions of interleukin-6 and neutrophil elastase are also unlinked to 
IgA antibodies to gliadin nonapeptides, epidermal and tissue transglutaminases in dermatitis 
herpetiformis
J Gornowicz-Porowska,1 M Bowszyc-Dmochowska,1 A Seraszek-Jaros,2 E Kaczmarek,2 
P Pietkiewicz1 and M Dmochowski1 1 Dermatology, Poznan University of Medical Sciences, 
Poznan, Poland and 2 Bioinformatics and Computational Biology, Poznan University of 
Medical Sciences, Poznan, Poland
We identified middle-aged, itchy rash-having women with concurrent dermatitis herpetiformis (DH) 
diagnosed with direct immunofluorescence and nickel hypersensitivity as suggested by epicutaneous 
patch testing. Interleukin-6 (IL-6), the pleiotropic cytokine, might be a factor linking pathogeneses 
of those illnesses. Thus, an issue-probing study was done to assess the role of IL-6 in DH lesions, 
a disease characterized by neutrophil elastase (NE)-releasing neutrophils as well as IgA antibodies 
to gliadin nonapeptides (IgA/npG), tissue and epidermal transglutaminases (IgA/tTG, IgA/eTG), 
by examining the relationships between IL-6/NE cutaneous expression and levels of serum IgA/
npG, IgA/tTG, IgA/eTG in DH. In total, 24 DH patients were studied. Immunohistochemistry on 
paraffin-embedded sections with quantitative digital morphometry was used to measure the IL-6/NE 
intensity expressions. IgA/npG, IgA/tTG and IgA/eTG levels were evaluated with ELISA. We found 
no significant correlation between the NE and IL-6 expression intensities. We revealed a lack of 
correlations between NE/IL-6 expressions and IgA/npG, IgA/tTG, IgA/eTG levels. The IL-6 expression 
was significantly lower than that of NE (p=0.0006, Wilcoxon test; p=0.0001, Mann-Whitney test). 
Hence, the lack of correlations suggests no substantial interplays between IL-6, NE, IgA/npG, IgA/
tTG or IgA/eTG in DH. The intense NE expression does indicate this protease as the major mediator 
of dermal-epidermal junction remodeling in DH, whereas weak IL-6 expression might reflect faulty 
IL-6 signaling in the acute DH. Seemingly, releasing of NE at sites of inflammation in active human 
DH may not be primarily associated with IL-6 action.    
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Visualization of autoantibodies and neutrophils in vivo identifies novel checkpoints in auto-
antibody-induced tissue injury 
H Iwata*,1 M Pieper*,2 JE Kloepper,1 D Zillikens,1 P König*2 and R Ludwig*1 1 Department 
of Dermatology, University of Luebeck, Luebeck, Germany and 2 Institute of Anatomy, 
University of Luebeck, Luebeck, Germany
Many autoimmune diseases are characterized by the presence of autoantibodies. In some of these 
diseases, e.g. autoimmune bullous dermatoses (AIBD), autoantibodies directly cause clinical disease 
manifestation. Key requirements for antibody-mediated tissue injury have been identified. However, 
their interactions, especially their temporal and spatial interactions, have remained unsolved. As the 
skin is easily accessible for imaging techniques, we selected epidermolysis bullosa acquisita (EBA), 
an AIBD with autoantibodies to type VII collagen (COL7), to visualize interactions of autoantibodies, 
target tissue and effector cells (neutrophils) in vivo. When injected into mice, fluorescently labeled, 
fully pathogenic, anti-COL7 IgG bound to the dermal-epidermal junction (DEJ) within minutes, as 
determined by two-photon microscopy. Unexpectedly, we observed an inhomogeneous, patchy 
distribution of autoantibodies along the DEJ. We hence hypothesized that certain external triggers 
might affect autoantibody distribution. Indeed, mechanical irritation, without causing histological 
alterations, led to increased autoantibody binding. Next, fluorescently labeled anti-COL7 IgGs 
were injected into LysM-EGFP mice (EGFP gene was knocked into the lysozyme M locus resulting 
in fluorescence-positive neutrophils) and followed up by two-photon microscopy. We observed a 
rapid extravasation of LysM-EGFP+ cells into the skin. Intriguingly, these cells did not immediately 
co-localize with tissue-bound autoantibodies, but this co-localization occurred 24 hours after the 
initial autoantibody injection. Overall, this defines checkpoints for autoantibody-induced tissue 
injury exemplified in EBA: (i) Immediate autoantibody binding to the target tissue influenced by 
mechanical trigger factors, (ii) rapid neutrophil recruitment into the vicinity of autoantibody deposits 
and (iii) delayed co-localization of neutrophils with these deposits and subsequent autoantibody-in-
duced tissue damage.    
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Vitamin D3 differentially induces TSLP in mouse and human skin
B Giovannone,1 J Landheer,1 S Sadekova,3 C Hofstra,4 C Bruijnzeel-Koomen,1 C Chang,3 
Y Ying,3 R De Wall Malefyt,3 E Knol2 and D Hijnen1 1 Dermatology and Allergology, UMC 
Utrecht, Utrecht, Netherlands, 2 Immunology, UMC Utrecht, Utrecht, Netherlands, 3 Merck 
Research, Palo Alto, CA and 4 Merck Sharpe and Dohme, Oss, Netherlands
Thymic stromal lymphopoietin (TSLP) plays an important role in allergic diseases and is highly 
expressed in keratinocytes in human lesional atopic dermatitis (AD) skin. In nonlesional AD skin 
TSLP expression can be induced by applying house dust mite allergen onto the skin in the atopy 
patch test. Several studies have demonstrated that the induction of TSLP expression in mouse skin 
does not only lead to AD-like inflammation of the skin, but also predisposes to severe inflammation 
of the airways. In mice, TSLP expression can be induced by application of the 1,25-dihydroxyvitamin 
D3 (VD3) analogue calcipotriol and results in the development of eczema-like lesions. The aim 
of this study was to investigate the effect of VD3 (calcitriol) or calcipotriol on TSLP expression in 
human skin and compare it to (non-)human primate skin and mouse skin. In contrast to mouse, 
no induction of TSLP expression (mRNA or protein) was observed in human keratinocytes, normal 
human skin, nonlesional AD skin or cynomolgus monkey skin samples after stimulation with cal-
cipotriol or topical application of calcitriol. The biological activity of calci(po)triol in human skin 
samples was demonstrated by the increased expression of the VD3-responsive Cyp24 gene. TSLP 
expression was induced by pro-inflammatory cytokines (IL-4, IL-13 and TNFα) in all three species. 
In silico analysis revealed that the architecture of vitamin D response elements in the TSLP promoter 
was more conserved among (N)HP than mouse. In conclusion, VD3 failed to induce expression of 
TSLP in human or monkey skin in contrast to mouse.    
   
